
















Submitted in partial fulfillment of the 
requirements for the degree 
of Doctor of Philosophy 
under the Executive Committee 






































Electronic Health Record Summarization over Heterogeneous and Irregularly Sampled Clinical Data 
Rimma Pivovarov 
 
The increasing adoption of electronic health records (EHRs) has led to an unprecedented amount of 
patient health information stored in an electronic format.  The ability to comb through this information is 
imperative, both for patient care and computational modeling. Creating a system to minimize unnecessary 
EHR data, automatically distill longitudinal patient information, and highlight salient parts of a patient’s 
record is currently an unmet need.  However, summarization of EHR data is not a trivial task, as there 
exist many challenges with reasoning over this data. EHR data elements are most often obtained at 
irregular intervals as patients are more likely to receive medical care when they are ill, than when they are 
healthy. The presence of narrative documentation adds another layer of complexity as the notes are 
riddled with over-sampled text, often caused by the frequent copy-and-pasting during the documentation 
process.  
This dissertation synthesizes a set of challenges for automated EHR summarization identified in the 
literature and presents an array of methods for dealing with some of these challenges.  We used hybrid 
data-driven and knowledge-based approaches to examine abundant redundancy in clinical narrative text, a 
data-driven approach to identify and mitigate biases in laboratory testing patterns with implications for 
using clinical data for research, and a probabilistic modeling approach to automatically summarize patient 
records and learn computational models of disease with heterogeneous data types.  The dissertation also 
demonstrates two applications of the developed methods to important clinical questions: the questions of 
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Chapter 1: Introduction  
1.1 The Need for Summarization of EHR Data 
The increased adoption of electronic health records (EHRs) has led to an unprecedented amount of 
patient health information stored in electronic format.  Within the past decade, the number of healthcare 
practices that have some electronic capability to store patient data has grown to almost 80% and now 
hundreds of millions of patients across the United States have extensive medical histories in electronic 
form.  As health information exchanges promise patient record integration across multiple care settings, 
the amount of available patient data will continue to explode (Adler-Milstein, Bates, and Jha 2011). In 
these health records, clinicians routinely document the care of their patients. Throughout the years, patient 
records accumulate medical history as a myriad of individual observations: results of laboratory tests and 
diagnostic procedures; interventions; medications; and detailed narratives about disease course, treatment 
options, and family and social history.  
There is great potential for research in leveraging these large amounts of clinical data to learn about 
human health. The informatics community is posed to develop methods to mine the available information 
and ask questions such as: how can we further clinical knowledge, how can we assist clinicians in 




how can we automatically condense records to provide succinct summaries of a patient’s medical history?  
With this eruption of rich, complex, and essential health data for millions of patients, the informatics 
community has a new opportunity to tackle the challenges entailed in interpreting a wealth of health 
information.  
However, this same availability of large records has raised concerns of information overload for the 
healthcare practioner (Farri 2012), with potential negative consequences on clinical work, such as errors 
of omission (McDonald 1976), delays (McDonald et al. 2014), and overall patient safety (Holden 2011). 
When caring for an individual patient, clinicians reason in the context of the patient’s medical history. 
This is a cognitively difficult task. First, the search space for potential diseases that may account for the 
patients’ symptoms is very large. Second, the individual clinical observations that form the patient’s 
record are many, thus potentially overwhelming in aggregate, and at the same time each of them is 
potentially imperfect and uncertain.   
Current EHR systems often do not present this tremendous amount of patient data in a way that 
supports clinical workflow or cognitive reasoning (Stead and Lin 2009). It is therefore imperative for 
patient care to automatically comb through the raw data points present in the records and detect timely 
and relevant information.  Even more alarmingly, as the most chronically ill patients often have the 
largest datasets, their records are the most difficult to present coherently (Christensen and Grimsmo 
2008). As an example, for a prevalent chronic condition in our institution, patients with chronic kidney 
disease have 338 notes on average in their record (from all clinical settings) gathered across an average of 
14 years, with several patients’ records containing over 4,000 notes. It is clear that during a regular 
medical visit, no practitioner can read hundreds of clinical notes.  Fortunately, electronic storage of this 
health information provides an opportunity for EHR systems to “aid cognition through aggregation, 
trending, contextual relevance, minimizing superfluous data” (Schiff and Bates 2010). Currently available 
commercial EHR systems, however, inadequately address this need, sometimes providing organization of 
data but lacking in information synthesis (Laxmisan et al. 2012). Some vendor EHR dashboards display 




2008; Rosenbloom and Shultz 2012). 
The focus of this thesis is to develop algorithms for automatically summarizing EHR data by 
creating methods to identify and address inherent challenges in the EHR data. 
1.2 EHR Datasets 
To develop robust methods for reasoning and learning over clinical datasets derived from EHRs, we 
must be cognizant of challenges that derive from the uniqueness of medical data. Here we list a set of 
issues confronted when developing methods for these clinical datasets:   
Uncertainty: medicine inherently deals with uncertainty about both diagnoses and individual 
observations about patients.  Clinicians observe patient symptoms and patient histories with different 
levels of certainty, and diagnoses themselves are probabilistic in nature.  
Data Heterogeneity: clinical records are composed of different structured and unstructured data types, 
each with complementary information.  Often, medications are listed as pharmacy orders and discussed in 
the clinical notes as well, and laboratory tests are reported in structured form and additionally recorded in 
clinical notes.  To make matters more difficult, it is not uncommon for different data types to disagree; 
medication lists in clinical notes are often out of sync with structured medication lists from pharmacy 
orders.  
Temporality: diseases evolve over different time scales.  Some diseases are chronic in nature and 
their progression is documented in the record across many years, whereas other ailments are acute and 
appear in short spurts in the patient records.  
Data sparsity: records are riddled with missing observations, and there is very often no regularity in 
the rate at which patients are observed.  Many clinical observations are missing not at random (e.g., 
patients are observed more frequently when they are ill and come to see their physicians for treatment).  
Healthcare features: in addition to the raw observations from clinical records (words in clinical 
notes, medications prescribed, etc.), features representative of the process of healthcare (rate of visitation, 




Inaccuracy: as clinicians themselves populate EHR information during the process of patient care, 
many mistakes are entered into the system: typos, selections from dropdowns, copy and paste errors that 
propagate old information, etc. This characteristic of EHR data differs greatly from clinical trial data, 
where there is a lot of manual effort involved in ensuring accuracy and validity of observations.  
We specifically develop algorithms to take these challenges into account.  For the experiments 
reported in this thesis, we use two different EHR datasets: the MIMIC II ICU dataset and the clinical data 
warehouse at NewYork Presbyterian Hospital (NYPH).  All of the studies presented in this thesis are 
completed on varying subsets of these data, depending on the purpose of the study. Here we broadly 
describe both datasets and within each study detailed later, we specify the preprocessed subset used. 
1.2.1 MIMIC II ICU Dataset 
The MIMIC II Clinical Database (v2.26) (Saeed et al. 2011) is available at 
http://physionet.org/mimic2_clinical_overview.shtml. MIMIC II contains a de-identified set of over 
23,000 adults from the Beth Israel Deaconess Medical Center’s Intensive Care Units, including medical, 
surgical, and coronary care units. The dataset contains structured record data, and unstructured clinical 
note data. Patients have a broad set of existing conditions and reasons for being in the ICU. As this 
dataset is available to researchers who sign a data usage agreement, any work on this dataset can serve as 
a benchmark for future automated phenotyping algorithms.  
1.2.2 NYPH Dataset 
This dataset is derived from data collected at NewYork-Presbyterian Hospital (NYPH), a not-for-profit 
hospital in New York City. The clinical data warehouse at NYPH contains patient data for over 4 million 
patients from as early as 1985 to present day.  The information in these records include pertinent 
information for medical care such as demographics, visits, medications ordered, laboratory tests 
performed, diagnoses that are billed for, problem lists, and clinical notes written by healthcare 
practitioners.  For all of the experiments reported in this thesis, only adult (18 years old and older) patient 




admissions, to emergency department visits. Like the MIMIC patients, the NYPH patients have a broad 
set of conditions, but unlike them their records span years instead of days, and the documented conditions 
differ as well.  
1.3 Thesis Approach 
The dissertation describes mixed-methods approaches to dealing with some of the underlying issues 
in the summarization of both narrative and structured EHR data. Our goal was to use knowledge- and 
data-driven approaches to comb through clinical data and devise novel methods for dealing with 
redundancy, missing data, and automatic determination of saliency. Clinical records store patient 
information across a diverse set of data types. The work presented in this thesis examines a broad array of 
challenges in summarizing and making sense of clinical record data across many clinical data 
categories.  The thesis explores the challenge of redundancy through the lens of clinical notes, examining 
how a patient’s health history can influence which clinical concepts are redundant and which are not.  The 
challenge of irregular sampling is explored through the lens of laboratory tests, examining whether the 
sampling rate of each laboratory test can provide important clinical insight.  Finally, the thesis presents a 
method for combining diverse clinical data types to address the challenge of saliency, examining whether 
modeling laboratory tests, medications, clinical text, and diagnosis codes together can provide a clinically 
relevant summary of a patient’s health states. 
Aim 1 describes an approach for minimizing redundancy in the narrative part of a patient record; 
Aim 2 defines a method for identifying and mitigating the biases that exist in laboratory test 
measurements; and Aim 3 designs a summarizer that uses heterogeneous data to identify salient pieces of 
a patient’s record. 
Aim I: Develop a methodology to contextually reduce narrative redundancy in a patient’s 
medical record by aggregating over-sampled concepts. 
Aim II: Create a method for exploiting a patient’s non-random patterns of missing laboratory test 




Aim III: Design a summarizer synthesizing heterogeneous data: clinical notes, laboratory tests, 
medications, and billing codes. 
1.3.1 Aim I: Contextual Redundancy Removal in Clinical Notes 
Objective: Develop a methodology to reduce over-sampling of concepts within patient records by 
identifying and aggregating similar concepts in clinical notes based upon the context of a patient’s 
medical history. 
Research Questions: 
1. Are there instances when clinical concepts should be aggregated? 
2. Can a patient’s medical history alter which clinical concepts should be aggregated? 
3. Does adding ontological knowledge to data-driven patient knowledge increase the accuracy of 
identifying concepts that should be aggregated? 
Methods and Materials: 
Aim 1 relies on a hybrid approach of data-driven and knowledge-driven complementary methods in 
order to identify contextually redundant concepts within a patient’s longitudinal health record. The data-
driven method of distributional semantics is able to capture the context surrounding each instance of a 
concept and has been successful in many settings including information retrieval (Manning and Schütze 
2003), while ontological techniques are used to refine the results from the data.  The methodology for 
assessing redundant concepts consists of three complementary similarity measures (Figure 1.1).  One 
primary measure is data-based and relies on distributional semantics of patient notes authored by 
clinicians, while the other two are knowledge-based and rely on concept definitions and their 
relationships in the Systemized Nomenclature of Medicine – Clinical Terms (SNOMED-CT) 
terminology. Starting from a homogenous corpus of notes (i.e., notes about patients who share at least one 
clinical problem), notes are pre-processed to extract concepts mentioned in the corpus. The noted-based 
similarity measure ranks all pairs of concepts. The top-k pairs with the highest note-based similarity are 






Figure 1.1 Our methodology for finding context-dependent similar concepts.   
We choose to collect a homogenous and semantically coherent corpus of clinical notes; in order to 
ensure that concepts, which are clinically relevant to the patients, are likely to appear frequently enough 
and as the patient set is homogeneous we are able to find concepts that are similar specifically for the 
context of this particular disease. For this study, we collect a corpus of notes from patients with chronic 
kidney disease (CKD). The methods we employ are disease independent, but the fact that we select notes 
from patients all with at least one condition in common allows us to identify and aggregate concepts 
frequently mentioned when documenting a particular set of patients. Furthermore, CKD is a prevalent 
condition in our institution, thus allowing us to collect a large corpus of notes. Patients with CKD have 
many comorbidities and disorders, providing us with many different concepts to consider in our similarity 
computation.  
Primary Findings: 
Our approach scores the similarity of two input concepts by combining complementary information 
derived from usage patterns of clinical documentation, accepted definitions, and position of the concepts 
in an ontology.  Our experiments show that given a coherent corpus of clinical notes, it is possible to 
determine automatically which concepts convey similar meaning in the context of the corpus. We 
demonstrate that by combining information from usage patterns in clinical notes and from ontological 
structure, the method can prune out concepts that are simply related from those which are semantically 




to outperform the baseline methods and reached an AUC (area under the curve) of 92%. The results of the 
top 10 concept pairs identified by our method are demonstrated in Table 1.1.  
UMLS Concept  
Preferred Term 
UMLS Concept  
Preferred Term 
Similarity Score Similar according to 
Expert Consensus 
C1998242 

















Cardiac thrill (finding) 
0.958 N 
C0677659 



























Signs and Symptoms 
0.933 Y 





1.3.2 Aim II: Exploiting Patterns of Missingness for Clinical 
Modeling of Laboratory Tests 
Objective: Create a method for investigating and mitigating the effects of non-random sampling in 
laboratory tests on clinical modeling. 
Research Questions: 
1. Are there different missingness motifs across different laboratory tests? 
2. Do the missingness motifs provide separate information to the laboratory test’s numerical value? 
3. Can adding the missingness motif to a laboratory value threshold increase phenotyping 
accuracy? 
Methods and Materials: 
The studies performed in Aim 2 categorize the different missing data patterns of irregularly 
sampled laboratory tests and evaluate the effect of these different patterns on EHR studies. 
The first part of this study explores different patterns of irregularly sampled laboratory test data by 
considering the irregular sampling as a missing data problem. To understand the overall dynamics of 
laboratory tests recorded in the EHR, we categorize types of laboratory measurement motifs, identifying 
those more likely to cause biases in EHR-based research.  We examine laboratory measurement patterns 
by looking at the distribution of days between consecutive measurements of each laboratory test, across 
the entire population. We examine and catalogue these resulting measurement gap histograms.  If there is 
linearity in a measurement gap histogram when presented in log-log coordinates (i.e., a power-law) that 
implies scale-free measurement dynamics; in this situation all time scales are explainable by a single 
equation and likely represent a single context for ordering the laboratory test.  If no approximately linear 
relationship between the frequency of measurement gaps exists, we looked for changes (e.g., peaks) that 
separate the different dynamics patterns; these different patterns may qualitatively imply different 
contexts of measurement based on either a change in health state or based on the healthcare 




based on observed approximate linearity and the presence of peaks in the histograms.  
Missingness Motifs vs. Laboratory Test Values 
In research with clinical data, there is an implicit assumption that a laboratory test’s numerical 
value and the rate at which the test is ordered are highly correlated features. This assumption about value 
and measurement correlation likely stems from the existence of value-based guidelines and the 
widespread expectation that laboratory test values which fall outside of normal ranges prompt 
intervention and retesting.  To investigate and quantify this assumption we ask: is there added information 
in looking at how a patient was measured, not only at the measurement value?  Given a particular lab and 
all patients' time series for that lab, we construct a joint probability density function consisting of 
laboratory values and time between consecutive lab measurements (or gaps between measurement) in 
days. Using (i) linear correlation, (ii) mutual information, and (iii) differential entropy we explore the 
correlation of laboratory values to the laboratory test's time to repeat, examining whether the value and 
time between consecutive measurements (measurement gap) encode separate information or overlap in 
information content. 
The Effect of Patterns of Missingness on Phenotyping 
To demonstrate the utility of identifying and accounting for patterns of irregular sampling we 
conduct a typical EHR association test (Warner and Alterovitz 2012). In this task, we focus on a specific 
laboratory test as a use case for studying effect of measurement motifs on EHR-driven research. We 
examine lipase measurements and their impact on identifying acute pancreatitis. We asked the question: 
can the known association between an abnormal lipase value and acute pancreatitis be recovered from 
EHR data? To verify our hypothesis that patterns of missingness can impact the accuracy of identifying 
patients with acute pancreatitis, we considered three views of the data, based on the dynamics of lipase 
measurements within each patient’s record: (i) only visits with short lipase measurement gaps, (ii) only 
visits with long lipase measurement gaps, and (iii) all visits independent of their lipase measurement gap. 
In each of these settings, we assessed the association between acute pancreatitis and lipase and studied the 




acute pancreatitis is an acute disease, visits with short lipase measurement gaps will be more highly 
associated and relevant to acute pancreatitis. 
Primary Findings: 
We show that the context of a laboratory test measurement can often be captured by the way the 
test is measured through time. We perform three tasks to study the properties of these temporal 
measurement patterns. In the first task, we confirm that laboratory test measurement patterns provide 
additional information to the stand-alone numerical value. The second task identified three measurement 
pattern motifs across a set of 70 laboratory tests. Of these, two motifs exhibit properties that can lead to 
biased research results. In the third task, we demonstrate the potential for biased results on a specific 
example. We conduct an association study of lipase test values to acute pancreatitis. We observe a diluted 
signal when using only a lipase value threshold, whereas the full association is recovered when properly 
accounting for lipase measurements in different contexts (leveraging the lipase measurement patterns to 
separate the contexts) (Figure 1.2).  We find that aggregating EHR data without separating distinct 
laboratory test measurement patterns can intermix patients with different diseases, leading to the 
confounding of signals in large-scale EHR analyses. This study results in a general methodology for 





Figure 1.2 The results of a binomial association test between high lipase and ICD-9 codes. The 
binomial test was performed in all three settings (short gaps between measurements of 0–3 days, long 
gaps of more than 3 days, and all visits regardless of gaps between lipase measurements). The top 20 most 
significant associations are shown. For illustration purposes, the ICD-9 codes are sorted by association to 
high lipase in the 3 + days gap. 
 
1.3.3 Aim III: Probabilistic Modeling of Patient Health States  
Objective: Design a summarizer synthesizing heterogeneous data: clinical notes, laboratory test 
measurements, medications, and ICD-9 codes. 
Research Questions: 
1. Is there a benefit to modeling different EHR data elements separately? 





3. Does the incorporation of ontological knowledge create inferred topics that better explain the 
data? 
Methods and Materials: 
Building computational models of disease has been an active area of research, with approaches 
ranging from building ontologies and taxonomies of diseases based on clinical expertise, to creating 
highly precise model of specific diseases of interest through a mix of data-driven and clinical expertise, to 
discovering models directly from clinical observations. In this Aim, we create a model, the Phenome 
model, which works with the heterogeneous and irregularly sampled data types studied in Aims 1 and 2.   
The Phenome model is an unsupervised, generative model, which given a large set of EHR observations, 
learns probabilistic phenotypes. The model is a mixed membership probabilistic model of longitudinal 
patient records and phenotypes. Under this model, a patient record can be represented as a probabilistic 
mixture of phenotypes, and the phenotypes can be defined as a mixture of characteristics derived from a 
large, diverse population. Phenotype is defined here as a set of observations all related to a particular 
condition. The observations types used in this model are: medications, laboratory test instances, billing 
codes, and words from the narrative clinical documentation. The Phenome model is based on Latent 
Dirichlet Allocation (LDA) (Blei, Ng, and Jordan 2003; Griffiths and Steyvers 2004). The model enables 
the heterogeneous data elements encoded in a patient’s record to be grouped through one phenotype 
definition and distributed across a predetermined number of P phenotypes. The phenotypes are learned 
jointly over heterogeneous EHR observations drawn from a large set of potential medications, diagnosis 
codes, laboratory tests, and free-text clinical notes. When applied to specific patient records, the Phenome 
model can provide actionable representation of the records, by describing them as a distribution over the 
patient’s inferred phenotypes.  
The goal of the Phenome model is to probabilistically identify sets of related heterogeneous 
clinical concepts that comprise phenotypes. Our goal is to learn phenotypes that are interpretable so that 
the model can be most useful in a clinical setting. To achieve this goal, we experiment with specifying 




associated with concepts of clinical significance. We use a set of knowledge-bases to inject this clinical 
knowledge into the model. 
We perform a set of different evaluations for this research.  Automated evaluations include log-
likelihood on a held-out set and automated topic coherence measures (Lau, Newman, and Baldwin 2014). 
A clinical expert performed evaluations about the coherence and granularity of learned phenotypes and 
did pairwise assessment of phenotypes learned by the Phenome model and the baseline methods.  In 
addition, to examine how well the automated evaluations correlate with clinical expert judgment, we 
report on their correlation with the clinician. To evaluate the inferred phenotypes for patients given their 
EHR, we quantified the association between learned phenotypes and manually annotated disorders 
extracted from patient records. To evaluate the a priori grounding of phenotypes using clinical knowledge 
bases, we compared coherence and granularity scores between ungrounded and grounded phenotypes. 
Primary Findings: 
We demonstrate that the Phenome model can learn from different care settings and documentations 
of different healthcare institutions, without any adaptation needed. Our experiments show that the 
Phenome model yields phenotypes that (i) combine all these data types in a coherent fashion better than 
baseline models; (ii) are representative of single diseases, while baseline models tended to produce 
representations of either mixes of disease or high-level healthcare process; and (iii) when applied to 
unseen patient records, are highly correlated with the patients’ ground-truth disorders.  We also 
demonstrate that incorporating encoded clinical knowledge into the model leads to more coherent and 
cohesive phenotypes. Figure 1.3 presents an example of a phenotype that was learned after grounding the 
Phenome model.  We demonstrate that large-scale probabilistic phenotyping is a promising approach to 





Figure 1.3 An example of a grounded phenotype learned by the Grounded Phenome model. 
1.4 Contributions 
The contributions of this dissertation are two-fold.  The dissertation provides a literature review 
on work on clinical summarization as a whole and identifies important gaps that remain unsolved. The 
methodological contributions of this work include three novel methods for addressing some of the 
challenges in summarizing EHR data, namely: redundancy, irregular sampling, heterogeneity, and 
salience determination.   
This dissertation also presents different ways in which raw data and ontological knowledge can be 
married, providing evidence for the benefit of combining these two data sources.  The work presented 
here provides a platform for future work in applying latent variable models to EHR data as the models 
presented here are extendable in many different ways.  Finally, the dissertation also presents two studies 
that demonstrate the applicability of the created methods for answering clinical questions. 
1.5 Guide for the Reader 
Chapter 2 is an in-depth review of the literature on EHR summarization. I identified published EHR 
summarization systems along with their inputs, outputs, method of summarization, methods of evaluation, 
and notable information.  In addition, I highlight some of the remaining challenges in creating next 
generation EHR summarization systems. 
Chapter 3 describes an approach that uses both knowledge-bases and clinical note structure to 
identify similar concepts in clinical text, as a way of finding which concepts can be aggregated for which 
groups of patients in an effort to reduce signal dilution and redundancy in studies with EHR data. 
Chapter 4 reports on a study of the biases in laboratory test measurement and how these biases in 




Chapter 5 presents a probabilistic graphical model for summarizing patient data across 
heterogeneous data types along with an evaluation that demonstrates the utility of modeling different data 
types separately but jointly. 
Chapter 6 details two separate experiments that showcase the applicability of the methods outlined 
in this thesis to clinical questions.  One experiment applies laboratory test measurement pattern analysis 
to identify hemoglobin A1c testing trends over time, and the other uses the probabilistic graphical model 
to identify cohorts of diabetic patients. 
Chapter 7 summarizes the contributions of the research described in this dissertation, as well as 
what I see as the next steps in EHR automated summarization.
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Chapter 2: Background1 
 
2.1 Approaches to EHR summarization 
Given the unmet and well-recognized need for comprehensive EHR summarization (Powsner and 
Tufte 1994; Payne 2000), many research groups have designed and evaluated clinical data summarizers. 
In this chapter, we sample summarization applications to highlight different features including seminal 
work, different evaluation strategies, and various input/output data.  We also examine the current work 
and future directions for six challenges of EHR summarization: information redundancy, temporality, 
missing data, salience detection, rules and heuristics, and deployment of summarization tools. 
There are multiple theoretical frameworks for summarization in the clinical domain (Feblowitz et 
al. 2011) as well as for textual summarization in the general domain (Alterman 1991; Radev, Hovy, and 
McKeown 2002). In the broader field of summarization, there has been a lot of work in automated text 
                                                      
1 A large part of this chapter was originally published in JAMIA. The full citation for this publication is:  
Pivovarov R, Elhadad N. Automated Methods for the Summarization of Electronic Health Records. JAMIA 2015.  
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summarization, specifically within the genres of news stories and scientific articles (see (Nenkova and 
McKeown 2012) for an in-depth review). Clinical summarization, “the act of collecting, distilling, and 
synthesizing patient information for the purpose of facilitating any of a wide range of clinical tasks” 
(Feblowitz et al. 2011), presents a different set of challenges from summarization in other domains and 
genres of texts.  
While there exist other discussions on biomedical literature summarization methods (Afantenos 
2006; Mishra et al. 2014) and EHR visualizations (Roque, Slaughter, and Tkatsenko 2010; Rind et al. 
2010; West, Borland, and Hammond 2014), in this review we focus on characterizing existing clinical 
summarization systems by outlining the system outputs and evaluations as well as highlighting the 
remaining challenges that exist in automated summarization.   
To categorize the summarizers highlighted in this review, we focus on two common dimensions 
used in the text summarization literature: extractive/abstractive summarization, and indicative/informative 
summarization.  We define the four categories that describe summary types. 
(1) Extractive summaries are created by borrowing phrases or sentences from the original 
input text. In the domain of clinical summarization, an extractive approach can identify pieces of the 
patient’s record and display them without providing additional layers of abstraction.   
(2) Abstractive summaries generate new text that synthesizes the original text. In the domain 
of clinical summarization, abstractive summaries may provide additional higher-level context to explain 
the data, such as computed quantities (e.g., trends) or automatically generated text.  
Extractive and Abstractive summaries are further categorized as either indicative or informative. 
(3)  Indicative summaries point to important pieces of the original text, highlighting 
significant parts for the reader. In the domain of clinical summarization, indicative summaries may 
convey, for instance, when key tests were performed or diagnoses were made. Indicative summaries are 
meant to be used in conjunction with the full patient record.  
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(4) Informative summaries replace the original text.  In the domain of clinical summarization, 
informative summaries are designed to be used independently of the full patient record, meaning they are 
used as a replacement for the original full set of raw data. 
How to evaluate a summarizer, both its accuracy and its added value in supporting users carry out 
information-related tasks has also been the subject of investigation in general domain and clinical 
summarization. Intrinsic evaluations focus on the internal validity of a summarization tool. Typically, 
experts evaluate the quality of the automatically produced summaries; or themselves create gold-standard 
summaries, against which automatic ones are compared.  In an extrinsic evaluation framework, the 
usefulness of the summarization tool is assessed through its effectiveness in helping individuals carry out 
a task. For instance, a clinical summary could be evaluated in an extrinsic fashion by comparing how 
quickly and accurately trial coordinators can identify patients eligible for a trial with access to patients’ 
full records or with access to a summary instead.  
Almost since the inception of EHRs, there has been an interest in creating meaningful succinct 
summaries for clinicians.  The research on automated summary creation has spanned over 30 years and 
initiated with extracting recent structured events in a patient’s history (Rogers and Haring 1979) evolving 
into performing natural language processing (NLP) (Liu and Friedman 2004) and automatically linking 
different data types (Cao et al. 2005; Klann et al. 2013) to create a more holistic view of the patient 
record. Table 1 lists clinical summarization systems proposed in the research literature in chronological 
order.  We describe each system according to the following axes: the summarization approaches it 
implements, the type of input data it handles, the type of output summary, the way in which it was 
evaluated, and whether it was deployed in a clinical environment. Overall, summarization approaches 
investigated in clinical summarization have primarily been for indicative and extractive summarization. 
We also note a lack of evaluation, especially in the most recent years. We discuss in further detail the 
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pieces of the EHR 
including images 
and free text. 
A pilot study on Timeline 
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initial learning curve was 
high, with time, the 
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perform image review 
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confident in their clinical 
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visualization of a 
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A task-based, time 
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difference in ability to 
extract, compare, synthesize 
and recall clinical 
information when using 
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Aggregates information from 
multiple care settings. 
Operates on top of a 
commercial EHR system 
using HL7 messages. 
Distributed computing 
infrastructure to enable real-
time summarization. 
Table 2.1 A sampling of clinical summarization applications.  The table is organized by publication date. The inputs, outputs, methods, and evaluation strategies are listed along 
with notable additional information for each summarizer.
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2.2 Methodological challenges to EHR summarization 
The following sections present some unsolved challenges in clinical summarization.  A conceptual 
framework proposed by Feblowitz et al. (Feblowitz et al. 2011) defines a set of actions that successful 
summarizers should accomplish with raw information: Aggregate, Organize, Reduce/Transform, 
Interpret, Synthesize.  We discuss methodological challenges with automated summarization within the 
context of this framework. 
Specifically,  
- To successfully aggregate disparate clinical data sources, the ability to recognize and account for 
similarity is imperative.  Such similarity occurs at different levels within narratives: from word-level 
similarity to concept to statement-level; as well as in other data types and across. We focus our discussion 
on textual similarity. 
- The organization and interpretation of the aggregated data requires extraction and reasoning over 
clinical events and their temporality. We examine extraction of temporal information from text along 
with representation and reasoning over clinical events. 
- The organization and interpretation of the aggregated data also requires that missing data points 
be accounted for.  Patients are sometimes seen with predictable regularity but are most often seen at 
erratic intervals. Missing data points are often filled in by imputation, adding missing data indicators, 
deleting information with missing data, or other strategies.   
- In the reduction and transformation of data and its synthesis, it is critical to decide which pieces 
of information are important and must be contained in the summary.  Some methods for automatically 
detecting importance have relied on linguistic structure while others use probabilistic modeling 
techniques. 
- To provide context for interpretation and synthesis of clinical data, it is useful to employ existing 
knowledge and create rules for the summarization.  Knowledge-based heuristics often provide a way to 
specify time constraints, concept relationships, and abstractions. 
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- Finally, to successfully implement summarizers into clinical care, challenges of deployment need 
to be addressed. Because in vendor EHR systems there are limited opportunities to deploy innovative and 
experimental technology, there have been few attempts to translate patient record summarization systems 
into the clinic; however, to demonstrate utility, it is imperative to implement and study clinical 
summarization tools in the real world care setting. 
2.2.1 Identifying and aggregating similar information 
We review approaches to identifying and aggregating similar information on three different levels 
of language abstraction: words, concepts, and statements, as investigated within and outside the field of 
clinical summarization. 
Word-level Similarity 
In clinical NLP, much work has been devoted to identifying lexical variants that are similar in 
meaning (Friedman and Elhadad 2014). The Unified Medical Language System (UMLS), an 
agglomeration of different biomedical terminologies (Lindberg, Humphreys, and McCray 1993), for 
example, provides essential knowledge towards that goal by grouping words into concepts. The UMLS 
aggregates terms from different vocabularies and maps them to semantic concepts, each labeled with a 
Concept Unique Identifier (CUI). For instance, the terms MI, myocardial infarction, and heart attack all 
share lexical similarity, and map to the same underlying CUI. Within clinical summarization, 
normalization of words to concepts has only recently been investigated (Hirsch et al. 2014; Zhang et al. 
2011). 
An alternative, and most common approach in clinical summarization, is to identify word-level 
similarity by finding redundant strings of words. Patient records often contain redundant spans of text – 
this can be explained by the fact that documentation is often formulaic but also by the common habit of 
clinicians to copy and paste text from one note to another (Hirschtick 2006). Multiple different automated 
methods have been employed to identify copy and pasted words within clinical notes. A plagiarism 
detection tool called CopyFind has been used to identify overlapping phrases in input texts (Thornton et 
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al. 2013). More recently, global (Wrenn et al. 2010) and local (Zhang et al. 2011; Cohen, Elhadad, and 
Elhadad 2013) bioinformatics-inspired alignments have been proposed for identifying redundant sections 
along with language modeling techniques for assigning probabilistic similarity scores for phrase pairs 
(Zhang et al. 2011). 
Concept-level Similarity 
Concept-level similarity represents a more abstract level of similarity than similarity between words 
and strings. For instance, the concepts “epilepsy” and “seizure” – despite being two different UMLS 
concepts – share much semantic similarity when conveyed in a patient record.  
In certain well-defined domains, clinical summarization approaches have relied on aggregating 
concepts, helping further the goal of synthesis (Shahar et al. 2006; Hsu et al. 2012) primarily through 
well-defined ontologies. For broader domains, how to identify that two semantic concepts are similar 
enough to be aggregated remains an open question.  Furthermore, in text processing, mapping from words 
to concepts remains difficult because of the strong ambiguity of language (Friedman and Elhadad 2014). 
Detection of semantic redundancy has been investigated through two approaches: knowledge-free 
and knowledge-based. Knowledge-free similarity metrics have been developed for textual input. They 
rely on Harris’ 1968 hypothesis which stipulates that concepts that appear in similar contexts are similar 
(Harris 1968). In practice, concepts are compared in a vector space, where each concept is a vector 
representing the context in which the concept typically occurs. This method has been implemented 
multiple times in the clinical domain to identify similar UMLS concepts (Pedersen et al. 2007; 
Patwardhan and Pedersen 2006; Pivovarov and Elhadad 2012). Knowledge-free approaches are attractive 
when there is little ontological knowledge available. Alternatively, knowledge-based methods leverage 
existing resources to determine the similarity of two concepts. For instance, if the two concepts are 
present in an ontology, similarity can be assessed through the structure of the ontology. Other knowledge-
based methods include examining similarity of the two concepts’ definitions. We refer the reader to 
detailed reviews of concept-based similarity (Pedersen et al. 2007; Pesquita et al. 2009). We discuss our 
hybrid methodology for finding similar concepts using knowledge-free, knowledge-based, and 
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ontological definitions in Chapter 3.  However, despite the active research on this topic, these concept-
level similarity methods have not been yet translated to most clinical summarization systems. 
Statement-Level Similarity  
A pervasive aspect of a patient record is the high level of statement redundancy across notes. For 
instance, two pathology reports for a given patient share many similar statements. Beyond the formulaic 
nature of documentation, statement-level redundancy also occurs because of copying and pasting from 
previous notes with some minimal editing of the copied statements.   
In clinical summarization, there has been little work on this important aspect of similarity 
identification. Recently, a topic modeling approach was proposed to identify and control for such 
redundancy across patient notes (Cohen et al. 2014). In the general NLP community, identifying 
statement level similarity has been studied through the tasks of paraphrasing identification and textual 
entailment (Androutsopoulos 2010). Many of the methods in text summarization for identifying both 
unidirectional (textual entailment) and bidirectional (paraphrasing) similarity employ a hybrid of methods 
for word-level and concept-level redundancy such as string similarity, logic-based methods, and context-
vector (Dagan et al. 2010). 
Along with the need for higher order language similarity work in the clinical domain, there is an 
ongoing push to personalize similarity detection.  It is well established that semantic similarity is context-
dependent (Janowicz 2008) and a recent study suggests that redundancy be examined as a function of the 
patient’s previous history (Farri 2012). While identification of similar contexts based on the patient’s 
health is an ongoing direction of research (see Chapter 3), there is further work to be done in identifying 
context-specific similarity on higher-order semantic levels.  Identifying similar words, concepts, and 
removing redundancy by patient-tailored information aggregation is an important direction for future 
EHR summarization methodology. 
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2.2.2 Organizing and reasoning over temporal events 
Patients’ health evolves on many different time scales. Some health events such as pneumonia 
present themselves sporadically while chronic conditions like diabetes develop and worsen over a period 
of years. The importance of presenting clinical data in a time-dependent fashion has been recognized for a 
long time (Fries 1974; Cousins and Kahn 1991; Samal et al. 2011) however accurate temporal 
representation remains an open problem (Zhou and Hripcsak 2007; Sun, Rumshisky, and Uzuner 2013; 
Wu et al. 2014). Automatic creation of a clinical data timeline from textual and structured clinical records 
requires temporal event extraction, ordering, and reasoning. 
Temporality is an active research area in the genre of news summarization given the quick news 
cycle and fast-paced evolution of news stories (Allan, Gupta, and Khandelwal 2001).  However, news 
summarization research cannot always be readily translated into the health domain, as the challenges in 
health data are unique (Combi and Shahar 1997; Cios and Moore 2002). For example, different note types 
and specialties have different temporal relationships: pathology reports are often about one moment in 
time without reference to historical ailments whereas discharge summaries describe an entire inpatient 
hospital stay and instructions for future care.  Styler et al. identified four complexities with extracting 
temporal information in clinical data: (i) diversity of time expressions, (ii) complexity of determining 
temporal relations among events, (iii) the difficulty of handling the temporal granularity of an event and 
(iv) general NLP issues (Styler, Bethard, and Finan 2014). 
After the extraction of event time, there is a need for performing relative temporal ordering 
(Savova, Bethard, and Styler 2009). Event ordering is difficult in part due to inexact wording, but also 
because clinical knowledge is often needed to infer how long conditions may last (e.g., a diabetes 
diagnosis is often not discussed at every visit but a clinician is aware that diabetes is a chronic condition, 
not an intermittently reoccurring condition each time the “diabetes” term is mentioned or the diabetes 
ICD-9 code is recorded) (Hripcsak et al. 2009). Some recent work in event ordering includes the 
representation of temporal disease progression separately for each problem by Sonnenberg et al., an 
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approach they call “clinical threading” (Sonnenberg et al. 2012) and frame-like semantic representations 
with rule-based temporal extraction to arrange problems on a timeline (Jung et al. 2011). Raghavan et al. 
identify and temporally order cross-narrative medical events across documents in clinical text using 
weighted finite state transducers (Raghavan et al. 2014). 
Reasoning and abstraction of extracted clinical events to highlight disease progressions and trends 
is critical for creating succinct clinical summaries.  Abstractions of temporal data can include combining 
events within a certain time frame and performing interval-based abstractions such as combining multiple 
chemotherapy drug mentions into a chemotherapy regimen time span (Klimov, Shahar, and Taieb-
Maimon 2010) or reasoning about the length of time that symptoms lasted and their relation to diagnosis 
(Zhou, Parsons, and Hripcsak 2008). The questions of which events should be combined and what an 
appropriate time frame is remain difficult and currently resolved by leveraging clinical knowledge and 
ontologies. Time-dependent clinical summarization is a continuingly evolving research area and there is 
opportunity for automatically identifying, accurately ordering, and performing reasoning over temporal 
clinical events.   
2.2.3 Accounting for and interpreting missing data 
Clinical records are sparse: documentation only occurs when a patient is seen by a clinician, thus 
clinical records miss the overwhelmingly large amount of observations about a patient across their 
lifetime. When summarizing sparse data, a critical complication is how to interpret and reason over the 
missing data (Wells et al. 2013). In some cases, missing data is not important and can safely be ignored 
by a summarization system (e.g., a patient has no change in health status in between visits). In other 
cases, the presence of missing data hints at a salient aspect about the patient that needs to be highlighted 
within the summary (e.g., patient is too sick to come to their visit). How to interpret and determine the 
salience of missing data is a challenge, and one not investigated thus far in clinical summarization. 
In the field of general statistics, there are three types of missing data: Missing Completely at 
Random (MCAR), Missing at Random (MAR), and Missing Not at Random (MNAR) (Little and Rubin 
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2002). Most techniques for dealing with missing data assume that data are MCAR or MAR distributed, 
and include (i) variations of complete-case analysis, where only data with no missing values are used, (ii) 
single imputation, where missing data are imputed based on the values observed (using the mean, median, 
linear interpolation, etc.), and (iii) likelihood-based methods which compute maximum likelihood 
estimates for missing data (Enders 2006).  
In the clinical domain, there is mounting evidence that most of the data are MNAR (Lin and Haug 
2008; Pivovarov et al. 2014). For these data, the missingness is informative, meaning that there is an 
underlying reason that the data are missing but that this reason is simply unobserved.  Some techniques 
that use informative missing data properties to infer properties about clinical data have been proposed. 
Chapter 4 of this dissertation presents our work on identifying patterns of missing data and using them to 
help infer healthcare status of patients. A common way of using missing data in the clinical domain has 
been to look at how long values should last based on recorded measurements or documentation frequency.  
For example, laboratory test measurements have been studied to gather appropriate imputation time (Hug 
2006) and to infer health status features (Weber and Kohane 2013). Van Vleck studied duration and 
persistence of problems in notes (Van Vleck and Elhadad 2010) as a function of missing data, while 
Klann (Klann and Schadow 2010) and Perotte (Perotte and Hripcsak 2013) both studied the duration of 
ICD-9 codes. Klann estimated the durations for which each ICD-9 code remains valid and Perotte 
automatically classified ICD-9 codes into chronic and acute conditions.   The modeling work that most 
explicitly demonstrates informativeness in missing data examined the accuracy of prediction models 
when: (i) ignoring missing data, (ii) interpolating missing data, or (iii) incorporating a missing data 
indicator, and reported that the missing data indicator method performed best (Lin and Haug 2008). To 
properly provide context and infer trend lines, as demonstrated by Poh and de Lusignan for kidney 
disease data (Poh and de Lusignan 2011b; Poh and de Lusignan 2011a), or to make predictions in clinical 
summaries it is critical to incorporate missing data literature and techniques into summarizer applications. 
The utility of modeling missing data explicitly is clear, however this conclusion is not being translated 
into clinical summarization research yet. 
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2.2.4 Reducing information to only the most salient 
Salience identification has been heavily researched in the general domain text summarization 
literature.  Early methods for identifying important topics relied on counts: frequency (Luhn 1958) and 
term frequency-inverse document frequency, which corrects for word specificity (Jones 1972). Other 
methods have focused on structure, such as document structure (Edmundson 1969) or syntax structure 
(Marcu 1997) to identify important phrases. Syntactic information gleaned from the input document can 
identify which parts of a sentence are salient and which may be safely removed from a summary (e.g., a 
relative clause). It is unclear, however, how these approaches translate to the clinical domain, where 
syntactic structure is unconventional. Using prior knowledge of the input document structure (e.g., 
biomedical papers have an introduction, followed by a methods section) to weigh the salience of 
information pieces based on where they are conveyed in the document is, however, promising in the 
clinical domain (yet not investigated thus far). Clinical notes follow a pre-specified structure; a diagnosis 
mention might be more relevant when conveyed in the past medical history than in the family history for 
instance. A different method for salience identification, still within the general domain summarization 
field, leverages discourse by considering sentences in input documents through a network, where lexical 
similarity between sentences is represented by the network edges. In this representation, salient sentences 
are the ones with the highest centralities (Radev, Jing, and Budzikowska 2000; Erkan and Radev 2004).   
An alternative method for identifying relevant information relies on probabilistic modeling 
techniques such as Hidden Markov Models for identifying topics and topic changes in a set of documents 
(Barzilay and Lee 2004) or hierarchical Latent Dirichlet Allocation (LDA)-type models for identifying 
novel information with respect to older documents (Delort and Alfonseca 2012). Our work on employing 
Bayesian learning techniques to the construction of effective automated summaries is described in 
Chapter 5. 
The one type of salience detection that has been explicitly studied in the clinical domain is based on 
cue phrases.  Cue phrases are pieces of text that signify that what follows is likely to be important. For 
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example, “In conclusion” often precedes an important summarizing statement (Edmundson 1969). In 
clinical documentation, de Estrada et al. developed a system called Puya that found cue phrases indicating 
normality or abnormality in the physical exam sections of notes (de Estrada, Murphy, and Barnett 1997). 
Another way of detecting salience relies on n-gram language modeling to identify the most recent 
information in the record, under the assumption that the newest information is the most salient for the 
provider to see (Zhang, Pakhomov, and Melton 2012; Zhang 2014). A visualization prototype used this n-
gram model to automatically highlight text that was found to be novel, drawing the provider’s attention to 
the new findings (Farri et al. 2012). 
Defining salience in an operative fashion for automated summarization is an open question. In the 
general domain, there is evidence that humans sometimes disagree about what pieces of information are 
indeed salient, and that salience is often task-specific (Nenkova and Passonneau 2004). Similarly, in the 
clinical domain, determining what is important for a clinician is also probably quite task-specific. 
Nevertheless, it is safe to say that salience of elements in the patient record is related to capturing the 
health status of the patient and how it changes through time (Farri 2012; Suermondt et al. 1993). How to 
do so automatically, that is how to link textual and individual raw low-granularity observations to high-
level clinical abstractions is one of the paramount challenge of informatics research. For instance, there 
has been little formal investigation of clinically specific markers of importance such as absolute change of 
a laboratory test value, the rate of change, the rate of mention of a particular concept, and other 
importance cues.   
2.2.5 Using existing clinical knowledge  
The informatics community has invested enormous effort into codifying clinical knowledge in a 
variety of terminologies and ontologies. This knowledge representation effort has been successful in 
helping efforts like phenotyping combine terminological knowledge, expert reasoning, and machine 
learning to create actionable disease definitions (Pathak, Kho, and Denny 2013). Similarly in 
summarization work, it is important to make use of these available clinical knowledge representations and 
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use them to generate rules and heuristics.  Chapter 5 examines our efforts to incorporate coded clinical 
knowledge into an unsupervised, data-driven automated summarization engine.  
Several holistic summarization efforts leveraged terminologies to identify concepts that are 
semantically related (e.g., medications that treat particular conditions) (Klann et al. 2013) or rules to 
determine salience (e.g., identify and highlight the salient results that are abnormal) (Plaisant et al. 1998). 
However, summarization engines built for particular diseases benefit most often from manually crafted 
rules and disease-specific knowledge bases as they enable tailored, task-dependent systems. The 
KNAVE-II application (Shahar et al. 2006), created for synthesis of bone marrow transplant patients, 
relies on an expert-maintained knowledge base for creating a semantic navigation system and concept 
abstraction. The Timeline system (Bui, Aberle, and Kangarloo 2007) is also built on a manually coded set 
of rules which identify salient concepts for different diseases, and perform temporal event reasoning. In 
addition, summaries that are setting and user specific often use expert-driven rules to ascertain which 
pieces of data should be shown at which time and to whom.   Although the incorporation of clinical 
expertise into summarization is often a laborious process and sometimes only covers specific domains of 
expertise, it provides critical help in addressing some of the similarity, temporality and salience 
challenges. Of relevance to this review, we note that while existing summarizers rely on established 
knowledge resources, there is an active field of research to create these resources either by translating 
clinical expertise or acquiring the resources from data (Noy et al. 2009; Mortensen et al. 2012; Tao et al. 
2013). 
2.2.6 Deploying summarization tools into the clinic 
The ultimate goal of any clinical summarization tool is implementation and usage by clinicians at 
the point of care. To date, however, there has been no widespread adoption of automated summarizers, 
especially for the large holistic temporal summarizers (Samal et al. 2011). Pervasive deployment is often 
hindered by the commercial EHRs systems that have been adopted across the country.  Building real-time 
computational tools to work atop commercially built EHR systems is still a daunting task as these vendor 
 
37 
EHR systems are often not built to support interaction with outside applications.  In addition, as the 
systems are closed off, dissemination of summaries across different hospitals and EHRs is a challenge as 
well. However, there is promising work with the i2b2-SMART platform that enables easier translation 
across institutions; researchers have developed a system to automatically link different data types across 
the EHR (mainly diseases and medications) and display a newly organized view of the patient record 
(Klann et al. 2013). 
To create meaningful and practical summaries that assist clinicians during their point of care needs, 
summarizers need to provide real-time information with patient record updates immediately available in 
the summary. This is an especially difficult task when the summary tool works with natural language, as 
the processing must be completed quickly and accurately.  Current work with distributed infrastructures, 
like Apache Hadoop, provides promising results for immediate summarization (Hirsch et al. 2014).  
Another large barrier to translation of summarizer research into the clinical domain is rigorous 
evaluation.  Hospitals often call for evidence of a useful summarizer before investing expensive resources 
into the implementation of the summarizer, but without adoption a summarizer is extremely difficult to 
evaluate.  As is clear from Table 1, clinical summarization literature lacks standard evaluation metrics and 
there are very few extrinsic evaluations, a similar finding to a review of biomedical literature 
summarization by Mishra et al. (Mishra et al. 2014). Given the restriction of limited adoption, it is not 
clear on which dimensions clinical summarizers should be evaluated.  Initially, in order to avoid costly 
development and implementations with marginal benefit, it is imperative to study the need for a 
summarizer tool, context of usage, and clinician workflow. However, without eventual implementation 
into clinical care, showing any process- or health-level outcomes is not possible and therefore how to 
perform useful evaluations remains unclear: should, for instance, summarization systems focus on 
accurate information extraction, facilitating information exploration (e.g., which concepts are most 
relevant to the clinician), or user-friendly designs?  Although the rigorous user-interface and cognitive 
process evaluations that are necessary for creating new summarization systems often require deployment 
and study of actual use in practice, there exists guidance in the literature on cognitive aspects of clinical 
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reasoning that can inform summarization system creation. Prior work on general medical cognition (V. L. 
Patel, Arocha, and Kaufman 2001), clinical decision-making (Arocha, Wang, and Patel 2005; Kushniruk 
2001), human-computer interaction for interface design (Patel and Kushniruk 1998; Jaspers et al. 2004; 
Thyvalikakath et al. 2014), handoff communication (Abraham et al. 2011; Abraham et al. 2014), clinical 
workflow analysis (Militello et al. 2014; Unertl et al. 2009) and some recent qualitative work specifically 
on clinical document synthesis which has identified common cognitive pathways for EHR document 
synthesis (Farri 2012) and patterns of EHR data access (Reichert et al. 2010) can guide the development 
of summarization systems. However, we emphasize that without actually studying the clinical context and 
manner in which clinicians use summarizers (either in the laboratory with prototype systems or in the 




Chapter 3: Contextual Redundancy Removal in 
Clinical Notes2 
3.1 Introduction to Similarity Detection 
A standard way of approaching unstructured biomedical texts, such as patient notes written by 
clinicians, is to map mentions of biomedical terms, like symptoms and disease names, to semantic 
concepts in structured and standardized nomenclatures. The mapping helps group all lexical variants of 
the same biomedical concept under a unique semantic representation, thereby abstracting away from 
stylistic differences. For instance, the terms “heart attack,” “myocardial infarction,” and “MI” are all 
mapped to the same concept in UMLS. However, most biomedical ontologies and terminologies are 
designed based on a fine-grained organization of semantic concepts. As a result, when mapping term 
mentions in a text to semantic concepts, all too often semantically similar terms are mapped to different 
                                                      
2 Most of this chapter was originally published in the Journal of Biomedical Informatics. The full citation for this 
publication is: Pivovarov R, Elhadad N. A Hybrid Knowledge-Based and Data-Driven Approach to Identifying 




concepts in the ontology. When the concepts are fed to data mining or pattern recognition analyses, this 
ontological granularity can result in problems of signal dilution (Popescu and Xu 2009). To enrich the 
sparse datasets and thus enable meaningful analysis, concepts that are semantically similar can be 
aggregated.  The evaluation of whether two concepts are semantically similar enough for aggregation is 
often highly dependent on the context of the study itself (Dong, Hussain, and Chang 2010). For example, 
concepts such as “obese” and “morbidly obese” can be merged when studying Huntington’s Disease, but 
should remain separate when investigating predictors for heart attack.  
In this chapter, we examine the problem of concept aggregation in the context of a clinical data-
mining task. We assess the value of corpus-driven and knowledge-driven methodologies to compute a 
similarity score for concept pairs. To evaluate similarity within a specific situation we rely heavily on 
context-specific data.  Initial similarity calculations are compiled on a homogenous set of clinical notes, 
emphasizing the contextually dependent and corpus-driven methodology as a first step.  The further 
refinement of the corpus-based measure is created on two types of ontological knowledge (path length 
and definitional word overlap), both aiming to differentiate related from semantically similar concept 
pairs. We evaluate the different methods, including a hybrid score that averages the three measures, on a 
large dataset of concepts. This work fits primarily within the field of clinical informatics with the goal of 
defining a comprehensive way to enrich the analysis of unstructured data located in EHRs. 
3.2 Related Work on Similarity Detection 
It has been shown that people generally agree upon the notion of similarity or relatedness between 
ideas (Pakhomov et al. 2010; Tversky 1977). As a result, there has been a large effort across various 
disciplines, including natural language processing (Rada et al. 1989; Androutsopoulos 2010), and 
biomedical informatics (Benabderrahmane et al. 2010; Verspoor, Dvorkin, and Cohen 2009; Elhadad and 
Sutaria 2007; Pedersen et al. 2007), to create automated methods that can find semantically similar 
concepts. Much of the research focuses on the identification of both similar and related concepts. 
Relatedness indicates a semantic association between concepts, such as “ear” and “nose,” while similarity 
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specifies that two concepts can be used interchangeably (Budanitsky and Hirst 2005). The focus of this 
work is on similarity. Therefore, although many interesting methods have been published on relatedness 
identification, they are outside the scope of this chapter. 
3.2.1 Methods for Semantic Similarity Calculation 
Methods developed to identify semantic similarity among concepts fall loosely into two categories 
– knowledge-based (edge-based and syntactic) and corpora-based (distributional semantics), where 
information-content-based measures can span both.  In this section, we review previous work with 
specific emphasis on the methods we later use for comparison (and are included in the publicly available 
UMLS-Similarity package) (McInnes, Pedersen, and Pakhomov 2009). 
Edge-Based 
Many methods have been developed for a hierarchical interpretation of similarity, based on the 
location of the concepts in an ontology and the paths among them.  Some of the most common methods 
rely on edge counting, shortest path, and ontological depth (Rada et al. 1989; Caviedes and Cimino 2004; 
Leacock and Chodorow 1998), while others add the least common subsumer (LCS) to capture the 
granularity of a concept in the ontology (Wu and Palmer 1994; Al-Mubaid and Nguyen 2006). More 
recent advances have incorporated into similarity computation the distance to the LCS, assigning weights 
to the different path types (ontological depth, distance from concepts to LCS) (Matar and Egyed-
Zsigmond 2008), as well as all of the superconcepts between two terms as a way to account for multiple 
inheritances (Batet, Sánchez, and Valls 2010). We list a few of them below.  
Conceptual Distance (CDist) (Caviedes and Cimino 2004)  
simcdist (C1,C2)= | shortest_path(C1,C2) |       (1) 
Leacock and Chodorow (lch) (Leacock and Chodorow 1998)  
simlch(C1,C2)=-log(| shortest_path(C1,C2) |/(2*depth(ontology)))    (2) 
Wu and Palmer (wup) (Wu and Palmer 1994)  
simwup(C1,C2)=2*depth(LCS)/(depth(C1)+depth(C2))     (3) 
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Al-Mubaid and Nguyen (nam) (Al-Mubaid and Nguyen 2006)  
simnam(C1,C2)=log((|shortest_path(C1,C2)|-1)*(depth(ontology)-depth(LCS))+2)  (4) 
 
Information-Content (IC) Based 
IC-based methods aim to create measures that incorporate the specificity of a concept within a 
similarity calculation.  The IC calculation is based on the concept and all of its descendants’ frequencies 
within a corpus of texts. The original measure proposed by Resnik evaluated the information shared by 
two concepts by measuring the IC of their LCS (Resnik 1995).  As the Resnik measure can assign perfect 
similarity to any two concepts that share the same LCS, two other measures were proposed by Lin (Lin 
1998) and Jiang and Conrath (Jiang and Conrath 1997). They also take into account the IC of the concepts 
themselves, Lin using ratios and Jiang and Conrath using subtraction. More recently, Pirro and Seco 
devised a similarity measure founded on the idea of “intrinsic IC” which quantifies IC values by relying 
on the structure of an ontology itself as opposed to a separate corpus (Pirro and Seco 2008). 
Distributional Semantics 
Distributional semantics follow the assumption that the meaning of a target word or concept can be 
acquired from the distribution of words surrounding it, as a whole over its many mentions in a collection 
of texts. Thus, similarity between two concepts can be quantified according to the amount of overlap 
between their overall contexts. Here, by context, we are referring to a weighted count of all the words in 
the sentences surrounding all the instances of a concept.  Distributional semantics have been applied to 
several problems in biomedical informatics (Cohen and Widdows 2009). The distributional semantics 
methodology represents an abstraction of patterns over a larger corpus, where individual mentions of 
terms are agglomerated to derive an overall pattern of usage.  As the abstraction occurs over many 
mentions and the words in the vocabulary are weighted (typically tf-idf weights), individual negations and 
other modifiers all contribute to the salient textual patterns present in the corpus. As distributional 
semantics allow us to compare two concepts in their usage and thus assess their semantic similarity, 
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conversely, such a representation can help perform word sense disambiguation as different senses of a 
word will appear with different words and phrases surrounding them. 
The work of Pedersen et al. forms the basis of our context-based similarity measure (Pedersen et al. 
2007). Pedersen et al. calculate similarity based on patterns of usage in text with the help of a context 
vector (which in their case, relied on the Mayo Corpus of Clinical Notes). Each concept of the corpus is 
represented as a sum of all word vectors that map to the concept, each of dimension the size of the 
vocabulary. The vector representing word w at index t is the number of times w and t co-occur in the same 
line of a note in the corpus. The similarity between two concepts is then computed as the cosine similarity 
between their corresponding context vectors. Pedersen found that “the ontology-independent Context 
Vector measure is at least as effective as other ontology-dependent measures” (Pedersen et al. 2007). Our 
note-based similarity approach differs mainly in the type of corpus we employ to derive the context 
vectors.  Furthermore, we investigate to which extent this method and ontologically based methods, 
previously used independently of each other, can be used in complement.  
Definitional 
The idea of relying on the content of word definitions for assessing appropriate word senses was 
original proposed by Lesk (Lesk 1986). The Lesk algorithm selects the sense of a word in a text, which 
has the highest word overlap between its definition and its context in the text.  Banerjee and Pedersen 
(Banerjee and Pederson 2002) adapted this method further using WordNet and essentially reversed the 
methodology for the assessment of semantic relatedness (they also added WordNet hyponyms into the 
computation). Given the Lesk measure, which identifies overlaps in the extended definitions of the two 
concepts, the relatedness score is defined as the sum of the squares of the consecutive word overlap 
lengths. A similar methodology was employed by Hamon and Grabar in the biomedical domain (Hamon 
and Grabar 2008). 
Other Methods 
Other published measures include similarity calculations between sets of concepts (Cordí et al. 
2005), weights of different features in Gene Ontology (GO) (Benabderrahmane et al. 2010), and a 
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nonlinear model that is a function of various ontological features such as path length, depth, and local 
density (Li, Bandar, and McLean 2003). Alterovitz et al. implemented an information-theoretic technique 
to gauge similarity of GO terms and identify ontological inefficiencies (Alterovitz et al. 2010). 
Additionally, Rodriguez and Egenhofer  focused on hybrid methods that compute both over term 
definitions and various hierarchical attributes such as features and neighborhoods. Petrakis et al. (Petrakis 
et al. 2006) refined the methodology further to compute neighborhood similarity.  
3.2.2 Context-Aware Computing 
The notion that the context surrounding information is important is not a novel one and many have 
thought about applying it in the medical context.  Specifically, applications have been developed to 
facilitate context-aware data mining that would help provide background when evaluating the similarity 
of the data mining results (Singh and Vajirkar 2003). 
Others have devised methods to convert traditional similarity measures into contextually dependent 
ones.  Wu et al. propose a method in which given a similarity measure and a training set they are able to 
create a new distance function using the “kernel trick” (Wu, Chang, and Panda 2005). Dong et al. 
describe a method of ontological conversion designed to take context into account (Dong, Hussain, and 
Chang 2010). Other work has looked at the various types of context and how they affect similarity 
judgments specifically in the case of geospatial IR (Janowicz 2008; Kessler, Raubal, and Janowicz 2007). 
Most of these context measures are created to enhance personalization across information retrieval 
systems where the context consists of user, system, and background information. Our method is designed 
to incorporate an aggregate disease context over many patient records to create disease-specific similarity 
calculations. 
3.3 Method for identifying similar concepts 
Our composite methodology consists of three complementary similarity measures (Figure 3.1).  
One primary measure is context-based and relies on distributional semantics of patient notes authored by 
clinicians, while the other two are knowledge-based and rely on concept definitions and their 
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relationships in the SNOMED-CT ontology. Starting from a homogenous corpus of notes (i.e., notes 
about patients who share at least one clinical problem), notes are pre-processed to extract concepts 
mentioned in the corpus. A three-way filter is applied to prune out the extracted concepts and keep a 
homogeneous set of concepts to be aggregated. The context-based similarity ranks all pairs of concepts. 
The top-k pairs with the highest context-based similarity are then reordered using the two knowledge-
based similarity measures. This section describes the dataset and its pre-processing, the filtering of 
concepts, the three measures, and the experimental setup for our experiments. 
Figure 3.1 Our methodology for finding context-dependent similar concepts.  An overview of the entire pipeline, beginning 
with a set of patient notes and ending with a ranked list of similar CUI pairs. 
3.3.1 Data and Knowledge Sources 
Distributional similarity techniques assume that the meaning of a word or concept can be 
represented by the context in which it appears, across a large number of mentions. As such, the more 
frequent a concept is in a corpus, the more accurate its context will be at representing the meaning of the 
concept. Corpus selection is important – a random sample of notes from a random sample of patients 
might provide a large set of concepts pairs for which to assess similarity, but the concepts might be too 
sparse and the resulting contexts might be misleading. Our corpus selection process follows.  
We chose to collect a homogenous and semantically coherent corpus of clinical notes, in order to 
ensure that concepts, which are clinically relevant to the patients, are likely to appear frequently enough. 
For this study, we collected a corpus of notes from patients with chronic kidney disease (CKD). The 
methods we employ are disease-independent, but the fact that we select notes from patients all with at 
least one condition in common allows us to identify and aggregate concepts frequently mentioned when 
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thus allowing us to collect a large corpus of notes. Patients with CKD have many comorbidities and 
disorders, providing us with many different concepts to consider in our similarity computation. Using 
ICD-9 codes as evidence of CKD, all notes for CKD patients recorded between 1990 and September 2010 
were extracted from the NYPH dataset.  Each note was processed by our in-house NLP pipeline (Lipsky-
Gorman and Elhadad 2011), which identifies document structure (section boundaries and headers, list 
items, paragraph boundaries and sentence boundaries) (Li, Lipsky-Gorman, and Elhadad 2010), performs 
shallow syntactic analysis (part-of-speech tagging and phrase chunking), and named-entity recognition of 
UMLS concepts through dictionary matches. The named-entity recognition in our corpus was performed 
using the 2010AA UMLS version and restricted to the SNOMED-CT terminology.  The full pipeline was 
tested on a manually curated gold standard of 31 notes and yielded an F-measure of 88.55. The pipeline 
processed a patient note in 0.26 seconds on average. 
The knowledge-based part of our similarity computation relies on the SNOMED-CT.  SNOMED-
CT is a terminology of clinical terms and is a primary resource for concept standardization in the clinical 
domain. SNOMED-CT is particularly useful for our purposes because it provides term definitions and 
synonyms, as well as semantic relations among concepts.  The relationship types have very specifically 
defined attributes and lend themselves well to our ontological similarity measure. We utilize the concept 
definitions and synonyms encoded in SNOMED-CT for the definitional similarity. The version of 
SNOMED-CT we use in this study is from the July 31st 2010 release and consists of over 292,000 active 
concepts, 760,000 concept descriptions and 824,000 inter-concept relationships. 
3.3.2 Filtration 
Given the pre-processed corpus of CKD notes, we can extract a list of all mentioned concepts. In an 
effort to create a concise and unambiguous list of similar concept pairs, however, we perform a three-
tiered filtration step. The filtration relies on the concepts (semantic types), the structure of the notes 
(section types), and the note category (note types). 
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The concept filtration follows the hypothesis that two concepts are more likely to be similar if they 
belong to the same semantic group, whereas two concepts from different semantic groups can indicate 
semantic relatedness only. For example, it is unlikely that an anatomical concept is similar to a disorder, 
whereas it is possible that the disorder and the anatomical concept are semantically related (a stroke 
occurs in the brain, for instance). In practice, limiting the set of semantic types constrains the set of 
potential relationship types among CUIs, by reducing potential meronyms and focusing instead on 
hyponyms and metonyms (Elhadad and Sutaria 2007). In this study, we filter in all concept mentions that 
belong to the Disorder (DISO) semantic group, as defined by McCray et al. (McCray, Burgun, and 
Bodenreider 2001) The DISO group contains 123 out of the total 133 semantic types. We chose this group 
as it represents the types of concepts we are interested in examining (e.g., diseases, findings, and signs 
and symptoms), but the method is agnostic to the chosen semantic group(s). 
The section filtration’s aim is two-fold: to ensure the pool of input concepts is homogenous and to 
mitigate the potential CUI mapping errors that occurred during pre-processing. To keep the list of input 
concepts homogenous and specific to the patients under study, we filter out concepts mentioned in the 
Family History section of the notes. The concepts mentioned in the Medication section are filtered out in 
an attempt to reduce pre-processing mistakes, arising from the ubiquitous medication abbreviations that 
are prone to erroneous UMLS mapping. Because our pre-processing pipeline does not perform word-
sense disambiguation and keeps all possible CUI mappings instead, the input concept list to our similarity 
computation can contain incorrect concepts. For instance, “mg,” a common abbreviation in the 
Medication section of notes, which stands for “milligram”, is mapped erroneously to “Madagascar,” and 
“Magnesium.”   
                                                      
3 Acquired Abnormality, Anatomical Abnormality, Cell or Molecular Dysfunction, Congenital Abnormality, 
Disease or Syndrome, Experimental Model of Disease, Finding, Injury or Poisoning, Mental or Behavioral 




The note filtration operates at a higher level and selects the notes that contain the “richest” content 
for our purposes. Our initial corpus of CKD notes has more than 1,700 different note types (e.g. Primary 
Provider note, Cardiology Consult note, and Miscellaneous Nursing note). We identified the note types 
that had more than 60,000 occurrences of SNOMED concepts in the DISO semantic group over the entire 
set of patients. The filter helps producing a homogenous, focused list of input concepts, on which to 
compute pairwise similarities.  
3.3.3 Note-Based Similarity 
The note-based similarity takes two UMLS CUIs as input and returns a similarity score defined as 
the cosine similarity between the two concepts’ context vectors (Manning, Raghavan, and Schütze 2008). 
The context vectors are derived from the filtered, pre-processed notes for each CUI. They have V 
elements, where V is the size of the vocabulary. In our experiments, the vocabulary consists of all 
stemmed words present in the filtered notes.  
Given a CUI c and a stemmed word w, the value of the context vector for c at index w is defined as 
the tf-idf value of w, when c and w occur in the same sentence over the input filtered notes. The tf-idf 
value is based upon the number of times c and w appear both individually and together. Note that our 
metric differs from previous work slightly, as we operate over sentences, as opposed to lines in the note 
(Pedersen et al. 2007).  
The note-based similarity is computed for all concept pairs. However, because highly infrequent 
CUIs have very sparse context vectors, which do not represent their context accurately, we only 
considered CUIs that occur more than five times in the input corpus. Calculation of note-based similarity 
for all CUI pairs on our corpus took 5.28 hours on a linux machine with CentOS 5.4 16-core, 2.93GHz 
Xeon X5570 model, 24GB RAM, with a Hitachi 10,000 RPM drive. 
Following our hypothesis that contextual similarity is the basis for semantic similarity, concept 
pairs with high note-based similarity are kept as candidates for similarity, while all the other pairs are 
discarded. In our experiments, we set the threshold for note-based similarity at 75% which resulted in 794 
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CUI pairs. For instance, in the context of CKD patients, the concepts pairs (Muscle Injury, Traumatic 
injury of skeletal muscle) and (Acne, Common Acne) both have a cosine similarity above 75%, and are 
considered for further processing. The concept pairs with lower similarity scores are filtered out, such as 
(Localized mass, Nodule) and (Chronic Low Back Pain, Pain, NOS) which each have similarity scores in 
the low 50%.  
3.3.4 Ontological Similarity 
We describe a novel method for semantic similarity using ontologically defined relationships. We 
look at the SNOMED-CT ontology as a flat terminology and concentrate on edge types rather than the 
hierarchy itself.  With this view of SNOMED-CT we are able to look at all of the layers that consist of 
deleted, moved, and retired concepts.  This was highlighted as important in the Dong et. al paper that 
stated: “…in an ontology environment, the types of relations are various, and relations can be defined by 
multiple restrictions.  Obviously, the two factors cannot be ignored when computing similarity for 
ontology concepts.” (Dong, Hussain, and Chang 2010) The method is based upon the types of 
relationships between concepts where the different types are broken down into three tiers.  The tiers are 
defined by the characteristic and refinability features of SNOMED-CT relationships (Table 3.1) and used 
to group the relationships into ones resembling the most to least closely related.  The tiers were used to 
define weights for various relationships types and the weights were chosen to reflect the strength of each 
relationship type.  There seems to exist a natural hierarchy of relationship strengths that we chose to 
exploit in the method, such as the observation that non-refinable relationships are of a stronger nature 
than ones that are optionally or mandatorily refinable.  In addition, the weights chosen reflect a system to 
ensure a score between 0-1 for each relationship type and to delineate between tiers, a twice-larger 
difference between tiers was introduced (.2) in comparison to the weight difference within each tier (.1).  
To reduce complications every term listed as both qualifier and defining (Associated Finding, Access, 
Priority, Clinical Course, Laterality, Associated Procedure, Using Device, Surgical Approach) was 
grouped in the Defining, Optionally Refinable tier and always given a .5 weight.  The weights described 
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here can be tweaked to assess similarity alternatively or even a different semantic relationship; our main 
contribution lies in proposing a novel way to consider ontological path length calculations. 
 
Characteristic Refinability Example Tier Weight 
Defining Not Refinable Is A 1 1 
Historical Not Refinable Replaced By 1 0.9 
Additional Not Refinable Part Of 2 0.7 
Defining Optionally Refinable Associated With 3 0.5 
Qualifier Optionally Refinable Measurement Method 3 0.4 
Qualifier Mandatory Refinable Associated Finding 3 0.3 
Table 3.1 Relationship weights for our algorithm. Relationship tears are defined by concept Refinability and Characteristic, 
which are both assigned by SNOMED-CT. 
To find the path between two UMLS CUIs, each CUI was mapped to all of its SNOMED-CT 
concepts and all possible combinations of pairwise shortest paths were calculated. The average of these 
paths was taken and assigned as the official path length between the CUIs.  The ontological similarity was 
calculated in 2.18 seconds for all 794 CUI pairs (15,187 SNOMED concept pairs) on a Linux machine 
with Ubuntu 10.04.03 12-core, 2.4GHz Opteron 4176 model, 32GB RAM, with a Dell 7,200 RPM drive.  
The following algorithm (Eq 5) was used to assign ontological weights for each individual pairwise path: 
Sim0= !"#$ℎ&'(')*  / |E| - α(|E|-1)       (5) 
E = {e1,e2,…en} where "+= edge in path 
weight2= assigned weight for edge e   
3 =.2 
For example, one path between C0002622 (Amnesia) and C0751295 (Memory Loss) is between the 
SNOMED-CT concepts 247606008 and 162199006, with a path similarity of 0.5333 as illustrated in 
Figure 2 and Eq 6. 





3.3.5 Definitional Similarity 
The third similarity metric we used was definitional similarity. Definitional similarity is a measure 
of lexical commonality between two concepts – a metric widely used in word sense disambiguation, 
which can be seen as a reverse goal of our task (Banerjee 2002).  We focused on lexical inclusion as the 
metric and we used the following formula (Eq 7): 
SimD =|(C1+C2)|-|{C1+C2}|/Min(|C1|,|C2|)      (7) 
Where Ci={words in definition and synonyms of all mappings of CUI “Ci” in SNOMED-CT} 
We chose to use this metric as a way to capture complete subsets as being perfectly similar while 
adequately capturing the amount of discordance between the two sets of words.  While the Lesk methods 
look at consecutive words, we treat the definitions as a bag of words.  For example, the similarity between 
C0240419: Tender Muscles and C0575064: Muscle Soreness would be between SNOMED-CT concepts 
22166009 and 278018006 with a definitional similarity of 1. 
22166009 Skeletal muscle tender (finding), Skeletal muscle tender, Muscle tenderness, Muscle 
soreness, Tender muscles 
278018006 Tender muscles (finding), Tender muscles, Tender muscles 
C1= [skeletal, muscle, tender, tenderness, soreness, muscles] 
247606008 
Amnesia (disorder) 
162199006   
Memory disturbance (& amnesia (& symptom)) 
48167000 
Amnesia 
Is A  (1) 
Same As  (.9) 
386807006 
Disturbance of Memory 
May Be A (.9) 
Figure 3.2 An example of the relationship-weighted path calculation. This is the shortest SNOMED-CT path 
between 247606008 and 162199006.  An example of a path between two UMLS concepts that were mapped back to 
SNOMED-CT, the  “may be a” edge is not found by hierarchical path methods. 
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C2= [tender, muscles] 
SimD(22166009,278018006)=((6+2)-6)/2=1      (8) 
The definitional similarity calculation for all 794 pairs took 0.31 seconds on the same Ubuntu 
machine used for ontological calculations. 
3.3.6 Experimental Setup 
Our method finds similar pairs from a very large number of pairs (in our experiments, 
approximately 14 million); therefore, it would be impossible to create an annotated gold standard list for 
full evaluation of true negatives and positives.  In addition, because the set of input pairs is extracted from 
a corpus of notes, any gold standard is bound to be corpus-dependent. Therefore, for an evaluation 
method, we instead assess the accuracy of our methods, its variants and a baseline on a subset of all 14 
million pairs, namely the ones with high note-based similarity (i.e., above 75%). In our experiments, there 
were 794 such pairs.  
The evaluation of all three methods was calculated on the 794 pairs (those already filtered by the 
note-based similarity).  The definitional and ontological similarity measures were used and evaluated as 
secondary metrics.  The first evaluation was performed on the note-based method alone to assess its 
individual contribution.  Next, the average of the note-based and ontological methods as well as the 
average of the note-based and definitional methods were calculated to see the added benefit of each. 
Finally, the average of all three methods was computed.  
To further assess whether a threshold on note-based similarity at the 75% level is appropriate, we 
calculated similarities and collected gold-standard annotations for 100 random CUI pairs from the 25%-
50% note-based similarity bracket and 100 random pairs from the 50-75% bracket as well.  
Annotations 
Two physician annotators evaluated the results of the similarity calculations.  The annotators were 
presented with the 794 CUI pairs in random order along with all of their SNOMED-CT definitions and 
synonyms.  The annotators were specifically asked about the similarity of the concepts within the context 
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of a general population of CKD patients. The annotators were asked to answer the following question 
with yes, no, or maybe:  “Considering a patient with CKD, from a clinical standpoint, would you say that 
these two concepts could be used interchangeably?”  The annotators were not shown any actual medical 
notes but only a pair of terms.  Such an evaluation was chosen as the purpose of our method was to 
summarize the term usages from the corpus as a whole and use the shared kidney disease framework to 
find similarity specific to the kidney context overall. The inter-annotator agreement between the 
physicians was calculated using Cohen’s Kappa (Cohen 1960) and after converting all Maybe’s to Yes, 
this resulted in a kappa of .68 without any further adjudication. A kappa of .68 is accepted as representing 
a substantial amount of agreement between annotators (Landis and Koch 1977). A conversion of Maybe’s 
to No’s resulted in a slightly lower Kappa of .67.  The final conversion from Maybe to Yes was 
appropriate in this instance not only because of the higher Kappa, but also as the “Maybe” was used to 
annotate terms that are similar in some cases and would require more specific knowledge on the particular 
patient to determine definitive similarity.  A few examples of terms that were marked as “Maybe” are 
(Swollen Foot, Swollen Ankle), (Acute and Chronic Inflammation, Focal Chronic Inflammation), 
(Radiation Burn, Effects of Radiation).  The accepting of a “Maybe” annotation as “Yes” gives us more 
opportunity to create a comprehensive list of similar concepts for large-scale concept aggregation.   Given 
the two annotators’ answers for a particular pair, a consensus gold-standard answer was defined as “Yes” 
if both annotators answered yes, and “No” otherwise. Under this setup, the original list of 794 concept 
pairs contains 145 pairs annotated as similar. 
Baseline 
UMLS-Similarity (McInnes, Pedersen, and Pakhomov 2009) is a Perl package which encodes ten 
different similarity methods based on ontologies and corpora. UMLS-Similarity encodes path-based 
measures, information-content measures, definitional measures, and note-based measures. We ran five of 
the measures on the UMLS-2010AA as baseline, consisting of the path-based and definitional measures, 










Measure Used for 
Baseline? 
Why not? Parameters 
path No Same as the inverse of 
cdist 
- 
cdist Yes - SNOMED-CT vocabulary 
Parent/Child and Broader/Narrower lch Yes - 
nam  Yes - 
wup Yes - 
Information 
content 
jcn No IC was calculated on 
different corpus 
- 
lin No - 
res No - 
Definitional lesk Yes - Definitions from SNOMED-CT 
vocabulary 
All relationship types 
Note-based vector No Very similar to our vector-
based method 
- 
Table 3.2 All of the UMLS-similarity measures and their inclusion or exclusion in our baseline. 
Evaluation Metrics 
As we are interested in evaluating each similarity measure independently as well as their combined 
effect, we created receiver operating characteristic (ROC) curves for each combination of similarities at 
every similarity threshold (Hanley and McNeil 1983) for both our method and the baseline comparisons.  





The total dataset collected for this experiment consisted of 2,569 patients and their notes, which 
covered a span of over 20 years (1990-2010).  In total, there were 403,819 notes from which we extracted 
8,869 unique UMLS concepts that are in SNOMED-CT. The minimum unit of computation used in this 
study was a sentence containing a CUI and the corpus can be described as the set of these sentences. 
Figure 3.3 shows a histogram of the notes with respect to the number of sentences they contain. 
 
Figure 3.3 Descriptive Statistics for sentences in our CKD corpus. This graph illustrates the variety of sentence lengths found 
and chunked by the ClinNote pipeline. 
 The note filtration was used to narrow down the total notes used for the experiment, while 
keeping rich content.  Initially, the corpus consisted of 403,819 total notes with 1,739 unique note types. 
Selecting the note types with more than 60,000 DISO concepts occurrences overall resulted in keeping 17 
concept-rich note types (Table 3.3).  This filtration led to a total of 170,775 notes used for the analysis 
(that is, less than 1% of the note types captures over 40% of the notes).  As many institutions have a 
similar problem of unrestricted note type changes within their medical departments, the rapidly growing 
and changing EHR note structures make it difficult to keep track of which notes are most important.  As 
the importance of note types is dependent on the question being asked, it is possible to vary the semantic 
groups included in the analysis, thereby altering the concepts found and the note types considered to be 
most important.  This simple way of ranking note importance by concept density is a dynamic and 








Number of CUIs that map to 
SNOMED-CT from the DISO group 
Clinical_Note 743268 


















3.4.1 Concept Similarity Results 
To determine the best way to create the context vectors, we performed all experiments with 
stemming and without stemming the words in the corpus.  The stemming approach showed a minor 
improvement over the unstemmed version and therefore we chose to report the stemmed similarity 
results.   
Experiments for Concept Pairs with High Note-based similarity 
We report in this subsection results on a full list of pairs with a note-based similarity above 75% 
similarity, corresponding to 794 pairs.  
The lexicographical comparison of definitions and synonyms of the concepts created a second layer 
of similarity which we used in addition to the ontological method to move pairs which are simply related 
to further down on the ranked list than those which are semantically similar.  Given the algorithm used for 
definitional similarity, we often found high similarity between parent-child concepts or concepts with a 
short definition or list of synonyms.   
Figure 3.4 shows the ROC curves on the 794 pairs annotated for similarity with different 
combinations of the similarity measures (combinations represent an average of the individual measures). 
Although not reported in this chapter, we also experimented with the effect of simply applying the 
ontological and definitional scores to rank and re-order the 794 pairs (without averaging in the note-based 




Figure 3.4 ROC curves comparing different parts of our methodology. We compared the curves of all similarity 
combinations between note-based, ontological-based, and definition-based measures. 
 
Table 3.4 shows the top-10 concept pairs ranked by the composite method, which averages the 















UMLS Concept  
Preferred Term 




Similar according to 
Expert Consensus 
C1998242 

















Cardiac thrill (finding) 
0.958 N 
C0677659 



























Signs and Symptoms 
0.933 Y 
Table 3.4 Top-10 concept pairs found by the composite (average of the note-based, ontological-based, and definitional-
based) method. 
It is difficult to assess the coverage of our approach to identify similar concept pairs over the 
original set of 14 million pairs. Instead, we investigate to which extent the automatically discovered 
candidate pairs are relevant for the input corpus. Since the goal of this method is to aggregate concept 
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pairs that are semantically similar, it is important to know whether the discovered pairs are frequent 
enough in the input corpus. We assessed the coverage of the concepts that made it into our annotated list 
of 794 pairs. The concepts made up for 6% of the total number of concepts in the corpus. They are 
common concepts however, as they cumulatively make up for 30% of the concept frequencies in the 
corpus. This confirms that our approach is appropriate for discovering pairs of similar concepts, which are 
frequent in the corpus, and thus important to discover.  
We compared our comprehensive method with 5 methods (lch, wup, cdist, nam, lesk) packaged in 
the UMLS-Similarity perl program.  As all of the methods we used except Lesk rely upon the hierarchical 
relationships present in the UMLS only (Parent/Child or Broader/Narrower), they frequently missed paths 
between concepts.  This happens because many concepts are linked with non-hierarchical relationships 
such as “moved to” or “deleted from”. Table 3.5 shows the number of missing paths (from the 794 total 
pairs, 145 of which are similar) when using PAR/CHD, RB/RN, or both.  RB/RN misses the largest 
amount of paths and while PAR/CHD does quite a bit better, even combining the two, leaves over 10% of 
the total and 20% of the truly similar concept paths as null.  We present the ROC curves for the combined 
PAR/CHD and RB/RN hierarchical methods as well the Lesk method, although the Lesk and CDist 
scores are coarse whole number measures and lead to fairly few data points for the ROC curves (Figure 
3.5). The baselines all underperform compared to our three similarity metrics and their combinations.  
We compared our final list of similarities with the list of 566 concept pairs collected by Pakhomov 
et al. (S. Pakhomov et al. 2010) in their semantic similarity study. There were only four pairs in common 
(Rhonchi, Rales), (Polydipsia, Polyuria), (Vertigo, Dizziness), and (Constipation, Diarrhea).   Only 















Pairs with no path 
 
77.8% 15.6% 11.3% 
Pairs with no path 
that are similar 
 
75.9% 24.13% 20.0% 
Table 3.5 Missing paths in hierarchical methods.  For the  “PAR/CHD or RB/RN” method, we used a PAR/CHD path if it 
existed and RB/RN path otherwise. 
 
Figure 3.5 ROC curves of the baseline methods.  We used five methods encoded in UMLS-Similarity and calculated the ROC 
curves including only the pairs between which paths were found, leaving only 116 similar pairs and 704 pairs in total. 
Experiments for Concept Pairs with Low Note-Based Similarity 
In the experiments described above, we focus on concept pairs with a high note-based similarity 
(above 75%). This assumes that the context from notes is the most salient cue towards semantic similarity 
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compared to definitional and ontological similarities. As a sanity check that note-based similarity does not 
miss pairs that are semantically similar, we expanded our gold standard with 200 more concept pairs and 
collected similarity assessment from our judges, following the same methodology as in the above data set: 
100 random pairs from the set of pairs with a note-based similarity between 50% and 75% similarity and 
100 random pairs from the set of pairs with a note-based similarity between 25% and 50% similarity. We 
calculated the path-based similarity and the ontological similarity for the 200 concept pairs. Out of the 
200 pairs, only three were scored as interchangeable, and thus similar: (Respiratory alkalosis, Alkalosis), 
(Disturbance in sleep behavior, Sleep disorders) and (Liver palpable, Liver edge). Furthermore, none of 
the three were unanimously assigned a “Yes” by our experts. While, this is only for a random sample, it 
provides face validity to the claim that note-based similarity is the primary factor to assess context-based 
semantic similarity.  
3.5 Discussion 
3.5.1 Impact of Context 
The experiments confirm that context plays a crucial role in assessing similarity of medical 
concepts: the writing patterns of clinicians provide valuable information to determine which concepts are 
mentioned in similar contexts and thus are good candidate pairs for aggregation. However, these patterns 
are all the more visible because the information used for the note-based similarity is derived from a large 
corpus, with a coherent set of concepts, all related to a particular topic (chronic kidney disease in our 
experiments). For example, consider the two concepts “Difficulty Hearing” and “Complete Deafness.”  
Generally, the two might be similar enough for aggregation but not given a history of kidney disease.  
One of our physician annotators pointed out that difficulty hearing might serve as a clue of an adverse 
drug event caused by an overly high dosage of medication.  Complete deafness does not offer the same 
reaction, as total deafness is rarely an adverse drug event.  Such examples illustrate the need for context-
dependent similarity measures.   
 
63 
In our experiment, we found the inter-annotator agreement between the physicians was quite high 
given the subjective nature of the question.  The fair amount of agreement indicates that physicians 
generally concur on medical concept similarity within a particular context. It is a testament to the fact 
studied generally by Tversky (Tversky 1977) and in the medical arena by Pakhomov et al. (Pakhomov et 
al. 2010; Pakhomov et al. 2011) that there is a universal concept of similarity that most people agree 
upon. 
3.5.2 Impact of the Ontological-based Similarity 
The relationship-based ontological measure we proposed was able to locate many more paths than 
other popular methods encoded in the UMLS-Similarity package. Because the baseline methods rely upon 
hierarchical relationships only, they are often unable to find the complicated trajectories among concepts 
and focus primarily on more straightforward pairings.  This limits the types of paths that can be found 
between two concepts. In contrast, our ontological similarity incorporates all types of ontological 
relationships into its path computation, and due to the disease/disorder and SNOMED-CT only filtrations, 
ensures that a path will always be found between two concepts. Our method takes care to assign greater 
weight to more significant relationships (Is-A), but does incorporate edges between concepts that others 
do not, such as “may be a” or “moved to”. 
3.5.3 Impact of the Definitional-based Similarity 
The definitional similarity measure also provided important information about similarity and did 
surprisingly well, serving as the best individual similarity measure when averaged with the context-based 
primary. Nevertheless, it must be emphasized that this measure performs well as a discriminatory measure 
after the initial contextual similarity threshold, and would probably not perform well on its own to 
discover candidate similar pairs.  In fact, when applied to the 14 million pairs, 85% of them share no 
words in their definitions, and thus have a 0.0 definitional-based similarity measure and conversely, 2,099 
pairs have a perfect 1.0 definitional-based similarity measure. On its own, this measure does not have 
enough granularity to rank pairs. It performs well combined with more nuanced similarity metrics. 
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Leveraging the concept definitions for assessing similarity can be viewed as a word sense 
disambiguation method (the original proposition by Lesk was to use definitions in exactly this way (Lesk 
1986)).  Given the potential tagging ambiguity that may arise during the entity-recognition phase and 
would result in a perfect note-based similarity score, the definitional similarity helps to move apart those 
incorrectly perfectly similar concepts. 
3.5.4 Impact of Combining Data-driven and Knowledge-driven 
Similarity Measures 
The note-based similarity measure, which relies on patterns of clinicians writing their notes, and the 
knowledge-based similarity measures, which rely on ontological knowledge, provide complementary cues 
to the assessment of concept similarity.  Concepts that appear far away from each other in the ontology, 
but are used comparably in the clinical notes are generally irrelevant in the CKD context and can be 
aggregated for the purpose of data mining.  For instance, the concepts C0025874 (Metrorrhagia) and 
C0312414 (Menstrual spotting) have a low ontological similarity score of .126, but a note-based score of 
.904, and thus can be correctly identified as similar. Alternatively, concepts may appear very close in a 
medical ontology but be used vastly differently in context.  Such use indicates general similarity but a 
notable difference in the context of CKD.  For example, the concepts C1444079 (Focal chronic 
inflammation) and C0021376 (Chronic inflammation) had a full ontology-based similarity of 1, but the 
note-based score was 0.814.  In general, we found that it was essential to incorporate ontological and 
definitional similarity to separate pairs misguided by abbreviations used in medical text. Although the 
note-based similarity helps anchor variants of the same concept it has no mechanism for word-sense 
disambiguation specifically when an abbreviation maps to multiple SNOMED concepts.  Out of the 794 
pairs that were evaluated, 80 of them had a note-similarity of 1, indicating that they were used in exactly 
the same way throughout the entire corpus.  Most of this is due to a shared “trigger,” as our named-entity 
recognition tool maps each word to all possible UMLS CUI matches.  The letters RA could trigger both 
Rheumatoid Arthritis and Refractory Anemia, giving them a note-based similarity of 1, but clearly they 
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are semantically different.  Of the 80 pairs with perfect note similarity, 42 of them were actually similar 
such as (Incomplete Spontaneous Abortion, Incomplete Abortion Unspecified) both triggered by 
“Incomplete Abortion” and (Tonsillar Carcinoma, Malignant neoplasm tonsil) both triggered by “Tonsil 
Cancer”; the rest were disambiguated thanks to the addition of ontological and definitional similarity. 
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Chapter 4: Exploiting Patterns of 




Automating feature selection from EHR variables is a difficult task, as the EHR is an inherently 
biased data source: EHR data are collected with the primary goal of delivering and documenting patient 
care, not with the primary goal of creating a curated research dataset (Hripcsak and Albers 2013; Hersh et 
al. 2013). Identifying and then mitigating such biases will result in not only the development of more 
accurate methods for deriving computational models of disease but also in learning better prediction 
                                                      
4  This chapter was originally published in the Journal of Biomedical Informatics. The full citation for this 
publication is: Pivovarov R, Albers DJ, Sepulveda JL, Elhadad N. Identifying and mitigating biases in EHR 




models from EHR data. Currently, laboratory tests are one of the most widely used features in EHR 
disease-modeling research and are therefore the focus of this chapter.  
In this work, we hypothesize that (i) the specific context of a laboratory test order can be derived 
from EHR-observed measurement patterns, and (ii) that this context can be leveraged for better disease 
modeling. While a laboratory test’s numerical values can help distinguish healthy from sick patients, test 
values themselves cannot separate sick patients by their ailment when the test is associated with multiple 
diseases. For instance, while the numerical results may be comparable, the rate of measurement for a 
gestational diabetes screening glucose test and a chronic diabetes monitoring glucose test will differ 
greatly. We predict that how often a laboratory test is ordered within a particular time window can help 
correctly separate one disease state from another. We further hypothesize that laboratory test 
measurement patterns provide complementary and independent information from the numerical values 
indicated by the laboratory tests. We formally explore the relationship between both laboratory test 
measurement gaps and laboratory test values to determine whether the context in which a laboratory test 
is ordered alters the way its value should be interpreted, and is therefore a critical feature for disease 
modeling. While analyses of laboratory measurement patterns have been conducted (Lyon et al. 2009; 
Saxena et al. 1993; Weber and Kohane 2013; van Walraven 2003), the analyses and interpretations have 
focused on resource overutilization and informing clinical practice rather than on EHR-driven research.  
Before describing our methods and findings, we provide background on laboratory testing from an 
informatics standpoint and report on previous work in the emerging research area of EHR bias 
identification and mitigation.  
4.1.1 Capturing the Context of Laboratory Testing  
At the point of patient care, different laboratory tests are ordered at different rates, often dictated by 
what physiologic process the test is measuring, and very often there exist multiple reasons for ordering a 
particular laboratory test. The three most common reasons for ordering a test are (i) diagnosing a 
condition, (ii) screening for a condition, or (iii) monitoring a pre-existing condition. Some laboratory tests 
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are ordered for one specific, clinical reason: for instance, the prostate-specific antigen (PSA) test is 
ordered exclusively to screen patients for prostate cancer. Others serve multiple clinical purposes: TSH, 
for instance, is used both to diagnose and monitor patients with disorders associated with the thyroid 
hormone. Finally, some tests, such as creatinine, are ordered both for clinical purposes like monitoring 
chronic disease progression and diagnosing acute conditions, and for healthcare process purposes like 
following guidelines as part of a routine panel for preventive testing (McPherson and Pincus 2011). When 
hospital protocol dictates measurement times, as is the case with routine preventative panels, creatinine’s 
measurement patterns arguably reflect healthcare processes more than they reflect the health status of a 
patient. Thus, the context in which a laboratory test is ordered depends both on its clinical purpose and the 
surrounding healthcare processes.  
Deriving the context of a laboratory measurement is a challenge, however. EHR data lack an 
explicit indication for why each laboratory test was ordered, and using other dimensions of EHR data for 
derivation of such information (such as ICD-9 codes and clinical notes) is equally problematic. ICD-9 
codes are notoriously non-specific to patient disease state and are often not recorded for all patient 
ailments (Birman-Deych et al. 2005; Farzandipour, Sheikhtaheri, and Sadoughi 2010). Clinical notes 
rarely explicitly state the exact reason a test has been ordered.  
The specific description of the context in which a laboratory test is measured, therefore, is not 
included in most computational models of disease. In fact, most often models include only a laboratory 
test’s numerical value, a range of values (Chen, Dudley, and Butte 2010; Lasko, Denny, and Levy 2013), 
or the presence or absence of a laboratory test (Lin and Haug 2008) as features, but no contextual 
information about the situation surrounding the order. In this chapter, we investigate whether aggregating 
numerical values of laboratory tests taken in multiple separate contexts without explicitly separating the 
contexts can lead to the confounding of research conclusions.  
In research with clinical data, there is an implicit assumption that a laboratory test’s numerical 
value and the rate at which the test is ordered are highly correlated features. This assumption about value 
and measurement rate correlation likely stems from the existence of value-based guidelines and the 
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widespread expectation that laboratory test values which fall outside of normal ranges prompt 
intervention and retesting. Value-based guidelines for laboratory test ordering dictate measurement 
frequency based on a test’s numerical value. For instance, the guideline for performing a diagnostic PSA 
test states that if a patient’s PSA is slightly over 4.0 ng/mL in the initial measurement, the PSA test 
should be remeasured within 48 hours to confirm the need for a biopsy. Our work formally investigates 
the linear and nonlinear relationship between numerical value and measurement patterns in EHR-recorded 
data.  
4.1.2 EHR Biases 
EHR data are biased because they are gathered in an uncontrolled environment and are not 
carefully curated for research purposes. EHR data are noisy, sometimes erroneous, and often sparse 
(Lasko, Denny, and Levy 2013). At the same time EHR data contain sometimes conflicting (e.g., notes 
and coded data provide differing medication lists) and redundant information (e.g., clinicians often copy-
and-paste from previous notes). From a temporal standpoint, the EHR contains data about elements that 
evolve at different time scales and often evolve over time, as treatment affects patient state. Because of 
these complexities, assessing the impact of EHR biases and correcting for their impact on data-driven 
methods is an emerging research topic.  
Recent research has shown that naive EHR statistical analyses can lead to the reversals of cause and 
effect (Hripcsak, Albers, and Perotte 2011), induction of spurious signals (Albers and Hripcsak 2010), 
large errors when predicting optimal drug dosage (Sagreiya and Altman 2010), value cancellation of 
temporal signals when aggregating different cohorts (Albers, Hripcsak, and Schmidt 2012; Albers and 
Hripcsak 2012; Albers and Hripcsak 2011), and model distortion when not accounting for redundancy in 
the narrative part of the EHR (Cohen, Elhadad, and Elhadad 2013).  
One particularly problematic bias inherent to the EHR is the prevalence of data points that are 
missing not at random (Rubin 1976) (e.g., patients are seen and measured more often when they are sick, 
and measured less often when they are healthy). Inferring missing information, such as values when the 
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patient is not seen, is a challenging research area. While there have been different approaches to 
mitigating this type of missingness (Schafer and Graham 2002; Lasko, Denny, and Levy 2013; Sammon 
et al. 2015), mostly researchers ignore missing values or interpolate them (Farhangfar, Kurgan, and 
Pedrycz, 2007.; Abdala and Saeed 2004; Hug 2006), with some recent work on classifying which 
variables should be interpolated and which should be ignored. Lin and Haug demonstrated that some 
missing values are themselves informative by creating Bayesian networks that explicitly model the 
absence of clinical variables; these models were able to predict medical problems better than those that 
ignored or interpolated missing values.(Lin and Haug 2008) Our work builds upon Lin and Haug’s 
findings and focuses on leveraging the temporal missingness within laboratory measurement data. We see 
the patterns of laboratory test measurement as patterns of missing data. As a way to mitigate the EHR 
biases, we explore the use of different missing-not-at-random patterns to classify different patient health 
states and stratify heterogeneous populations into homogenous patient groups.  
4.2 Materials and Methods 
Our study is carried out in three consecutive tasks, as described below:  
Task 1 We explored the correlation of laboratory values to the laboratory test’s time to repeat, examining 
whether the value and time between consecutive measurements (measurement gap) encode separate 
information or overlap in information content.  
Task 2 To understand the overall dynamics of laboratory tests recorded in the EHR, we categorized types 
of laboratory measurement patterns, identifying those more likely to cause biases in EHR-based research.  
Task 3 We used lipase as a case study for how rates of measurement can be used to account for biases in 
laboratory test measurement data.  
We narrowed our population to patients that have visited the NYPH Ambulatory Internal Medicine 
clinic at least 3 times. The full longitudinal records (i.e., all inpatient and outpatient data points) for these 
patients were gathered.  
Three physicians reviewed and edited a list of frequently measured laboratory tests. They 
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constructed a set of 70 laboratory tests of interest to primary care and internal medicine. We extracted the 
time series for these tests between September 1990 and September 2010 for all of the patients in the 
population.  
4.2.1 Task 1: Correlation between Measurement Gap and 
Numerical Value 
We quantified the relationship between value and measurement gap, asking: in the patient 
population, is there added information in looking at how a patient was measured, not only at the 
measurement value? Given a particular laboratory test and all patients’ time series for that test, we 
constructed a joint probability density function (PDF) using a kernel density estimate in Matlab. The PDF 
consisted of laboratory values and time between consecutive lab measurements (or gaps between 
measurements) in days.  
To assess the degree of correlation between a laboratory test’s numerical values and its 
measurement gaps, we experimented with (i) linear correlation (estimated at the 95% confidence interval) 
and an associated p-value and (ii) a non-linear measure of correlation, mutual information (MI) between 
laboratory test values and gaps between measurements. Mutual information attains a value of zero when 
the random variables underlying the distributions (values and measurement patterns) are completely 
independent. Mutual information attains a maximum when the two distributions are deterministic. 
4.2.2 Task 2: Finding Laboratory Test Measurement Motifs 
We explored the different types of laboratory test measurement dynamics that exist in the EHR data 
by creating measurement gap histograms for 70 different laboratory tests. We computed the following 
quantity: for each laboratory test taken on each patient, we calculated the days between two consecutive 
measurements of that laboratory test on that patient. A histogram was created for each test, mapping the 
day gap between consecutive measurements and number of such gaps, when aggregated across the entire 
patient dataset. For example, if a patient had a creatinine test taken on February 3rd and another creatinine 
test taken on February 5th, the count of creatinine tests with a measurement gap of 2 days would be 
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incremented by one.  
We visualized the measurement gap histograms in different coordinate systems to explore the 
measurement dynamics across laboratory tests. We uncovered differences when examining the histograms 
in the logarithmic coordinate system. Using log-log coordinates, we visually looked for modes present in 
the histograms. If there is linearity in a measurement gap histogram when presented in log-log coordinates 
(i.e., a power-law) that implies scale-free measurement dynamics and that all time scales represent a 
single context or reason for ordering the laboratory test. If no approximately linear relationship between 
the frequency of measurement gaps exists, we visually looked for changes (e.g., peaks) that separate the 
different dynamics patterns; these different patterns may qualitatively imply different contexts of 
measurement based on either a change in health state or based on the healthcare documentation process. 
We catalogued the measurement gap histograms based on observed approximate linearity and the 
presence of peaks in the histograms, as determined by a manual review of the curves.  
4.2.3 Task 3: Studying the Potential Effect of Measurement Motifs 
on Research 
In this task, we focus on a specific laboratory test as a use case for studying the effect of 
measurement motifs on EHR-driven research.  
For the use case, we chose to study lipase and acute pancreatitis. Acute pancreatitis is a well-
understood condition and because its diagnosis is largely laboratory-based it is a good test case to validate 
our hypotheses. Both amylase and lipase tests have been used for acute pancreatitis diagnosis but they are 
not specific for this condition: both tests are also used for monitoring of chronic pancreatitis and 
diagnosing pancreatic cancer. We conducted all experiments on both laboratory tests; in this chapter, we 
focus on lipase as recent literature has shown it to have higher diagnostic sensitivity and specificity 
(Banks, Freeman, and Gastroenterology 2006). Our results for amylase were similar to those for lipase.  
We asked the question: can the known association between an abnormal lipase value and acute 
pancreatitis be recovered from EHR data? To verify our hypothesis that laboratory measurement 
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dynamics can impact the accuracy of identifying patients with acute pancreatitis, we considered three 
views of the data, based on the dynamics of lipase measurements within each patient’s record: (i) only 
visits with short lipase measurement gaps, (ii) only visits with long lipase measurement gaps, and (iii) all 
visits independent of the length between lipase measurements. In each of these settings, we assessed the 
association between acute pancreatitis and lipase and studied the properties of visits that belong in the 
setting using ICD-9 codes and clinical notes. We hypothesize that as acute pancreatitis is an acute disease, 
visits with short lipase measurement gaps will be more highly associated and relevant to acute 
pancreatitis.  
Settings 
We divided each patient record into individual visits (defining a full inpatient admission as one 
visit). Each record (represented as a set of visits) was divided into bins of visits with short lipase 
measurement gaps and visits with long lipase measurement gaps. Figure 4.1 shows a schematic diagram 
of an individual’s longitudinal record: visits 1 and 5 belong to the short-gap bin because the lipase 
measurements were taken in rapid succession, the other visits belong in the long-gap bin because they 




Figure 4.1 A schematic of a longitudinal record. A single patient’s longitudinal record is divided up into visits (represented 
here as a set of notes written during the visit) and visits are binned into short or long gaps with respect to lipase measurements. 
For instance, the first and fifth visit are binned as short-gap visits, because they contain at least two consecutive laboratory test 
measurements that occur within a short time period. Visits 2, 3, and 4 are long-gap visits because they occur between two 
consecutive lipase measurements that are taken over a longer period of time. 
To determine the threshold for how many days define a short-gap and long-gap, we used the 
laboratory test’s measurement pattern histogram. Under the hypothesis that peaks in the histogram are 
indicative of the context within which a laboratory test is ordered we use the location of peaks and trends 
around them as thresholds for separating visits into short- and long- gap bins. This visit-separation 
method is generally insensitive to the exact threshold and is heuristically defined for each laboratory test 
as a function of the location and number of peaks in the measurement histogram. The measurement 
histogram of lipase (Figure 4.2) had one peak at one day and showed a change in measurement pattern at 
3 days (the lipase histogram is only nearly linear after the 3-day gap).  
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As there is only a measurement gap when a patient has two or more tests, only patients with at least 
two lipase measurements were included in the analysis. Similarly, no visits after the last recorded lipase 
test were added to either bin. Our visit-binning method is not limited to two (short- and long- gap) bins 
and there can be more granular bins such as bins of regular weekly visits. In the case of lipase, the 
measurement pattern histogram illustrated two distinct measurement patterns.  
To analyze the differences between bins of short-gap measurements and long-gap measurements, 
we separated all ICD-9 codes and clinical notes created during short-gap lipase measurements from those  
collected during long- gap bins. We conducted association studies for lipase and acute pancreatitis in all 
three settings: (i) only short-gap visits, (ii) only long-gap visits, (iii) all visits.  
Analyses 
To assess in what ways the visits with short lipase measurement gaps differ from visits with long 
Figure 4.2 The measurement gap histogram curve for the lipase laboratory test.  The measurement curve is presented 
on log–log scale as a histogram of the days between consecutive lipase test measurements for each patient, aggregated 
across the full population. We examined the figure visually and found that the pattern in measurement gap frequency 
changes at approximately 3 days; after 3 days the histogram curve is nearly linear. We used 3 days as a threshold for 




lipase measurement gaps, we ran three analyses using ICD-9 codes and clinical notes. For all of the 
following analyses, we used patients who exist in both the short-gap and the long-gap bins. This filtration 
reduced the confounders and ensured that differences we uncovered were from genuine separate health 
states. All p-values were Bonferroni-corrected.  
Note Types. We looked at note types across the short and long measurement gap bins. Note types 
can inform the status of the patient. For example, a high frequency of admission and discharge notes 
indicate many inpatient visits, while primary provider notes are indicative of outpatient doctor visits. We 
performed a chi-squared test to assess the strength of association between the frequency of each note type 
and the gap bin; this test was chosen because we are comparing counts across different bins.  
Note Content. We analyzed the frequency and coverage of all words across the notes in each bin. 
Differences in note content indicate differences in topics and hint at different contexts of measurement 
across gap bins. To correct for the redundancy within notes, we calculated word coverage. Redundancy 
across notes within a patient was implicitly handled, as individual patient records were divided into both 
bins. We look at the note content, both frequency and coverage, to check the separation created by long 
and short lipase gaps. The presence of certain words that relate to specific health states can hint at the 
level of separation across the gap bins and provide clues as to whether relevant parts of the patient’s 
record are indeed being separated out.  










We performed a chi-squared test to assess the strength of association between the coverage of each 
word and the gap bin.  
Association Study. To test whether laboratory measurement dynamics affect a typical EHR 
association study (Warner and Alterovitz 2012), we conducted a phenome-wide search using the binomial 
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test to find ICD-9 codes associated with an elevated lipase. For every ICD-9 code, we compared its 
frequency of occurrence with high lipase in all three settings. The binomial test was used to assess the 
statistical significance of deviations due to high lipase from the expected distribution of ICD-9 codes. The 
variables were defined as follows, per ICD-9:  




#	trials = #	visits	where	median	lipase > 43 
#	successes = #	visits	where	(median	lipase > 43	AND	the	ICD − 9	is	recorded) 
4.3 Results 
Our final dataset consisted of 14,141 patients, their notes, ICD-9 codes, and laboratory test times 
and values for 70 tests, spanning 20 years. On average each patient had 150.4 ICD9 codes [95% CI: 
147.7-153.1], 825.8 laboratory tests [95% CI: 807.7-847.0], and 133.5 clinical notes [95% CI: 130.8-
136.3] over the entire study period.  
4.3.1 Task 1: Correlation between Measurement Gap and 
Numerical Value 
Both correlation metrics, linear and nonlinear (through mutual information), between measurement 
patterns and test values were carried out for the 70 laboratory tests (see Appendix A Tables 1 and 2 for 
full results). When we did not separate by time scale, there was little correlation: with the linear measure, 
all laboratory tests had a correlation very close to zero. With the mutual information measure, although 
also very low, a few laboratory tests demonstrated some level of correlation. The highest mutual 
information was 0.15, detected for the albumin laboratory test and only nine other tests had a mutual 
information higher than 0.1 (see Appendix A Tables 1 and 2). Overall, these very low correlations 
indicate that there is separate information encoded in the laboratory test measurement pattern and the 
laboratory test’s numerical value.  
Exploring the correlation statistics separately for different time scales (short and long gaps), some 
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laboratory tests such as LDL displayed no correlation (Figure 4.3(a)), using either metric, on any time 
scale, while other laboratory tests such as HbA1c and creatinine, showed some degree of correlation. For 
LDL, the numerical value does not affect its testing rate. We interpret the absence of correlation in 
measurement patterns and value as a result of healthcare process, such as adherence to guidelines for 
testing (Grundy et al. 1993). HbA1c displays a clear negative linear correlation of -0.193 only on the slow 
time scale, a higher HbA1c value is correlated to a shorter time until next measurement (Figure 4.3(b)). 
Creatinine also displays a clear negative linear correlation of -0.208, but on the short time scale.  
The results from the linear correlation calculations were consistent with earlier work on the 
relationship between laboratory value and measurement frequency (Weber and Kohane 2013). Weber and 
Kohane assigned categories to laboratory tests based on how numerical values were perceived (e.g.: 
“Bad-Good” represented a laboratory test where a low value was bad, and a high value was good). In our 
work, a positive linear correlation indicates a “Bad-Good” test where a low value prompts rapid retesting 
and a high value has a longer measurement gap, similarly a negative linear correlation represents a 
”Good-Bad” test.  
The interplay between correlations on the full time scale and separately on the short and long time 
scales revealed interesting findings about measurement dynamics. For example, bicarbonate showed a 
positive linear correlation on both long and short time scales (the higher the value, the longer the gap 
between measurements), but when aggregating the time scales together and computing the total linear 
correlation, the correlation disappeared (Figure 4.3(c)). By contrast, the PSA screening test had very 
similar mutual information on the full and long time scales. The differences between tests such as 
bicarbonate and the PSA screening test hint at differences in the contexts in which laboratory tests are 
ordered (Figure 4.3(d)). As PSA is measured in a single context, it is not subject to signal dilution due to 
timescale aggregation. Alternatively, the correlation results for laboratory tests such as bicarbonate, which 
are measured for multiple reasons and in various contexts, indicate that it is sometimes necessary to 




Figure 4.3 Density plots of the PDFs (consisting of laboratory values and time between consecutive measurements) for 
four laboratory tests shown on the full time scales. The x axis represents the log time to next measurement in days: log 
(1 h) = −1.38, log (1 day) = 0, log (1 week) = .85, log (1 month) = 1.47, log (1 year) = 2.56. Each graph shows different levels 
of correlation: LDL has no correlation on any time scale as shown by the mostly round ball, HbA1c has a negative correlation 
as shown by the L-shape of the curve, Bicarbonate separates along two time scales while PSA is almost exclusively measured 





4.3.2 Task 2: Laboratory Test Measurement Motifs 
Manual cataloguing of the measurement gap histograms for 70 laboratory tests uncovered a set of 
three motifs that were most common. The three motifs of laboratory test ordering are influenced by two 
factors: patient health state and the healthcare process (Figure 4.4). These two factors contribute to create 
the shape of the laboratory test’s histogram. Certain histogram motifs highlight the presence of multiple 
contexts in which the test is being ordered. The histogram shape can determine whether further population 
stratification is necessary for conducting analyses or whether the laboratory measurements already 
represent a mostly homogenous patient set. The contributions of the patient health state and the healthcare 
process is dependent on the laboratory test itself and define the three motifs of test ordering: (i) primarily 
inpatient, (ii) primarily outpatient, (iii) a mixture of in- and outpatient. Figure 5 shows typical graphs 
from each of these three categories.  
 
Figure 4.2 A Bayesian network describing the two factors that influence a laboratory tests measurement pattern. The 
extent to which each factor contributes, changes which motif the test belongs to, thereby changing how it can be used in research 
settings.  The “mixed in- and outpatient” motif represents laboratory tests taken across patients with multiple health states. 
Laboratory tests with mixed motifs may contribute to biased results when computing over the multiple health states as one 
population of patients. 
 
In general, laboratory tests that show peaks at very short time gaps in their measurement histograms 
are representative of tests taken during inpatient stays; laboratory tests with measurement graphs that peak 
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at longer gaps of a few months are representative of measurements obtained during an outpatient visit. 
For some tests, the documentation (outpatient vs. inpatient) reason is aligned with the clinical reason; 
related to the fact that the numerical value obtained from a particular test is valid for a specific time 
period only. For example, troponin levels are representative of a patient state at the hour level, and thus 
their measurements are on the timescale of days. Because troponin is measured for patients suspected of 
suffering a myocardial infarction, and such a diagnosis has a high rate of inpatient admission, the troponin 
measurement dynamics are representative of an inpatient stay.  
Troponin’s measurement dynamics represent a primarily inpatient laboratory test, motif (i). Other 
laboratory tests such as microalbumin and HbA1c change at a slower time scale and are ordered primarily 
in outpatient settings; as the values change slowly, there is no need to repeat their measurement during a 
short-term hospital admission. Therefore, HbA1c and microalbumin measurement dynamics represent 
primarily outpatient visits, motif (ii).  
Laboratory tests that follow motif (iii) represent a set of tests whose measurement dynamics result 
from a mixture of both clinical and documentation reasons. For instance, glucose changes rapidly and is 
widely used in inpatient settings to monitor short-time scale changes but is also a regular test performed 
during outpatient visits to monitor chronic diabetics. The glucose dynamics are evident by the histogram 
diagram in Figure 5 where there is a fast time scale peak at 1 day, and a smaller slow time scale peak at 
91 days. The peak at 91 days shows quarterly patient monitoring. Many other laboratory tests have motif 
(iii) measurement dynamics: for example, creatinine displays an almost identical histogram as glucose 
because they belong on the same basic metabolic panel and lipase along with amylase also have a mixture 
motif because of their use in both inpatient settings for acute events and outpatient settings for long-term 
monitoring.  
Triglycerides is also a laboratory test with a mixture motif but with very different mixture weight 
(iii.b). This type of mixture laboratory test represents a dynamic that is also a result of mixed 
documentation and clinical reasons but with much heavier weight on the outpatient component mixing. 
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Most of the population receives triglycerides at 3-month time scales to assess heart health but a small 
subset of patients have their triglycerides monitored on a much shorter time scale, these are ICU patients 
with feeding tubes. The large portion of outpatient testing is seen in the triglycerides measurement gap 
histogram because the peak at 91 days is at a similar height as the peak at 1 day.  
These three laboratory measurement motifs determine how to use different laboratory tests in EHR 
research. The tests for which clinical and documentation reasons align (laboratory tests used almost 
exclusively for in- patients or outpatients) represent a homogenous set of contexts, or patient states. Thus, 
with laboratory tests in motif (i) or (ii), aggregating across patient values is a safe approach. In contrast, 
the laboratory tests with the mixed measurement motifs, might represent several separate patient states 
(such as patients receiving triglyceride measurements as outpatient patients and patients receiving 
triglyceride measurements as ICU patients). Aggregating patient’s values without separating the different 
patient state contexts in a large-scale study may introduce biases. The next section shows results of 
selecting patient cohorts by relying on a laboratory test with mixed dynamics (lipase) and how it impacts 
disease modeling (acute pancreatitis).  
4.3.3 Task 3: Measurement Patterns Highlight Clinical State 
We considered the histograms of measurement dynamics as plots of missing measurements. We 
presumed that for laboratory tests in the mixed motif category (iii), the data are missing not at random and 
may be informative of the patient’s health state. Following intuition from Little’s pattern mixture models 
(Little 1993) we hypothesized that different missing data patterns (or varying gaps between 
measurements) define different health states.  
We explored this idea using lipase and hypothesized that (i) lipase measurement dynamics indicate 
two distinct missing values patterns, each representative of a clinical condition, rather than a 
documentation state; and (ii) separating the dataset by missingness patterns (visits with short gaps 
between measurements vs. visits with long gaps between measurements) helps recover the association 





Figure 4.3 Representative examples of the three measurement gap motifs identified.  Each laboratory test motif is presented 
on a log–log scale as a histogram of the days between consecutive test measurements for each patient, aggregated across the full 
population. (i) Troponin represents a primarily inpatient laboratory test, with a peak at 0 days and displays an approximately 
linear relationship in the coordinate system; (ii) HbA1c is an example of a primarily outpatient laboratory test, showing a highly 
peaked distribution around 91 days; (iii.a) Glucose represents a mixture of in- and outpatient measurements, evidenced by the 
complex histogram: a high peak at on a short time scale (less than 10 days) and another peak at long time scales (multiple 
months); (iii.b) Triglycerides is another example of mixed laboratory test dynamics but with a slightly different mixture type: 
triglycerides has a high outpatient component and shows two different time scale peaks with a large quantity of measurements on 
the long time scale. 
 
Note Types 
The note-type analysis indicated a significant difference between the common note types used in 
the short-gap and long-gap bins. The note types in Table 4.1 showed that lipase measurement dynamics 
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can highlight true clinical differences, rather than documentation differences between inpatient and 
outpatient visits.  
Note type 0-3 Day measurement gap 3+ Day measurement 
gap 
Difference in % 
 Raw 
frequency 







Signout 6,269 0.144 21,345 0.039 0.105 
Miscellaneous Nursing 
Note 
4,443 0.102 14,944 0.027 0.075 
12-Lead Electrocardiogram 2,126 0.049 9,217 0.017 0.032 
X-ray of Chest, Portable 1,460 0.034 3,901    0.027 
Discharge Summary 783 0.018 3,030 0.006 0.012 
Progress Note 837 0.019 3,937 0.007 0.012 
Adult Social Work Progress 
Note 
662 0.015 2,383 0.004 0.011 
Physical Therapy 605 0.014 2,325 0.004 0.01 
Admission Note 579 0.013 2,154 0.004 0.009 
Respiratory Care Patient 
Assessment 
512 0.012 1,434 0.003 0.009 
Table 4.1 Note types indicative of healthcare setting (in vs. outpatient) are spread across short and long gap bins, hinting 
that the measurement gap-based separation is not representative of healthcare, but rather of health states. This table 
shows the top 10 normalized differences in % of total note types in each bin, each has a highly statistically significant difference 
in % total note types. 
 
There are note types that are only written during inpatient stays: an admission note, a signout note 
during a hospital shift change, and a discharge note. If separating visits based on lipase measurement 
dynamics were separating on a purely documentation basis with inpatient visits in the short-gap bin and 
outpatients in the long-gap bin, we would expect these inpatient-specific notes to be exclusively present in 
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the short-gap bin. Instead, there are more inpatient notes in the longer gap bin but the coverage of 
inpatient notes is larger in the 0-3 day bin; the signout, admission, discharge account for 14%, 2%, and 
1% of the total note-types, respectively. The long-gap bin contains a large amount of inpatient data 
demonstrating that the laboratory test measurement dynamics are able to isolate visits based on health not 
hospital status in the short-gap bin. The note types present in the short-gap bin are relevant for diseases 
associated with lipase measurement as well. Elevated lipase often leads to testing for inflamed pancreas 
by ordering ultrasound scans, CT scans, ERCP or Chest X-Rays. Common note-types for all 4 procedures 
were significantly more frequent in the 0-3 gap bin and ranked in the top 10% of Table 4.1. The results 
from the note type analysis suggest that lipase measurement dynamics are able to separate by patient 
health status and find specific visits that more likely pertained to acute pancreatitis events.  
Note Content 
The words with the largest difference in coverage between the short-gap and long-gap bins are very 
relevant to pancreatitis (Table 4.2): both lipase and amylase can be used to diagnose pancreatitis, Librium 
is an anti-anxiety drug often given to alcoholic patients with withdrawal symptoms, and alcoholic patients 
often have pancreatitis. There are more references to “pancreatitis” in the long-gap bin but the normalized 
frequency and coverage of the word is much higher in the short-gap bin. This indicates that the notes 
written during shorter gaps in measurement are more focused on the pancreatitis diagnosis.  
The word “pancreatic” modified “cancer” with a high prevalence in both gaps. This results from 
many patients with long-term pancreatic disorders experiencing acute episodes during their illness. We 
found that the word “cancer” has a coverage and frequency about 3 times higher in the long-gap bin than 























pancreatitis 10,732 0.14 6.94 13,303 0.01 1.41 5.52 
lipase 4,908 0.06 4.28 9,728 0.01 1.5 2.79 
amylase 3,855 0.05 3.48 98,246 0.01 1.3 2.19 
withdrawal 4,139 0.05 2.8 12,562 0.01 1.28 1.52 
librium 3,303 0.04 2 6,064 0 0.59 1.42 
pancreatic 4,393 0.06 2.76 15,992 0.01 1.38 1.38 
epigastric 3,668 0.05 2.92 15,767 0.01 1.89 1.04 
Table 4.2 Words associated with a pancreatitis health state are more frequently found in the short gap bins, suggesting 
that the separation is grouping notes written during visits that are more concentrated on the pancreatitis diagnosis into 
the 0–3 day measurement gap. The raw, normalized, and coverage frequencies of words in each gap sorted by the difference in 
coverage between the two bins is shown in this table. The words with a larger than 1% difference are shown, each of the words 
shown is highly associated with the 0–3 gap. 
 
4.3.4 Recommendation for EHR Research with Laboratory 
Measurements 
Knowing that acute pancreatitis is associated with high lipase levels, we used the binomial test to 
investigate whether separating visits by lipase measurement gaps highlight this association more 
prominently. In each setting, we performed a phenome-wide analysis to see the association between high 
lipase and ICD-9 577.0 (Acute Pancreatitis).  
In the 0-3 day gap setting, the binomial test found the top association to be acute pancreatitis with 
an extremely significant Bonferroni corrected p-value of < 1 × 10−234. In the other two settings (greater 
than 3 day gap, and no separation by gaps), acute pancreatitis was also found to be the top association but 
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with a much smaller p-value (Figure 4.3). The long-gap setting had the smallest association and therefore 
the no separation setting also showed a much lower p-value. These p-value differences demonstrate that 
signal dilution is a consequence of ignoring measurement frequency bias during phenome-wide analyses. 
The process of binning laboratory values by their gaps between measurements (Table 4.3) can reduce 
confounding by not mixing different patient health states. Our results also demonstrate the 
generalizability of this measurement gap separation method. The measurement bins, created based on 
lipase measurement dynamics, were able to differentiate levels of association in other diseases as well. 
Type II diabetes (which may reflect clinicians screening type II diabetics with high triglycerides for 
pancreatitis) and HIV were differently associated with each setting. Without the lipase measurement- 
based separation of visits these disease associations are confounded by the bias of short-term lipase 
measurements. Interestingly, the ICD-9 for chronic pancreatitis is similarly associated with all three 
settings. The consistency of chronic pancreatitis is from patients having acute episodes during their 
chronic illness, conversely, not all acute pancreatitis patients have chronic pancreatitis. This asymmetry is 




Figure 4.4 The results of a binomial association test between high lipase and ICD-9 codes.  The binomial test was performed 
in all three settings (short gaps between measurements of 0–3 days, long gaps of more than 3 days, and all visits regardless of 
gaps between lipase measurements). The top 20 most significant associations are shown. For illustration purposes, the ICD-9 















Step Action Motivation 
1 Plot a histogram of the frequency and 
measurement gap in log–log coordinates 
The histogram provides a method to visually examine the 
laboratory tests measurement dynamics 
2 Examine the modality of the plot; looking 
for multi-modality 
If the histogram is multi-modal, it may imply a difference in 
patient health states or a healthcare process bias 
3 If there are multiple peaks, define a 
measurement gap threshold to separate the 
peaks 
This separation defines multiple settings for the EHR 
experiment, creating sets of homogenous data points with 
respect to their measurement gaps 
4 Perform the EHR experiment separately 
for each setting 
Separately performing experiments for different settings may 
remove confounding bias 
Table 4.3 Measurement gap separation method. The actionable measurement gap separation method for finding and removing 
a confounding bias in laboratory test EHR data. 
 
4.4 Discussion 
EHR research studies rely heavily on laboratory tests and their numerical values. We studied how 
laboratory test’s pattern of measurements may provide additional information to a laboratory test’s values. 
We discovered there is very limited correlation between how often a test is ordered and the value of the 
test. This lack of correlation implies that the value and measurement gap are informationally orthogonal 
to each other and are both important features to include when looking at laboratory tests, and specifically 
when using laboratory tests as features to represent patient disease state. In addition, there is evidence of 
different correlation results when examining laboratory test values on different time scales, showing that 
temporality plays a crucial role in the use of clinical laboratory test data.  
We found evidence that measurement patterns of laboratory tests are dictated by clinical and 
physiological knowledge, but often confounded by the healthcare process, such as hospital documentation 
practices whether from workflows or guidelines.  
One clear artifact of hospital document patterns was revealed by examining the measurement gap 
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histograms of 70 laboratory tests. Many laboratory test histograms have peaks at exactly 91 days, 
although their histogram height is varied. Our hospital serves a highly captive and sick population of 
patients in the surrounding neighborhoods. As the population is sick, 3-month checkups are a common 
practice and as the population lives nearby, the general adherence to a strict 3-month (91 day) schedule is 
high. It is clear that this 91-day peak is caused by the operations of the hospital and makeup of the 
population – not the clinical state of each individual patient. Although this particular healthcare process 
bias is specific to our institution, we postulate similar types of biases exist across the country and should 
be mitigated before using the EHR-recorded data for research.  
Upon cataloguing all 70 laboratory tests we uncovered three types of measurement dynamics 
motifs, one which represents “mixed” laboratory tests where clinical factors and documentation standards 
are misaligned.  
4.4.1 Separation by Measurement Pattern Mitigates EHR Bias 
Laboratory tests with multiple ordering reasons, such as those used for both diagnosis and 
monitoring, present challenges to EHR-based research. When using laboratory values without accounting 
for the laboratory test’s frequency of measurement, confounders can dilute the results of a study. The 
dynamics of laboratory measurement gaps across a population can reveal different measurement patterns 
present in the data; examining the measurement patterns of a particular test and then performing patient 
record decomposition in a strategic manner reduces signal dilution. For example, filtering the full patient 
cohort by visits within a particular measurement pattern of missingness will provide a more focused 
dataset of patient states.  
We demonstrated our method of visit separation through measurement gap analysis on lipase as a 
specific use case. Using note types, note content, and ICD-9 codes we showed that our method could 
group inpatient visits pertinent to a particular clinical condition (acute pancreatitis in our example) away 
from inpatient visits pertinent to other clinical reasons. We also performed a secondary analysis to test 
that separating on hospital status does not yield the same results as separating by measurement gap. When 
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looking exclusively at inpatient visits (without accounting for measurement gap), the association between 
high lipase and acute pancreatitis was only as high as the ”3+ Days” association found using the 
measurement gap separation method (Figure 4.6). Therefore, we infer that the measurement gap 
separation method can indeed separate on health status, not simply healthcare process.  
The work presented in this thesis is highly relevant to researchers working on cohort identification 
algorithms, especially with the recent push for more automated ways to perform high-throughput 
phenotyping (Chen et al. 2013; Wei et al. 2010; Lussier and Liu 2007). We present the stratification of an 
individual’s medical record by laboratory test measurement frequency as a new conceptual paradigm for 
studying EHR data with EHR-recorded laboratory tests.  
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Chapter 5: Learning Probabilistic 
Phenotypes from Heterogeneous EHR Data5 
5.1 Introduction to the Phenome Model 
Computational tools and techniques that reduce the dimensionality of many individual patient 
characteristics documented in the EHR, that discover underlying clinically meaningful latent states of the 
patient, and that allow reasoning in a probabilistic fashion over them would be powerful allies to 
clinicians. In fact, these tools would also facilitate many analytics tasks when applied to entire patient 
populations, including predicting disease progression, comparing effectiveness of treatments, and 
studying disease interactions (Hripcsak and Albers 2013; Wei and Denny 2015; Liao et al. 2015). For 
such tools to operate in a robust fashion across varied patients and enable high-throughput search over 
many diseases, modeling from large amounts of patient records is critical. How to build these tools is an 
open research question.  
Here, we tackle this challenge through jointly modeling a very large set of diseases and an 
overwhelmingly large set of clinical observations. The observations are drawn directly from the 
heterogeneous EHR data, and the diseases are modeled in an unsupervised fashion. We refer to this task 
as large-scale probabilistic phenotyping, in essence building computational models of diseases from 
patient records.  
We introduce the Phenome model in its first iteration, a graphical model for large-scale 
probabilistic phenotyping. The key contributions of the model are:  
 
                                                      
5  This chapter was originally published in the Journal of Biomedical Informatics. The full citation for this 
publication is:  Pivovarov R, Perotte AJ, Grave E, Angiolillo J, Wiggins CH, Elhadad N. Learning Probabilistic 




• It models diseases and patient characteristics as a mixture model, thus scaling easily to large sets of 
diseases and clinical observations;   
• It derives phenotypes—individual disease distributions over patient observations—from raw data 
and diverse data types common to most EHRs: text, laboratory tests, medications, and diagnosis 
codes;  
• It is unsupervised, and as such, can learn disease models across datasets from different institutions 
and different care settings, such as intensive care, emergency care, and primary care;  
• It can incorporate clinical knowledge through informative priors; thus enabling the phenotypes 
learned in an unsupervised manner to be guided towards more established models of disease. 
• It leverages a topic modeling approach, handling issues inherent to EHR data such as sparsity and 
noise, and capturing relations amongst observations that are implicit in the records.  
5.2 Related Work 
We discuss related work according to two areas of research: computational models of disease and 
probabilistic graphical models in the clinical domain. 
5.2.1 Related work in Computational models of disease 
One of the promises of the EHR is to enable reasoning and decision support over patient record 
data. Therefore, deriving a computationally actionable representation of patients based on their clinical 
records has been a grand research challenge, with proposed solutions from several disciplines and 
research fields. Since healthcare is driven almost entirely by the presence and/or severity of disease, 
representing diseases in an actionable fashion has been much investigated over the years.  
The eMERGE phenotyping effort aims to model individual diseases one at a time. It relies heavily 
on expert consensus to build disease definitions that can be applied over a large set of EHRs. While time 
consuming, this effort yields precise phenotypes of single diseases (Newton, Peissig, and Kho 2013). 
More recently, single disease modeling efforts have experimented with automated feature extraction from 
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knowledge sources to reduce the manual effort involved in creating precise phenotypes (Yu et al. 2015). 
In addition to single disease phenotyping, researchers have also explored the use of clustering techniques 
to identify subtypes of a given individual disease (Doshi-Velez, Ge, and Kohane 2014; Lasko, Denny, and 
Levy 2013; Marlin et al. 2012; Schulam, Wigley, and Saria 2015). 
When it comes to modeling a very large set of diseases at once, most of the work to date has been 
heavily reliant on manual knowledge curation. Ontologies like SNOMED- CT encode information about 
diseases such as potential treatments, symptoms, and the relationships amongst them. Bayesian networks 
which encode relationships amongst diseases and symptoms have also been developed (Miller, Pople, and 
Myers 1982). The Internist 1/QMR-DT resource was created manually and allows for computational 
reasoning about diseases and symptoms (Shwe et al. 2005; Jaakkola and Jordan 1999). One drawback of 
these resources is that, while their content is curated, they do not necessarily link to observation types 
documented in patient records.  
Approaches that leverage healthcare data—whether claims data or EHR data—to represent diseases 
and their interactions have also been proposed in the literature (Hanauer, Rhodes, and Chinnaiyan 2009; 
Hidalgo et al. 2009; Roque et al. 2011). However, these approaches focus on interactions amongst 
diseases rather than modeling the diseases themselves.  
Recently, a novel method to learn representations of multiple diseases across a large set of patients 
was proposed based on matrix factorization (Ho, Ghosh, and Sun 2014). In this framework, unseen 
patients can be assigned phenotypes, as defined by a collection of diagnosis codes.  
Our work aims for a similar goal to that of Ho and colleagues (Ho, Ghosh, and Sun 2014): the 
Phenome model learns phenotypes for a wide range of diseases, and derives the model based on EHR 
data. However, the Phenome model departs from previous work in disease modeling in the following 
ways: (i) it learns a representation jointly over heterogeneous EHR data types (as it has been 
demonstrated that unstructured data adds valuable information to purely structured data in the context of 
phenotyping (Liao et al. 2015)), (ii) it operates in a probabilistic framework, thus enabling modeling of 
the uncertainty inherent in noisy EHR observations, and (iii) the model is not inherently limited to a set 
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number of data types, in this current iteration the Phenome model incorporates four different data types 
but provides a framework to expand and include many other clinically relevant data types as well. 
5.2.2 Probabilistic graphical models in the clinical domain 
With the growing amount of EHR data in electronic format, modeling the EHR with latent variable 
models has been an increasingly active area of research. The well-established Latent Dirichlet Allocation 
(LDA) model (Blei, Ng, and Jordan 2003) has been applied to raw clinical text for several tasks, such as 
identifying sets of similar patients (Arnold et al. 2010), correlating disease topics with genetic mutations 
(Chan et al. 2013), analyzing themes in patient safety event data repositories (Fong and Ratwani 2015), 
and predicting ICU mortality (Ghassemi et al. 2014), with success, suggesting that topic modeling can act 
as a powerful and reliable dimensionality reduction technique. Such unsupervised modeling of topics is 
attractive as the language of clinical notes is particularly noisy with much paraphrasing power, and styles 
(e.g., abbreviations) that vary widely from one institution to another and from one care setting to the next. 
More recently, researchers applied LDA to billing codes from disparate EHRs and found sets of 
phenotypes that remain consistent across multiple institutions, further demonstrating the power and 
portability of unsupervised learning techniques (Chen et al. 2015). Researchers have also investigated 
novel probabilistic graphical models, also used in a variety of tasks, including ICU illness severity scoring 
(Saria, Koller, and Penn 2010), diagnosis code prediction (Perotte et al. 2011), redundancy-aware topic 
modeling (Cohen et al. 2014), disease progression modeling (Wang, Sontag, and Wang 2014), and 
disease subtypes identification (Schulam, Wigley, and Saria 2015). 
While some clinical latent variable models have been evaluated in task-based settings (Ghassemi et 
al. 2014), evaluating the intrinsic value of the learned latent variables beyond their face validity, as well 
as their ability to infer meaningful latent states on unseen data can yield much information about the 
models. For general domain texts, evaluation methods of topic modeling have been much investigated. 
Experiments to obtain human judgments have been proposed (Chang et al. 2009), and automatic metrics 
that aim to correlate with such judgments (i.e., held-out likelihood and automatic topic coherence) have 
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been explored (Wallach et al. 2009; Newman, Lau, and Grieser 2010; Lau, Newman, and Baldwin 2014). 
Reliable and valid human judgments of topics are difficult to obtain, and as such automatic metrics are 
attractive. In the clinical domain, these metrics have not been validated fully, and quality judgments from 
clinicians are critical. When it comes to our phenotyping task, we want to evaluate how well the latent 
variables represent individual diseases. Because clinicians are trained to think about diseases as 
probabilistic mixture of symptoms, treatments, and comorbidities, we can leverage this training towards 
collecting qualitative judgments of phenotypes.  
Our goal in developing the Phenome model is to build interpretable disease models that are 
clinically valid and actionable. As such, we developed the model with knowledge of the EHR 
characteristics in mind and designed experiments to test for clinical relevance of the learned phenotypes.  
5.3 The Phenome Model 
The Phenome model proposed in this chapter is a mixed membership model, inspired by the topic 
model literature (Blei, Ng, and Jordan 2003; Griffiths and Steyvers 2004). This model learns 
computational representations of disease based on observations from patient records, as encoded in the 
EHR. In this chapter we present two versions of the Phenome model, the fully unsupervised (UPhenome) 
model, and the grounded (GPhenome) model which incorporates clinical knowledge via known 
relationships between diseases and medications, laboratory tests, words, and diagnosis codes.  
5.3.1 Inputs and Outputs of the Phenome Model 
The input to the Phenome model consists of a large set of patient records, where each record is 
composed of free-text notes, medication orders, diagnosis codes, and laboratory tests. Each data type is 
treated as a bag of elements. The words in the notes are tokenized and simple filtering of vocabulary is 
based on token frequency as well as stop words removal. The medication orders are mapped whenever 
possible to bag of medication classes. The diagnosis codes are also encoded as a bag of codes.  
There are two outputs to the Phenome model: learned phenotypes and an inference mechanism to 
identify a specific phenotype distribution for an unseen patient record. The learned phenotypes can act as 
 
97 
computational models of disease, and can be evaluated according to their interpretability and clinical 
relevance. In addition, the top-ranked diagnosis for a given phenotype can be used as a label proxy, thus 
supporting the interpretability of the disease model.  
The inference mechanism acts as a dimension reduction technique, where each new patient record 
can now be represented as a distribution over a concise set of clinically meaningful variables (the learned 
phenotypes). Such a representation can be leveraged in many health analytics tasks, including patient 
record summarization, risk prediction, and patient cohort selection. The variables of the model are listed 




Number of phenotypes  
Number of patient records 





Diagnosis code distribution for phenotype p 
Number of diagnosis codes in record r  
Diagnosis code instance i in record r  





Words distribution for phenotype  p 
Number of words in record r  
Word instance n in record r  





Medications distribution for phenotype p  
Number of medication orders in record r  
Medication instance o in record r  







Laboratory test distribution for phenotype p  
Number of laboratory tests in record r  
Laboratory test instance m in record r  
Phenotype assignment for laboratory test instance m in record r 
Table 5.1 Variables in the Phenome model. 
5.3.2 Baseline Models to compare against the Phenome Model 
Before describing the Phenome model, we first describe two baseline models. The baseline models 
use LDA and are built on (1) clinical text and (2) all data types.  Although billing codes are often used for 
identifying patient cohorts, it has been demonstrated that individual billing codes are not a reliable proxy 
for disease modeling (Wei et al. 2015).  In addition, in our preliminary experiments (not shown) we were 
unable to produce clinically-reasonable phenotypes when running LDA with only billing codes.  
The first baseline, LDA-text, considers only the notes in the records, following the hypothesis that 
clinical information about the diseases of a patient will be documented in the notes and thus can be 
captured through standard topic modeling. This is a state-of-the-art approach in several models for 
clinical data. Our first baseline is thus a vanilla LDA applied to the bag of words in the notes.  We 
additionally experimented with modeling the other data types separately but as they yielded much less 
interpretable phenotypes due to sparsity (each patient record has many fewer diagnosis codes than words), 
we only used the LDA-text as a baseline. 
The second baseline, LDA-all, learns topic models based on all observations in the record (words, 
medications, diagnosis codes, and laboratory tests). In this baseline we apply a vanilla LDA on all 
observation types in a single bag. The working hypothesis for this baseline is that diseases can be 
represented across the different data types in the record. This baseline model has the exact same input as 
the Phenome model.  
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5.3.3 Graphical Model representation of the Phenome model6 
In the Phenome model, a patient record is represented as a probabilistic mixture of phenotypes, and 
the phenotypes are defined as a mixture of characteristics derived from a large, diverse population of 
patients. More specifically, a phenotype is defined as a set of distributions over the observation 
vocabularies, one for each of the four heterogeneous data types. As in the LDA baselines, we model the 
observations and phenotype assignments as multinomial distributions, and the phenotype distributions as 
sets of Dirichlet distributions. The details of the probabilistic latent variable model are shown in Figures 
5.1 and 5.2.  
The Phenome model departs from the LDA-text baseline by considering all data types in the record. 
It departs from the LDA-all baseline by treating each data type on its own, and learning the type-specific 
phenotype distribution separately (ηp , θp , ιp , κp variables). There are multiple advantages to treating the 
data types this way: (i) this formulation adheres to the genre and characteristic of EHRs; (ii) it allows for 
future specification of different levels of sparsity and distributions for each data types; (iii) it enables a 
platform for incorporating domain knowledge specific to each data type which we explore further in this 
chapter; and (iv) it enforces the principle that conditioned on phenotype assignments, the per-data type 
phenotype distributions are independent of each other. Since the four phenotype distributions must 
separately sum to one, this mitigates potential imbalance in data type prevalence, and thus hinders one 
frequent observation type (e.g., words) from overwhelming the less frequent ones (e.g., diagnosis codes).  
                                                      
6 The notation used in Figure 5.2 and in Section 5.3.4 differs slightly from the notation used in the 
journal publication version of this work.  The thesis notation is more precise, however, for readability purposes 




Figure 5.1 Graphical representation of the Phenome model. 
 
 




5.3.4 Inference in the Phenome Model 
To perform inference on the Phenome model, we derived a collapsed Gibbs sampler which 
collapses the parameters β, η, θ, ι, κ. Due to the similarity of the models, inference in the Phenome model 
follows methods previously outlined for inference in LDA (Griffiths and Steyvers 2004). The derivations 
for the sampler are available in Appendix B. For illustrative purposes, in equation (1), we show the 
conditional distribution necessary for Gibbs sampling for one of the phenotype assignment variables, the 
laboratory test phenotype assignment, and note that the conditionals for the other phenotype assignment 
variables follow closely.  
  (1) 
Here, the notation XY, . ,*:\]
^  represents the total count of all diagnosis code tokens Ir in patient 
record r, that are assigned to phenotype p. Similarly for XY, . ,*:_]
^  (word tokens) and XY, . ,*:`]
^  
(medications). The counts for laboratory tests are performed without counting the particular laboratory 
test instance, m, which  belongs to the type l∗ and for which the conditional distribution is being 
evaluated. Therefore, X . ,a∗,*:c]
d^,d(e,Y)
 represents the total count of all laboratory tests, Mr, in patient record r, 
that are assigned to phenotype p, except (represented by a minus) for the current laboratory test instance 
m in record r.  Finally, we note that the denominator of this conditional only contains counts for the 
laboratory test, demonstrating the differences across the phenotype distributions for each data type. 
5.3.5 Grounding the Phenome Model 
A primary goal of our work is to generate phenotypes compatible with clinician’s mental models of 
diseases. Incorporating a human in the loop, like in interactive topic modeling (Hu, Boyd-Graber, and 
Satinoff 2011) and clinical anchor learning (Halpern et al. 2014) is a promising approach. Another 
 
102 
approach to support this goal is to incorporate knowledge from existing clinical knowledge resources, 
inspired by the advances in constrained topic modeling (Andrzejewski, Zhu, and Craven 2009; 
Andrzejewski et al. 2011; Hu, Boyd-Graber, and Satinoff 2011), and incorporating known semantic 
relations in disease modeling (Doshi-Velez, Wallace, and Adams 2015). 
In this work, we experiment with automatically grounding the unsupervised Phenome model 
algorithm using existing clinical knowledge resources.  Links between different data types and diseases 
are derived from a variety of curated terminologies.  We used the following sources: RxNorm and 
NDFRT for medications linked to diseases by the “May Treat” or “May Prevent” relationship, Medical 
Entities Dictionary (MED - the terminology that underlies the NYPH data warehouse) for laboratory tests 
linked to diseases by the “Procedure indicates Patient Problem” relationship, UMLS for billing codes to 
diseases links through the ICD-9 to SNOMED-CT link, and the Observational Medical Outcomes 
Partnership Standard Vocabulary for words to diseases by collecting at all first-order relationships from 
that disease to all other entities and tokenizing the results.  Although the Logical Observation Identifiers 
Names and Codes (LOINC) terminology is more widely used for encoding laboratory tests, we chose to 
implement the GPhenome model using the MED because the link between laboratory tests and diseases 
was readily available from the MED. The link information was encoded into the model priors by creating 
informative, asymmetric priors with pseudo counts when the links were identified.  To ensure that this 
prior information would not be completely overwhelmed by the data, every observation-disease link 
found in the clinical ontologies had the pseudo count for the prior set to 100.   
5.4 Experimental Setup for the Phenome Model 
We now describe our datasets, parameter settings and model selection, as well as the different 
evaluation experiments we carried out.  
5.4.1 Datasets 
To investigate the generalizability of the Phenome model, we experimented with two 
qualitatively different mixtures of patients and patient diseases: (1) records of extremely sick patients who 
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are in the intensive care unit (ICU) with constant monitoring, which usually spans a few days; and (2) 
records for outpatients regularly followed by care providers over multiple years. These datasets are also 
from different institutions using different EHR systems. In each dataset, 80% of the records were used for 
training, and 20% for testing. Descriptive statistics about the training sets for each dataset are given in 
Table 5.2.  
 MIMIC  ICU Dataset NYPH  Outpatient Dataset 
 Total / Unique Total / Unique 
Patients  18,697 / 18,697  9,828 / 9,828  
Words  13,086,278 /12,919  12,840,334 /12,295  
Medications  1,044,541 / 855  22,146/ 353  
Lab Tests  7,499,446 / 309  549,699 / 318  
Diagnoses  159,740 / 985  233,214 / 931  
Table 5.2 Descriptive statistics for the MIMIC ICU and NYPH Outpatient training datasets.  In this work, the number of 
patients and the number of input records is equivalent. Each MIMIC patient has one input record consisting of all data gathered 
during one ICU stay and each NYPH patient has one input record consisting of all data gathered during four consecutive 
outpatient visits.  
 
MIMIC II ICU Dataset 
We included all adult patients in the dataset, independently of their present or absent conditions. 
For each record, we selected one ICU admission and all of its corresponding observations: discharge 
summary, all medications, all diagnosis codes, and all laboratory tests. Medications and laboratory tests 
were mapped to the standard vocabulary definitions provided by MIMIC. For all data types, we limited 
the vocabulary to observations that appeared at least 20 times in the training dataset.  
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NYPH Outpatient Dataset 
For this study, the NYPH data was subset to select only outpatient visits, providing a contrast to the 
MIMIC ICU dataset.  We included all patients, independently of their conditions.  Since their records 
span decades and often hundreds of visits, we considered slices of records for each patient that capture a 
somewhat stable health status. We selected the most recent time slice of each record that contained four 
different primary provider notes with no intervening inpatient stays. We defined record lengths by 
number of notes and not absolute time to account for different rates of visit (Hripcsak, Albers, and Perotte 
2015). Any patient whose record slice lasted less than 1 month or greater than 4 years was removed and 
this resulted in patient records with mean length of 10 months (7 months standard deviation). 
As in MIMIC, we collected all observations related to primary provider notes, medications, 
diagnosis codes, and laboratory tests. The range of medications is much more diverse than MIMIC 
medications, and thus we mapped all medications to their therapeutic class when possible (e.g., “Tylenol” 
was mapped to “Analgesic”). Similarly, the laboratory tests were mapped to groups of tests when possible 
(e.g.,“Glucose finger stick” was mapped to “Glucose”). As this dataset (in contrast to MIMIC), is not 
deidentified, we applied a simplistic method for trying to automatically remove as many patient and 
physician names as possible by removing any first and last names that appeared in the “Top 1000 Names” 
as listed by the US Census.  Thus, the vocabulary sizes for these observations were dramatically reduced. 
We applied frequency thresholds to the data to closely match MIMIC vocabulary sizes whenever 
possible.  
5.4.2 Model Parameters and Model Selection 
MIMIC II ICU Dataset 
With the MIMIC dataset, we focused our model selection on identifying the best number of latent 
variables (P).  We ran the UPhenome model with the following P settings on the MIMIC ICU dataset: 50, 
75, 100, 250, 500, 750. All of the hyperparameters (α, µ, ν, ξ, π) were set to 0.1 for all models. To ensure 
appropriate burn-in time for each model, the Gibbs sampler was run 7,000 iterations and the log- 
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likelihood curves on training data were examined to verify burn-in. The learned phenotype assignment 
settings for each model were selected as the ones that produced the maximum log-likelihood over all 
7,000 iterations on the training set.  
For model selection, we optimized for interpretability of phenotypes, and thus relied on both held-
out likelihood and coherence of the learned phenotypes. The automated phenotype coherence calculation 
was performed using normalized pointwise mutual information (NPMI) over all observation types, as 
described by Lau et al. (Lau, Newman, and Baldwin 2014) and using the provided open source code. For 
each model, we used the average NPMI across all phenotypes to represent the overall coherence of the 
learned phenotypes from the model.  
For this experiment, NPMI is calculated for each observation (zi) in each phenotype, limited to the 
top N=40 most probable observations. The per-phenotype NPMI is the average of the NPMI of each 
word, and the model NPMI is the average of each per-phenotype NPMI value, defined by:  






v)*  ,     (2) 
where P(zi) = probability of seeing observation zi and  
P(zi,zj) = probability of seeing both observation zi and observation zj in the same patient record.   
To calculate the likelihood on the held-out set, we implemented a Chib-style estimator as described 
by(Murray and Salakhutdinov 2009). The likelihood was calculated using 1,000 iterations of the estimator 
for every setting of P (likelihood curves and the NPMI coherence are provided in the online supplement 
material).  The combination of the two metrics suggested that P=250 was likely to produce the best 
phenotypes given the current parameter settings on the MIMIC dataset.  
For both baseline models LDA-text and LDA-all, we used the MALLET software package 
(McCallum 2002) with similar number of topics as the selected UPhenome model (K=250) and similarly 
with 7,000 iterations to ensure burn-in. The hyperparameter settings for the baseline models were 0.01 to 
increase sparsity due to the larger size of the combined vocabulary. 
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NYPH Outpatient Dataset 
With the NYPH dataset, we experimented with grounding the Phenome model and with 
hyperparameter optimization.   
Grounding 
To identify the correct phenotypes on which to ground the Phenome model, we explored the 
disorders frequently documented in the NYPH dataset.  Using counts of SNOMED-CT Core Problem List 
disorders most commonly found across the entire NYPH dataset, we found that 695 disorders were 
common enough in the NYPH dataset and contained enough information upon which to ground (ie. 
enough medications, laboratory tests, words, or diagnosis codes that are linked to this disorder across 
clinical ontologies).  We ran GPhenome on 750 phenotypes: 695 of them had augmented counts for the 
identified grounding and the remainder were left ungrounded to learn other phenotypes present in the 
data. 
Hyperparameter Setting 
We ran several iterations of the UPhenome model with different hyperparameter settings to 
determine the best setting for α and the rest of the hyperparameters  (µ, ν, ξ, π). The models were run until 
the burn-in and the log- likelihood curves on training data were examined to verify burn-in. The learned 
phenotype assignment settings for each model were selected as the ones that produced the maximum log-
likelihood over all iterations on the training set.  
To find which hyperparameter setting produced the best model, we used the same Chib-style 
estimator as described by (Murray and Salakhutdinov 2009). The likelihood was calculated using 1,000 
iterations of the estimator for every setting of the hyperparameters. 
For the baseline models LDA-all baseline model, we used the MALLET software package 
(McCallum 2002) with similar number of topics as the selected GPhenome model (K=750) and with a 
similar number of iterations to ensure burn-in. The hyperparameter settings were set to be the same as the 
optimal settings found for the NYPH dataset (α =0.1, [µ, ν, ξ, π]=0.001). 
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5.4.3 Evaluation Experiments 
In addition to the automated evaluation metrics, such as held-out likelihood and automatic 
coherence of the learned phenotypes, we carried out the following set of experiments: qualitative 
assessment of learned phenotypes (manual coherence, manual granularity, pairwise phenotype 
comparison, label quality) and ability of the phenotypes to characterize ground-truth disorders present in a 
set of unseen patients (disorders to phenotypes associations).   
All qualitative judgments were obtained from a clinical expert. The learned phenotypes were 
displayed using a modified version of the interactive topic modeling interface (Hu, Boyd-Graber, and 
Satinoff 2011). The interface is particularly useful to us because it enables users to edit learned 
phenotypes by adding/removing observations and marking them as important or ignorable. For each 
phenotype, the top 40 most probable observations were displayed and weighted by their phenotype 
probability (normalized by their data-type specific phenotype probability). The observations were also 
color-coded to signify their data types (purple for words, grey for medications, green for laboratory tests, 
and blue for diagnosis codes).  
Manual Coherence 
This experiment allows us to capture the intrinsic quality of the learned phenotypes across its 
probable observations, very much like the automatic coherence metric aims to. In our case, a coherent 
phenotype is one that describes a single condition and that does not contain observations that are not 
typically seen in patients with this condition.  
In the MIMIC ICU dataset we compared the UPhenome model with the baseline LDA-all model 
each.  In the NYPH dataset, we compared the UPhenome model, the GPhenome model, and the baseline 
LDA model. For each experiment, 50 phenotypes were randomly selected from each model and presented 
one at a time to the clinical expert. The expert was asked to score the coherence of a given phenotype 
(without being told which model produced the phenotype) according to a 1-5 Likert scale, where 1 
designated no coherence (i.e., uninterpretable) and 5, perfect coherence. To help the expert in his 
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assessment, we instructed him to use the interface to edit the phenotypes, and use his number of edits as a 
cue for lack of coherence.  
Manual Granularity 
Because both the baseline and the Phenome models are unsupervised, there is no guarantee that the 
learned phenotypes are good representations of clinically meaningful diseases. In particular, it is possible 
that the modeling of patient observations generates clusters that are reflective of the documentation 
processes of healthcare rather than of the documentation of clinical status of a patient. For instance, 
patient discharge to a nursing home in the MIMIC dataset contains very specific documentation patterns, 
which in an unsupervised setting could be easily grouped.  
We asked the clinical expert to categorize the random phenotypes into one of the following three 
granularities: (i) a non-disease phenotype (e.g., a healthcare process or uninterpretable phenotype 
phenotype); (ii) a mix of diseases; (iii) a single disease.  
Pairwise phenotype comparison 
In this experiment, we assess the compared overall quality between phenotypes learned from the 
different models. In the MIMIC dataset, we compared the learned UPhenome phenotypes and learned 
LDA-baselines phenotypes. To ensure that the comparison is fair, we selected the 50 random Phenome 
phenotypes, and identified the most similar corresponding LDA-all phenotype for each.  For the NYPH 
dataset we compared the UPhenome and GPhenome phenotypes and selected 50 random UPhenome 
phenotypes and identified the most similar corresponding GPhenome phenotype for each. To compute 
pairwise phenotype similarity, we used Jensen-Shannon divergence over the posterior probabilities of all 
observations.(Manning and Schütze 2003) The clinical expert was presented pairs of phenotypes without 
him knowing which model generated which phenotype. The expert was asked to choose which phenotype 
was more clinically coherent or to code the comparison as impossible when both phenotypes were 
unintepretable, equivalent, or paired improperly.  
Label Quality 
One of the data types used in the Phenome model is diagnosis codes. The diagnosis codes are ICD-
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9 codes, which often describe specific diseases (e.g., “breast cancer”), but can also describe classes of 
diseases (e.g., “malignant neoplasms”), as well as generic statements about a patient (e.g., “personal 
history of other diseases”). Since the diagnosis codes are often used in the clinical world as proxies for 
conditions present in a patient, this experiment assesses to which extent the most probable diagnosis code 
for a learned phenotype is a clinically appropriate label for the phenotype as a whole.  
Since the LDA-text baseline does not include diagnosis codes, this experiment was skipped for this 
model. Similarly, since in the baseline LDA-all model it is possible that the top-40 most probable 
observations do not include any diagnosis code (in our experiment, this happened actually very often), we 
assessed label quality for the 50 Phenome phenotypes only.  
We asked the clinical expert to categorize the top diagnosis code with respect to the phenotype as a 
whole as (i) related; (ii) unrelated; or (iii) actionable. An actionable label is one that accurately represents 
the phenotype at the right granularity and it can be relied upon when making a decision about a patient 
with the phenotype assigned.  
Disorders to Phenotypes Associations 
While the previous experiments assessed the quality of the learned phenotypes, this experiment 
assesses the ability of the Phenome phenotypes to characterize clinically relevant and ground-truth 
disorders present in a set of unseen patient records. If there is a strong association between phenotypes 
and the disorders in these records, then the phenotypes can be considered clinically relevant for a given 
patient.  
A potential application of the Phenome model to identify present disorders for a given patient by 
inferring the most probable phenotypes for the record. To validate this point, we relied on a gold-standard 
set of records, which contain manual annotations of the disorders present and mentioned in the records’ 
notes. The ShARe gold standard is based on MIMIC notes and contains such annotations (Semeval-2015 
task 14: Analysis of clinical text, 2015.; Pradhan et al. 2014). We included the 350 discharge summaries 
from the ShARe corpus in our test set. For each record, gold-standard annotation provided a list of 
SNOMED-CT Disorder concepts, along with modifiers such as negation and uncertainty. Ground-truth 
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disorders for a record were defined as concepts with no negation or uncertainty.  
In total, for each of the 350 records, we have ground-truth disorder concepts (from a set of 2,000+ 
unique concepts in the corpus) and inferred phenotype assignments. We created an association matrix, 
similar to work by Griffiths and Steyvers (Griffiths and Steyvers 2004), visualizing the degree of 
association between present concepts and phenotypes. We selected concepts, which occurred in at least 50 
records. We selected the concepts that occurred in at least 50 records. This experiment examines 
associations between common disorders and learned phenotypes; with 350 patients, there are not enough 
annotations to associate phenotypes with rare disorders. The association was computed using normalized 
pointwise mutual information, and for each concept the top phenotype was selected.  
5.5 Results 
 
Figure 5.3 An example of a learned phenotype. The top 40 most probable observations for the phenotype are listed. 
The Phenome model is able to produce interpretable results: Figure 5.3 shows an example of 
learned phenotype on the NYPH dataset. The label on the left is the most probable diagnosis code, in this 
case SLE (Systematic Lupus Erythematosus). The words (in purple) are indeed related to this disease and 
refer to abbreviations in clinical notes (“rheum”) or mentions of important laboratory tests for SLE 
(“ana”, “esr”), as well as mentions of specific drugs indicated for SLE (“plaquenil”). The medications are 
also related (plaquenil, one of the most common drug for SLE is an antimalarial medication), as well as 
prednisone. Both C3 and C4 levels are used as diagnosis tests for SLE, while ESR and others test for level 
of inflammation in a patient. SLE is a phenotype learned from the NYPH dataset, which represents 
outpatient records over long periods of time. Since SLE is a chronic disease it makes sense that it was 
discovered in this dataset. For comparison, there is no phenotype learned on the MIMIC dataset that 
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captures characteristics of SLE. Because the Phenome model is unsupervised, it models the diseases that 
are of interest to a given input clinical setting/patient cohort.  
5.5.1 Model Selection 
MIMIC II ICU Dataset 
Using the NPMI (Table 5.3) and held-out likelihood (Figure 5.4) calculations together identified P=250 as 
the best number of latent variables to explain the MIMIC dataset.  The likelihood was calculated on a 
held-out dataset of 4,685 (20%) MIMIC ICU patients. 
 
 
Table 5.3 Average NPMI for different numbers of latent variables 
 
Model Number of Latent 
Variables 










LDA-all 250 0.0750 




Figure 5.4 Held-out likelihood calculation for the MIMIC dataset for different numbers of latent variables. 
NYPH Outpatient Dataset 
The number of phenotypes (750) for the NYPH dataset was determined by disease concept frequency in 
order to perform grounding. Nine different hyperparameter settings were tested (Table 5.4) on a 
validation set to determine the optimal setting for the NYPH dataset.  To ensure that (0.1, 0.001) is the 
optimal setting, the held-out likelihood for (0.1, 0.0001) was also calculated; the result was -2.522x107. 
 α parameter setting 
µ, ν, ξ, π 
parameter 
settings 
 0.1 0.01 0.001 
0.1 -2.610x107 -2.569x107 -2.57 x107 
0.01 -2.610x107 -2.519x107 -2.531x107 
0.001 -2.511x107* -2.512x107 -2.530x107 
Table 5.4 Held-out likelihood on a test set for different parameter settings. * represents the optimal setting. 
5.5.2 Evaluation 1: Coherence 
MIMIC ICU Dataset 
For the comparison of the Phenome model with baselines, we report its comparison to the LDA-all 











Figure 5.5 Distribution of manual coherence scores for the UPhenome and LDA-all phenotypes on MIMIC data.  A score 
of 1 represents an unintepretable phenotype and 5, a perfect phenotype. 
Figure 5.5 shows the distribution of coherence scores for the 50 phenotypes from the Phenome 
model and the 50 phenotypes from the LDA-all model. The LDA-all phenotypes contained many more 
unintepretable phenotypes than the Phenome ones, and at the same time contained slightly more perfectly 
coherent phenotypes than the Phenome ones. Overall, about 66% of the Phenome phenotypes were scored 









Figure 5.6 shows the distribution of coherence scores for the 50 phenotypes from the Phenome 
model, 50 phenotypes from the grounded Phenome model, and 50 phenotypes from the LDA-all model. 
The LDA-all phenotypes contained many more uninterpretable phenotypes than either of the Phenome 
ones.  The GPhenome model was able to create more coherent phenotypes than the fully unsupervised 
Phenome model. Overall, about 48% of the Phenome phenotypes were scored as good (coherence score 
above 4), 56% of the Grounded Phenome model phenotypes were good, but only about 36% of the LDA-
all phenotypes were scored as good.  We note, however, that by performing ad-hoc post-processing on the 
LDA-all results such as data-type mapping and data-type normalization (a step that the Phenome model 
does inherently during learning), we were able to achieve manual coherence results comparable to the 
Phenome model results. 
5.5.3 Evaluation 2: Granularity 
MIMIC ICU Dataset 
The UPhenome model yielded more phenotypes that are clinically well-defined as representing a 
single disease than the LDA-all baseline. Furthermore, the LDA-all baseline suffered from a high number 
of unintepretable phenotypes (as confirmed by the Manual coherence experiment).  
For the UPhenome phenotypes, the clinical expert categorized 10% as non-disease phenotypes, 
10% as a mix of diseases, and 80% as representing a single disease. In contrast, for the LDA-all 
phenotypes, the clinical expert categorized 42% as non-disease phenotypes, 6% as a mix of diseases, and 
52% as representing a single disease.  
NYPH Dataset 
For the UPhenome phenotypes, the clinical expert categorized 46% as non-disease phenotypes, and 
54% as representing a single disease. In contrast when the model was grounded, the clinical expert 
categorized 14% as non-disease phenotypes and 86% as representing a single disease.  For the LDA-all 
model, the expert found that 62% of the phenotypes were non-disease, 4% represented a mixture of 
diseases, and only 34% of the phenotypes represented a single disease. 
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5.5.4 Evaluation 3: Pairwise Phenotype Comparison 
MIMIC ICU Dataset 
 
(a) LDA-all phenotype 
 
(b) Phenome phenotype 
Figure 5.7 An example of LDA-all and Phenome phenotypes, both about Iron Deficiency Anemia, as paired automatically 
by Jensen-Shannon divergence. 
Figure 5.7 displays an example of paired phenotypes shown to the clinical expert. We can see that 
the most probable observations in the LDA-all phenotype are words and laboratory tests (except for one 
medication), with only a few highly probable and relevant words/tests and most irrelevant to iron 
deficiency anemia. In comparison, the most probable observations in the Phenome phenotype are spread 
across data types, with a majority of observations relevant to iron deficiency anemia.  
Overall, out of the 50 pairs of phenotypes assessed, the clinical expert considered comparison 
impossible for 9 pairs. The Phenome phenotype was superior to the LDA-all comparison in 80.4% of the 
remaining pairs and superior to LDA-text in 68.3% of the remaining pairs. 
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For this outpatient dataset, we performed a pairwise comparison between grounded and ungrounded 
phenotypes, to assess the effect of grounding on the quality of the learned phenotypes.  Overall, the JS 
divergence was not able to match the phenotypes as well for this task and the clinical expert found that 12 
pairs were not matched well or represented uninterpretable phenotypes.  Of the remaining pairs, the 
clinician found that 55% of the time, the ungrounded Phenome model was superior to the grounded 
Phenome model. 
 
(a) Ungrounded Phenotype for Sinusitis.  
 
(b) Grounded Phenotype for Sinusitis 
Figure 5.8 Grounded and ungrounded Phenome model phenotypes.   
 
Figure 5.8 displays two phenotypes paired for the clinical expert evaluation.  Since the NYPH data 
is not de-identified, names sometimes appear in phenotypes (especially clinicians that specialize in 
particular diseases as they often sign the clinical notes). A name has been blurred in the Figure 5.8.  The 
expert chose the grounded phenotype (b) over the ungrounded phenotype (a) as a better representation of 
sinusitis.  In both of the phenotypes, the learned laboratory tests are not ideal, however in the grounded 
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phenotype displays a more relevant set of terms and medications.  The grounding of the sinusitis 
phenotype (Figure 5.9), demonstrates how the augmented priors that were inserted into the GPhenome 
model, the figure illustrated how the grounding is able to guide the phenotypes to better disease models 
using clinical knowledge encoded in available knowledge resources.  We note, however, that the 
informative priors specified by the grounding, apply equal weight to all of the words and medications 
displayed in Figure 5.9, but the phenotype (Figure 5.8b) has differing weights for the different 
medications and words; this confirms our hypothesis that the grounding can guide the modeling 
procedure but statistics of the input data are still well represented. 
 
Figure 5.9 The observations that had augmented counts for the grounded Sinusitis phenotype. 
 
5.5.5 Evaluation 4: Label Quality 
MIMIC ICU Dataset 
Overall, the most probable diagnosis code for a given phenotype was evaluated as good proxy for a 
phenotype label. In the MIMIC ICU dataset, the clinical expert assigned a label as actionable for 48% of 
the UPhenome phenotypes, 44% of them were considered related, while only 8% of them were 
considered unrelated. 
NYPH Dataset 
The clinical expert compared the UPhenome labels to the GPhenome labels.  The expert found that 
the UPhenome model, 42% of the labels were actionable, 26% were related and 32% were unrelated. The 
GPhenome labels were found to be superior: 56% actionable, 28% related, and 14% unrelated.  
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5.5.6 Evaluation 5: Disorders to Phenotypes Comparison 
As the ground truth disorders were available for the notes from the MIMIC ICU dataset, this 
evaluation was performed only on the MIMIC dataset, not the NYPH outpatient data. 
 
(a) Associations amongst ShARe annotations (y-axis) and phenotypes (x-axis). The x-axis is sorted to 
demonstrate the highest associations on the diagonal. 
        
(b) Phenotype 1      (c) Phenotype 7 
     
 (d) Phenotype 10      (e) Phenotype 11 
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Figure 5.10 Association of manually identified ground-truth concepts and automatically inferred phenotypes over a set of 
patients, along with four example phenotypes. 
 
Concept Unique Identifier (CUI)  Concept Description  
C0020538  Hypertension  
C0011860  Type II diabetes mellitus  
C0020443  Hypercholesterolemia  
C1956346  Disorder of coronary artery  
C0008031  Chest pain  
C0013404  Shortness of breath  
C0018802  Congestive heart failure  
C0026266  Mitral valve regurgitation  
C0004238  Atrial fibrillation  
C0002871  Anemia  
C0019080  Hemorrhage  
C0030193  Pain  
C0042963  Vomiting  
C0027497  Nausea  
C0013604  Edema  
Table 5.5 UMLS concept unique identifiers for the ShARe annotations in Figure 5.10. 
Figure 5.10 shows the association matrix between the present disorders in the gold standard ShARe 
corpus and the inferred phenotypes on the gold-standard records. There were 15 disorder concepts that 
were present for at least 50 patients in the dataset. As such the matrix is 15x15. Borrowing from the 
visuals displayed by (Griffiths and Steyvers 2004), we sorted the matrix to clearly display the ShARe 
annotated disorders and their mostly highly associated inferred phenotypes on the diagonal. For clarity 
purposes, we grouped the 15 disorder concepts based on each other’s clinical similarities. For instance, 
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hypertension, hypercholesterolemia, and type II diabetes are often seen together in patients, and similarly 
for the symptoms nausea and vomiting.  
The figure indicates there is an association between the disorders present in the gold-standard 
records and their inferred phenotypes. Upon inspection of the inferred phenotypes, they are good 
representations of the present disorders. For instance, Phenotype 7 has the highest association with the 
disorder Mitral Valve Regurgitation, and its most probable observations are perfectly coherent with 
respect to this disease.  
When concepts shared clinical characteristics (e.g., nausea and vomiting or the cluster of 
hypertension, diabetes, and hypercholesterolemia), the associated phenotypes are also shared amongst 
them (e.g., phenotypes 12,13 and phenotypes 1,2).  
We display two more examples of phenotypes. Phenotype 10, which is associated with hemorrhage 
shows several diagnosis codes, all potentially leading or describing hemorrhages. Phenotype 11 is an 
unintepretable topic, containing highly prevalent observations throughout the MIMIC dataset. 
5.5.7 Evaluation 6: Quantitative Metrics 
The quantitative metrics for the MIMIC ICU dataset were used to inform model selection and as such we 
report only the quantitative calculations for the NYPH dataset in this section. 
 Held-out likelihood NPMI 
UPhenome Model -2.512x107 0.021 
GPhenome Model -2.543x107 0.031 
LDA-All -3.501x107 -0.062 
Table 5.6 Quantitative evaluation for the unsupervised Phenome model, the grounded Phenome model, and the LDA-all 
model. All of the models were run on the same input set of Columbia patients, with 750 latent variables, 0.1 for the per-patient 
phenotype distribution hyperparameter and 0.001 for the per-phenotype data distribution hyperparameter. 
The UPhenome model is able to outperform both the GPhenome and LDA-all model when predicting on a 
held-out test set (Table 5.6).  As the GPhenome model is seeded with ontological knowledge that in some 
cases may not be perfectly aligned with the existing data, the model’s ability to predict may be hindered 
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and can account for the lower held-out likelihood score. The very large benefit that the Phenome models 
have over the LDA-all models is due to the separation of data types.  The LDA-all model is not inherently 
separating laboratory tests from medications from diagnosis codes from words, therefore the LDA-all 
model has a much more difficult task of predicting infrequent data types as they are competing with the 
overwhelming number of words that exist in the clinical notes.   
In contrast to the MIMIC ICU dataset, the Phenome models outperform the LDA-all baseline with 
the NPMI metric. 
5.6 Discussion 
The results of the various automated and manual evaluations suggest that the Phenome model is a 
promising approach to discovering models of disease. We discuss next two characteristics of our model—
the joint modeling of heterogeneous data types and their unsupervised modeling— as well as the 
differences between automated and manual coherence assessments for the task of phenotyping and the 
effects of grounding. 
5.6.1 Joint modeling of heterogeneous EHR data 
Previous work has shown that single data types are not sensitive enough to perform phenotyping at 
a high accuracy. Wei et al. demonstrated that when phenotyping ten chronic conditions, algorithms that 
only used single instances of billing codes as a phenotyping algorithm achieved an average F-score of 
0.17, algorithms that used multiple billing code instances achieved an average F-score of 0.60.  However, 
when multiple heterogeneous data types were leveraged (billing codes, clinical text, and medications), the 
algorithm was able to achieve an F-score of 0.70 on average (Wei et al. 2015).  The Phenome model 
builds upon this knowledge as it is designed to jointly model multiple, different EHR data types. 
The Phenome model leverages the innate heterogeneity and incompleteness of EHR data. By 
modeling each data type separately as opposed to a bag of observations like in the LDA-all baseline, the 
model can accommodate for imbalance of observations from each data type. For instance, there are many 
more words than diagnosis codes, even after stop words removal and vocabulary filtering. By design, the 
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Phenome model ensures that each data type is represented in the learned phenotypes, thus truly modeling 
across data types. This explains for instance, why all Phenome phenotypes given as examples in the 
chapter have a mix of data types, while most LDA-all phenotypes are overwhelmed by words and 
laboratory tests (i.e., the most common data types in our observations).  
The separation of each data type in the Phenome model allows for specification of informative 
priors that are different for each data type.  The ability to enhance the Phenome model with outside 
clinical knowledge, and even more specifically knowledge that is different for each data type is a 
powerful mechanism that will be explored further in the GPhenome model work.  Although the model 
separates the different data categories, this separation does not render the data types independent. On the 
contrary, because the patient-specific phenotype distribution (β) is unobserved, the data types become 
dependent from the explaining-away effect.  Therefore, the information learned about the billing code 
distribution across phenotypes is dependent on the medications distribution, the laboratory test 
distribution is dependent on the distribution of words, and so on. 
 
5.6.2 Generative unsupervised modeling of EHR data 
Like all unsupervised models, the Phenome model is exciting in its ability to discover patterns in 
input datasets, such as disease models. When applied to the MIMIC corpus, the learned phenotypes are 
representative of diseases that are documented in an intensive care unit, like acute kidney failure, while 
when applied to the NYPH dataset, the learned phenotypes are more representative of chronic and acute 
conditions that do not require intensive care, such as SLE.  
Without careful modeling however, unsupervised models can yield unwanted results. The LDA-all 
phenotypes often highlighted information about hospital course in aspects nonspecific to any underlying 
condition, such as coagulation status, palliative care status, type of drug exposure, and plan for discharge. 
All of these topics make sense and represent distinct patterns in the input datasets, but they do not 
represent diseases. In contrast, the Phenome phenotypes represented a greater number of distinct disease 
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than the LDA-all phenotypes. Furthermore, they were more clinically relevant, as multiple aspects of a 
given disease were included such as secondary complications or potential treatments.  
5.6.3 Automated coherence metrics vs. human judgments 
When comparing the average coherence of the LDA-all phenotypes and the Phenome phenotypes 
for MIMIC ICU data, LDA-all yielded a significantly higher average Normalized Pointwise Mutual 
Information (NPMI) (.07 vs. .014).  By contrast, in the NYPH dataset, the Phenome models had much 
higher NPMI scores than the LDA-all baseline (0.02 vs. -0.06).  NPMI was established as a valuable 
automated evaluation metric of learned topics and was shown to correlate with human judgments of topic 
coherence (Lau, Newman, and Baldwin 2014). In our experiments however, we found little correlation 
between the clinician’s judgments and the NPMI of the learned phenotypes (Pearson R=0.31 and 
Spearman=0.33 over the MIMIC ICU UPhenome phenotypes and Pearson R=0.34 and Spearman =0.31 in 
the NYPH UPhenome phenotypes). In our settings, the Phenome model is a mixture model over text but 
also coded data (e.g., diagnosis codes, medications, and laboratory results). It is possible that the 
computationally coherent (often co-occurring terms) are not actually clinically relevant. For instance, the 
LDA-all phenotype with the highest NPMI contained the following most probable observations: “pm total 
co pt potassium gap sodium urea chloride anion glucose creat hct hgb rbc mcv mchc mch wbc rdw”, a 
mix of routine, nondiscriminatory laboratory tests. By contrast, the NYPH data deals with much more 
varied note types and patient diseases and may explain the low NPMI scores yielded by the LDA-all 
model. 
 It is also possible that different observations within coded data types may not occur frequently 
together. For instance, there are several diagnosis codes which are highly clinically relevant with each 
other, and yet do not get coded together in patient records: different stages of pancreatic cancer for 
example, would make sense in a single phenotype for the disease, but will not be seen jointly over many 
patients at a time.  
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5.6.4 Effects of Grounding the Phenome model 
Augmenting the Phenome model with known associations that exist in clinical ontologies is able to 
provide more coherent and cohesive phenotypes.  A phenotype may be grounded by any combination of 
words, diagnosis codes, laboratory tests, or medications.  We found that often when a phenotype was 
grounded exclusively by words, the final learned phenotype often did not reflect the data it was grounded 
with.  However, when a phenotype was grounded with diagnosis codes or medications or laboratory tests, 
the phenotype would resemble the prior grounding information much more strongly.  We attribute these 
results to (i) the difference in observations counts and (ii) vague grounding of words. The differences in 
the observation counts means that prior pseudo count of 100 does not apply very strong grounding to 
words as there are many word instances but a prior pseudo count of 100 does make a large difference to a 
much smaller set of observations such as medications or laboratory tests.  The vague grounding of the 
words is due to the chosen method of word grounding: taking all first-order relationships that are encoded 
in the knowledge base as linked with the disease and tokenizing the results.  This method often results in 
comorbidities or vague terms such as “complications” and “chronic” being grounded to a phenotype.  
Although this work presents a first pass at how to incorporate clinical ontologies into the Phenome 
model, future work in pseudo count refinement (perhaps having a different pseudo count augmentation 
for each data type) and newer methods for identifying links for the chosen ontologies (perhaps only 
chosing words that have particular ontological relationships) may result in phenotypes that are even closer 
to clinicians mental models of disease. 
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Chapter 6: Applications to Clinical 
Questions 
6.1 Introduction 
In an effort to apply some of the techniques outlined in this thesis to open questions in clinical 
informatics, we used two techniques on two different questions.  High-throughput screening of laboratory 
test usage using measurement motifs was a helpful technique for identifying and mitigating biases that 
exist in irregularly sampled data (Chapter 3), and in this chapter, we apply the same idea and similar 
method to identifying laboratory test overutilization by examining measurement motifs.   
The other clinical question tackled in this section is one of high-throughput phenotyping 
(Hripcsak and Albers 2013), a question of identifying cohorts of patients using EHR data.  We employ the 
grounded version of Phenome model, which was developed to automatically learn computational models 
of disease (Chapter 5), to the task of automatically finding a set of type II diabetic patients from raw and 
heterogeneous EHR data. 
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6.2 Leveraging measurement motifs to study 
inappropriate use of laboratory tests7 
6.2.1 Introduction 
A recent report from the Institute of Medicine estimates that as much as 30% of healthcare costs in 
the United States are a result of unnecessary care.  Finding ways to reduce unnecessary care can ease 
some of the healthcare cost burden without affecting the quality of patient care (Smith et al. 2013).  One 
major contributor to excessive healthcare costs is the over-ordering of laboratory tests.  
Laboratory test orders recorded in an institution's EHR can be analyzed to identify patterns of 
ordering across a large patient population, study adherence to existing ordering guidelines, and quantify 
potentially unnecessary care. This approach is especially attractive for high-volume tests, for which 
robust pattern analysis can be conducted and for which guidelines have been specifically constructed 
through detailed analysis of the latest research and expert panel discussions to maximize the test’s utility. 
One frequently ordered laboratory test with specific ordering guidelines is Glycated Hemoglobin 
A1c (HbA1c).  HbA1c is the measure of average blood sugar control over 6-12 weeks. The healthy range 
of HbA1c is between 4-6% and diabetic patients have higher HbA1c values. Although diabetic 
classification as controlled and uncontrolled is usually measured with blood glucose measurements, it is 
commonly reported that the desired HbA1c level for a controlled diabetic is less than 7%.  For 
uncontrolled diabetic patients, HbA1c levels often rise much higher. 
Historically, HbA1c has been a standard test for the monitoring of diabetes: in 2002 the American 
Diabetes Association (ADA) established that uncontrolled diabetic patients should have their HbA1c 
measured every 3 months and controlled diabetic patients should have it measured every 6 months (Sacks 
                                                      
7 This chapter was originally published in JAMIA. The full citation for this publication is:  
Pivovarov R, Albers DJ, Hripcsak G, Sepulveda JL, Elhadad N. Temporal Trends of Hemoglobin A1C Testing. 




et al. 2002). Recently, new evidence suggests HbA1c can be used for the diagnosis of diabetes as well 
(Selvin et al. 2010; Handelsman et al. 2011). The 2009 ADA guidelines incorporated this finding and 
began recommending the use of HbA1c for the diagnosis of diabetes (International Expert Committee 
2009; American Diabetes Association 2010). These guidelines state that if a patient has a HbA1c value of 
6.5% or more for the first time, the patient should be retested (on a different day) to confirm the diabetes 
diagnosis; unless the patient exhibits clinical symptoms or has a blood glucose >= 200 mg/dl (American 
Diabetes Association 2013), then no retesting is necessary.  The presence of guidelines (both in 2002 and 
2009), along with the sharp distinction of how HbA1c should be ordered for monitoring and for 
diagnosis, both provide a point of comparison when analyzing patterns of HbA1c ordering. 
Despite these widely publicized guidelines for diabetes care, there are numerous reports of over-
ordering of HbA1c labs.  In a study focusing on newly diagnosed diabetes patients, HbA1c orders were 
analyzed over a period of two years (Laxmisan, Vaughan-Sarrazin, and Cram 2011). It was found that 
8.4% of patients (N = 11,003) received at least one repeat HbA1c within 30 days of their initial test and 
30.8% (N = 40,162) within 90 days.  A more recent 10-year retrospective analysis at a UK university 
hospital found that 21% of 519,664 HbA1c orders were ordered too soon (as defined by sooner than 6 
months for patients with < 7% HbA1c and less than 2 months for patients with 7% or over) (Driskell et al. 
2012). 
Striking differences have been shown in the frequency of HbA1c orders across different healthcare 
settings.  In a study at a Turkish university hospital, 10.3% of all 10,496 HbA1c orders over a two year 
study period were performed within less than a month of one another and when looking only at inpatient 
orders, 33.8% were found to be ordered within less than a month (Akan et al. 2007). Other studies have 
also found inappropriate repeat testing more frequent in hospitalized patients (van Walraven 2003; 
Salvagno et al. 2007). 
In this study, we focus on the overall temporal trends of HbA1c ordering across a 15-year span. 
Thus, we explore the ordering patterns across both inpatient and outpatient data points, as there might be 
an impact on ordering patterns for patients transitioning between outpatient and inpatient settings.   
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In this work, we analyze HbA1c laboratory test order data over a 15-year longitudinal time scale that 
covers the release of two separate ADA guidelines; thereby giving us an opportunity to retrospectively 
study the influence of both guidelines over time.  Guidelines for HbA1c provide instruction on when to 
measure HbA1c for different types of patients.  Specifically, we study how well both the diagnosis 
guidelines and the monitoring guidelines are being followed at our institution. 
Because of the large patient population with diabetes, HbA1c is a high-volume test and is one of the 
most frequently ordered tests in our institution. We comprehensively examine all of the HbA1c 
measurements in our clinical data warehouse; regardless of who is coded for having diabetes to generate a 
more complete view of the HbA1c measurement trends.  We are also in position to link clinical notes to 
ordering patterns in order to qualitatively assess the reasons behind the ordering patterns we observe.   
We ask the following research questions: (i) What are the patterns of ordering HbA1c in a large 
patient population? (ii) Do HbA1c orders follow guidelines with respect to frequency of measurement? 
and (iii) If patterns of ordering do not follow guidelines, in which ways do they depart from the guidelines 
and what are potential explanations for the departure? 
6.2.2 Methods for Identifying HbA1c Temporal Trends 
We collected all HbA1c measurements in the NYPH data between January 1996 and December 
2010. All measurements were included in the dataset, i.e., there were no selection criteria for the patients. 
Each data point consisted of a tuple (patient identifier, timestamp of individual measurement, and 
corresponding value). 
Patterns of HbA1c Ordering through Time 
To capture total yearly ordering patterns, we looked at all HbA1c orders performed in our 
institution. Across all 15 years, we report counts of HbA1c orders and stratify the counts by the numerical 
HbA1c values.   
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HbA1c Ordering Patterns Pre vs. Post 2002 Guidelines 
The 2002 ADA guidelines established that patients with controlled diabetes should be monitored 
every six months and patients with uncontrolled diabetes should be monitored every three months. To 
verify the extent to which these guidelines had an impact on practice, we aggregated our institution’s 
HbA1c measurement data into two subsets: pre-guideline measurements (1996-2001) and post-guideline 
measurements (2003-2010). 
For each year, we include only tests that are conducted within the same calendar year; therefore, 
tests that are conducted in December and repeated in January of the next year are not included in our 
results.  
To visualize repeat ordering patterns, we aggregated data in the following way. For each patient’s 
HbA1c time series we calculated the days between two consecutive measurements within a year and 
aggregated across all patients. A histogram was created for each year mapping the gap between 
consecutive measurements and number of such measurement pairs across the dataset that year. For 
instance, if a patient had two consecutive measurements 132 days apart and both measurements occurred 
in 2007, this would contribute twice to the 132-day gap for 2007. 
To test whether there was a change between the pre- and post-guideline ordering patterns, we 
performed a two-sample Kolmogorov-Smirnov (K-S) test (Massey 1951). The K-S test measures whether 
the pre- and post-guideline samples come from the same distribution.  To quantify the specific differences 
in pre- and post-guideline periods, we performed an L1 distance calculation separately on the 0-90 day and 
the 91-365 day sections of the distribution.  For the L1 distance calculation, we transformed the discrete 
measurement counts for the pre- and post-guideline periods to probability density functions (PDFs) 
representing the probability of every measurement gap across the time period.  We quantified the 
difference between the pre- and post guideline PDFs using the absolute difference between the 
distributions (i.e., the L1 distance) defined by: 
w x, y = |	{* | −
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Here, f1 and f2 are the probability density functions and a, b represent two time points.   
Additionally, to visualize measurement frequency differences between controlled and uncontrolled 
diabetic patients we created a density plot of the joint probability of HbA1c value and time to next 
measurement.  This comparison is important as ADA guidelines are defined based on controlled and 
uncontrolled diabetic patients, that correspond to glucose and HbA1c levels.  We hypothesize that high 
HbA1c values alert the physicians to an uncontrolled diabetic thereby influencing the patient's time to 
next measurement (likely closer to 3 months).  Alternatively, a well-controlled diabetic patient would 
likely not be tested for another 6 months. 
Finally, to enable comparison to prior work that focuses on over-testing of well-controlled 
diabetics, we used HbA1c <7.0% as a proxy measure for well-controlled diabetes and calculated how 
many of the total HbA1c orders each year, are unnecessary (repeated within 180 days for a patient with 
HbA1c < 7.0%). 
Diagnostic Use of HbA1c Ordering 
Considering the 2009 ADA's recommendation for diagnostic use of HbA1c (when a patient has an 
HbA1c of >=6.5% for the first time, it is then encouraged to have the patient’s HbA1c retested on another 
day to confirm a diabetes diagnosis), we tracked the values of the measurements across gaps.  Our 
hypothesis is that rapid re-measurement of HbA1c (within 10 days) is due to the occurrence of a first high 
value.  To test this hypothesis we looked at the proportion of rapidly retested HbA1c’s that follow the 
diagnostic guidelines.  Finally, we qualitatively assessed reasons that guideline deviations may occur by 
reading a sampling of clinical notes of patients who had HbA1c tests repeated within ten days. 
6.2.3 Results of Temporal Analysis of HbA1c Measurement 
Overall, our dataset consisted of 397,926 HbA1c orders, measured for 119,691 unique patients 
across 15 years.  The maximum number of orders per patient was 150, and the average was 3.32, with a 
large standard deviation of 5.83 orders. The high variance we observed is due to the various 
characteristics of our EHR data.  As we are not filtering our population for only diabetic patients we have 
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large differences between regularly monitored patients and those who were tested once for screening 
purposes.  In addition, we have a sparse dataset of patients some of whom may not be regularly followed 
up at the outpatient clinics and others who receive their care in other institutions.  
Patterns of HbA1c Ordering 
Over the 15-year period from 1996-2010, there was an increase in the raw number of HbA1c tests 
at NYPH (Figure 6.1). This increase follows a general increase in measured patients (6,232 patients who 
had their HbA1c measured in 1996 to 31,765 patients in 2010).  Over the 15-year period, the rates of 
HbA1c testing have remained fairly steady, between 2.09-2.7 tests per patient per year, with a very slight 
upward trend.  The increase of tests with <6.5% values is consistent with the use of HbA1c for screening 
purposes, as most screened patients will be normal. 
 
Figure 6.1 Counts of all HbA1c orders over the years 1996-2010, stratified by HbA1c numerical value.  This figure includes 
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To adjust for diabetes screening, we report statistics for patients who have had at least two HbA1c 
measurements within their record. There is still a steady increase of measured patients (4,434 in 1996 to 
19,302 in 2010) and a steady increase from 2.3 tests per patient per year in 1996 to 3.09 in 2010. 
Pre and Post 2002 Guideline Ordering Patterns 
The two-sample K-S test showed a statistically significant difference between the measurement gap 
counts in the pre and post guideline time periods (p<0.001). By estimating the probability density 
functions of the measurement gap counts, we found the measurement gap distribution changed from a 
fairly unimodal to a bimodal distribution (Figure 6.2).  The modality shift shows that a mostly 
homogenous dataset of measurement gaps transformed into a heterogeneous dataset.  We observed that 
that the probability density functions of the pre and post guidelines measurement gaps were highly similar 
after 3 months, both sharply peaking at the 3-month time frame and the post-guideline curve having a 
slight peak at 180 days. 
 
Figure 6.2 Probability density function estimated using a kernel density estimate on the aggregated gaps between HbA1c 
measurements for both the pre-guideline period (1996-2001) and the post-guideline period (2003-2010). 
Noting that the two distributions look very different in the 0-90 days time frame, we performed a 
separate L1 distance calculation for two parts of the distributions (0-90 day gap, 91-365 day gap) to 
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quantify the differences in the distributions.  We were able to detect an order of magnitude difference in 
the L1 distances: L1(0-90 days) = .0012 and L1(91-365 days) = 0.00029. 
We observed a sharp transition in 2002 in how patients are measured on short time scales of less 
than 90 days. This implies that how patients' HbA1c values are measured on time scales of longer than 
three months has not changed in 1.5 decades whereas there was a dramatic change in how patients' 
HbA1c values are measured on time scales of less than three months starting in approximately 2002. 
In addition to measurement gaps, we evaluated how values correlated to measurement gap in both 
pre and post 2002 guideline periods. Figure 6.3 is a density plot representation of the joint probability of 
each HbA1c level and the time to next measurement for both time periods. 
 
Figure 6.3 Joint probability between each HbA1c percentage and time to next measurement before the 2002 
guidelines (left) and after the 2002 guidelines (right). 
The density plots indicate a change in ordering after the 2002 guidelines as well.  Before the 
guidelines were released, there is almost no correlation between HbA1c value and time to next 
measurement; most of the population is measured between 60 and 500 days irrespective of the patient’s 
value.  After the 2002 guidelines, we see a much more prominent correlation between HbA1c value and 
time to next measurement as shown by the L-shaped curve; having a higher HbA1c value prompts quicker 
retesting (around 100 days) while lower HbA1c values have higher probabilities of being measured at 
longer time scales.  If one's diabetes is more controlled (towards the left of the x-axis), there is a longer 
time to next measurement.  
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However, when looking specifically at unnecessary repeat tests for well-controlled diabetics 
(repeats within 180 days for patients with HbA1c < 7%), we still find that rates of inappropriate use 
increase over time.  Between 1996-2000, 3.8-6% of the HbA1c tests were repeated inappropriately.  After 
2000, inappropriate testing rose to 11.8-19.5%, growing to over 20% in 2004 and remaining stable 
between 19-20% until 2010. 
Diagnostic Use of HbA1c 
After 2002, we found growing numbers of HbA1c tests repeated within 10 days. Orders repeated 
within 10 days accounted for 1-2% of all HbA1c orders in 1996-2001, and grew to 2.8-3.8% after 2001.  
Therefore, we examined the dataset in multiple ways to investigate whether the repeats were for justified 
diagnostic purposes or whether overutilization may be occurring.  The 2009 guidelines for diabetes 
diagnosis allow for HbA1c rapid retesting if the patient exhibits a HbA1c value of >=6.5% for the first 
time. 
Looking across all 15 years, we tested whether the patients with rapid retests meet the criteria for a 
diagnostic measure. Surprisingly, in 1996, 37% of retests were justified, whereas only 13% in 2010 were 




Figure 6.4 Proportion of HbA1c measurements taken within 10 days that follow the appropriate guidelines for diagnostic 
use.  This graph only examines HbA1c repeated orders that are within 10 days. Each point was calculated per year as: (# of ≤10-
day repeats where the initial test result was a patient’s first HbA1c of ≥6.5%)/(all ≤10-day repeats). 
 
We find that the rapidly repeated tests cannot be explained by adherence to guidelines. In fact, over 
time, a larger portion of rapid repeats is conducted on HbA1c tests with lower values even as there is no 
justification for any <=10 day repeats when a value is <6.5%. In particular, beginning around the year 





Figure 6.5 Numerical stratification of HbA1c tests reordered within 10 days over the years 1996-2010. 
The overall rate of rapid retesting has grown similarly across all HbA1c values (Figure 6.6), but as 
the number of initial <6.5% orders has increased over time so has the number of inappropriately retested 
HbA1c tests.  From 1996-2001, we find that 1-2% of HbA1c tests with an initial <6.5% value are rapidly 
retested and after 2001, 2-3.6% are rapidly retested.  
As a means to better understand the rapidly retested HbA1c phenomenon, we conducted a manual 
chart review for a subset of 100 randomly chosen patients that had HbA1c rapid repeats.  A common 
pattern we identified was outpatients receive a HbA1c test, are admitted to the hospital a few days later 
and have a repeat HbA1c upon admission to the floor. This could be indicative of care-coordination issues 
where inpatient physicians are unaware of their outpatient counterparts ordering the HbA1c test only a 
few days prior (even though the laboratory results are visible in the EHR). Multiple times, consecutive 
outpatient visits within 10 days resulted in HbA1c being tested during several of the visits. This could 
also point to care-coordination issue amongst clinicians with different specialties (even though, once 
again, the laboratory results are visible in the EHR).  Such care-coordination issues could lead to 








































6.5% <= HbA1c < 7.5%




Another pattern we identified was a retest of HbA1c because the value was much lower than 
expected; specifically, a HbA1c result seemed too low given a patient’s previous history and therefore the 
same physician re-ordered the test; sometimes the clinical notes even referred to the surprisingly low first 
value. Finally, we found that between 5-10% of the rapid repeat tests were a result of physicians 
conducting point-of-care HbA1c testing and ordering a confirmatory laboratory-run test HbA1c test. 
 




Distributional analysis over time of consecutive HbA1c measurements frequencies has uncovered a 
number of phenomena. Overall, the raw number of HbA1c tests has increased over time.  This can be 
explained in part by the natural increasing number of patients coming to our institution for care and in 
part by the increasing number of patients with diabetes.  In addition to the general increase in testing, we 
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also see evidence for increase of inappropriate use from the growing number of very short gap 
measurements (between 0-10 days) over the 15-year period. 
We note that some of the measurement patterns established by the 2002 and 2009 guidelines 
predate their releases, although there were publications that hinted at diagnostic and monitoring 
recommendations before the guidelines as well (Goldstein et al. 2004; Singer et al. 1989; Peters et al. 
1996). It seems that physicians have been using HbA1c as a diagnostic measure for at least 6 years before 
the official ADA guidelines which recommended HbA1c's usage for diagnostic purposes were released; 
we can see this by the prominent peak of short gap measurements that begins to appear around 2003.  
Additionally, we are able to see that during the mid 1990s, before the 2002 guidelines specifying 3 and 6-
month measurement intervals were released, there were already slight peaks at those two measurements 
gaps. 
Overuse of HbA1c Measurements: Retesting Within 10 Days 
While clinicians roughly follow the 3-month and the 6-month guidelines, we find that there is a 
strong signal for seemingly unnecessary repeated measurements within 10 days. The findings from this 
study are well aligned with recent literature about HbA1c measurement dynamics and the overutilization 
of HbA1c over short periods of time. For instance, Lyon et al (Lyon et al. 2009) also uncovered a highly 
prevalent short-gap peak, but their peak was at approximately 30 days, not as short as the time gap in our 
dataset. 
By comparing ordering distributions in our dataset we find the trend towards repeated testing over 
very short time periods (<= 10 days) is increasing in volume and is the most frequent in 2010.  In 
conjunction with a general increase in tests with values HbA1c <6.5%, we uncover a troubling trend: a 
growing proportion of rapid retests are conducted on tests with values <6.5%, despite ADA guidelines 
only recommending rapid retests on a subset of >=6.5% tests.  Moreover, the signal stays salient, even 
after controlling for the usage of HbA1c as a diagnostic tool through two tests a few days part.  
Based on the results illustrated in Figure 6.4, we postulate that between 65-85% of the HbA1c 
repeat measurements occurring within 0-10 days are unnecessarily ordered – a total of 9,491 tests from 
 
139 
1996-2010. The 9,491 tests represent HbA1c repeat test overutilization rate of 2.3% across the entire 15-
year period.  We use the Medicare reimbursement of $13.24 per test to estimate an unnecessary 
expenditure of approximately $125,600 at just one hospital in New York City.  This figure does not 
account for personnel, laboratory time, ordering or interpretation time, any patient care costs, or over 
ordered laboratory tests as a result of transferred patients and a lack of health information exchange, 
which has also been shown to contribute to laboratory test overutilization (Stewart et al. 2010). 
There are many potential explanations for the increasing rate of overuse of HbA1c tests. The 
addition of HbA1c to preset laboratory order panels may lead to the retesting, as often it is more efficient 
for the clinician to order an entire panel rather than remembering to exclude the HbA1c test.  Another 
reason for this trend could be a consequence of guideline-induced over-vigilance; providers are intent on 
following the monitoring HbA1c guidelines but do not always remember to check whether an HbA1c 
result has been recently recorded.   
In this chapter, we provided a methodology for studying utilization patterns that serves as a useful 
diagnostic approach for identifying trends of inappropriate laboratory test use over time.  We analyzed the 
laboratory measurements of HbA1c for all the patients in our institution, over 15 years. Our study 
replicates prior work on HbA1c overutilization and offers new insight into the trends of laboratory 
ordering over time, in particular pre- and post-guidelines for diabetes monitoring, correlations between 
HbA1c value and testing frequency, and the use of HbA1c as a diabetes diagnostic tool. With the number 
of diabetes patients expected to continue to grow (Huang et al. 2009), it is essential to identify the ways in 
which HbA1c ordering is misused. Our study contributes to this effort. 
Impact on Informatics Research 
As the number of EHRs across the country increases, there is a growing potential for pertinent and 
effective IT interventions to help optimize healthcare resources, as well as to ensure that that clinicians 
adhere more closely to national guidelines for testing (Baron and Dighe 2014). For instance, identifying 
rapid retests of HbA1c as a strong pattern in an institution, the EHR could now implement a module that 
denies rapid retest of HbA1c without appropriate reasoning from the ordering physician, and perhaps 
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require a phone call to the laboratory to verify the need for a second test.  Alternatively, there could be a 
systematic review and removal of HbA1c from laboratory test order sets.  
Our work on trends in measurement gaps is relevant to large-scale data analysis work in informatics 
as well. To properly study large patient populations (in our case, across the entire EHR), it is helpful to 
stratify or decompose the population into homogenous data points (Pivovarov et al. 2014). In the pre-
2002 guideline period, the distribution of HbA1c data points by gap is mostly unimodal, but the post-
guideline period shows that the distribution changes towards a bi-modal distribution. Thus, the population 
of laboratory measurements is decomposable according to different reasons, some health-related 
(measurements 3 months apart for uncontrolled diabetic patients), but some for reasons that might not be 
health-related (measurements less than 10 days apart).  The ability to quantify and recognize 
decomposable and not decomposable distributions of data points when performing large-scale research on 
the EHR is critical to ensure precise and robust inference. 
6.3 Leveraging the Grounded Phenome model for 
cohort identification  
6.3.1 Introduction 
Performing cohort selection, or phenotyping, for clinical research studies is an important area of 
informatics research.  The ability to accurately gather cohorts is necessary to perform studies on the 
exploding amount of electronic patient record data; studies on pharmacovigilance, comparative 
effectiveness, disease progression, and many others often rely on robust ways to measure cohorts.  
Recently, a consortium of informatics researchers (the eMERGE network) began creating repository of 
algorithms for selecting EHR patients with certain diseases. (https://phekb.org/). The algorithms use rule 
sets based on recorded laboratory tests, medications, billing codes, etc. to identify a set of case patients 
and control patients.  The algorithms have been shown to have high specificity and positive predictive 
value and have been replicated across a handful of institutions. However, these algorithms have a few 
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drawbacks: (i) the phenotype definitions are very labor-intensive, include iterative design processes, and 
require the insight of clinical experts; (ii) as the process is so involved, there is very limited coverage of 
diseases that have an eMERGE algorithm created; (iii) the diseases are treated as binary events, a patient 
has the disease or not – there is no severity scale or ranking or probability of having the disease. 
The Phenome model (presented in Chapter 5), presents an alternative to rule-based phenotyping.  
As the Phenome model learns phenotypes directly from the structure of the data (with the GPhenome 
model incorporating encoded clinical knowledge to provide prior information that can guide the 
phenotypes to be more clinically relevant), the model does not require heavy expert involvement.  The 
model is able to learn the composition of many diseases at once, and because it was constructed in a 
probabilistic graphical modeling framework, it represents diseases states as probabilities: each patient has 
a certain probability of being ill with each disease.  Because of the benefits outlined above, the Phenome 
model is an attractive alternative, leveraging unsupervised computational techniques for creating initial 
phenotypes, which can then be further refined by experts.  
 In this study, we assess the ability of the GPhenome model to gather patient cohorts and directly 
compare the GPhenome model method with the eMERGE algorithm. We focus on identifying a cohort of 
Type 2 Diabetes Mellitus (T2DM) patients as it is a highly prevalent disease in our population and there 
exists a validated eMERGE phenotyping algorithm for it. 
6.3.2 Methods for Identifying Type II Diabetics from EHR data 
The grounding of the Phenome model creates nonexchangeable phenotypes by augmenting counts for 
certain observations and for certain phenotypes.  These observation-phenotype links that inform the 
augmented counts are automatically derived from clinical ontologies. In turn, these augmented counts 
form informative priors and encourage the formation of more cohesive and representative phenotypes.  




The specific observations that were automatically identified from the clinical ontologies as related to 
T2DM are displayed in Figure 6.7.  These observations are weighted more heavily in the GPhenome 
model prior for the T2DM phenotype.  
 
Figure 6.7 The diabetes prior that was input to ground the Phenome model for T2DM. Billing codes are in blue, 
words are in purple, and medications are in grey. 
 
The GPhenome model was applied to the outpatient NYPH dataset described in section 5.4.1; each 
patient is represented by a recent outpatient time slice of their record. GPhenome was learned on the 
training set of 9,828 patients and tested on held-out test set of 2,457 patients. The GPhenome model was 
run with the same parameters as described in section 5.4.2 (P=750, α =0.1, [µ, ν, ξ, π]=0.001).   After the 
750 phenotypes were learned, a clinical expert reviewed the phenotypes and identified two that represent 
T2DM (Figure 6.8).  
 
(a) The T2DM phenotype learned around the grounded priors for T2DM 
 
(b) The additional T2DM phenotype learned by the GPhenome model. 
Figure 6.8  The two T2DM phenotypes used for identifying T2DM case patients. 
 
Using the GPhenome model inference mechanism, we inferred a distribution over phenotypes for each 
patient in the test set. As the GPhenome model assigns a weight to each phenotype for each patient, we 
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were able to rank the patients identified by the weight of their T2DM phenotype.  The T2DM weight of 
each patient was calculated as the sum of their weights for both of the T2DM phenotypes (Figure 6.8). 
This ranking provides a way to list patients by how prevalently the T2DM diagnosis is discussed in their 
record with respect to other diseases.  
Study 1: Precision-Recall of the GPhenome model 
Evaluation of the GPhenome model’s ability to identify patients who are Type II diabetics included 
the calculation of a precision-recall curve for a random 10% subset of the the test patients (246 patients). 
Gold-standard labels were assigned based on a chart review. A clinician was given the patient MRN, the 
patient record-slice date range, and asked to answer the question: “If all you have is the information 
contained in the EHR within this date range, do you think this patient has T2DM?”  
Study 2: Direct comparison of GPhenome and eMERGE 
In order to directly compare the GPhenome model with a well-accepted algorithm for phenotyping, 
the eMERGE algorithm for T2DM was implemented.  The eMERGE T2DM case algorithm presents five 
ways in which a patient can be classified as a T2DM patient; these five ways use four data types: 
medications, ICD-9 codes, laboratory tests, and problems lists. For example, one way that a patient can be 
classified as a T2DM case is by having no Type I diabetes mellitus (T1DM) diagnosis codes, at least one 
T2DM medication and at least one abnormal glucose or HbA1c laboratory test result.  The full algorithm 
flowchart can be found at: https://phenotype.mc.vanderbilt.edu/phenotype/type-2-diabetes-mellitus. The 
algorithm applies a set of strict criteria aiming to ensure that well-documented T2DM patients are 
captured and no T1DM patients are captured; the algorithm stipulates that if a patient has any T1DM 
diagnosis codes recorded, they cannot be considered at T2DM patient. Although the algorithm generally 
performs with a 98-100% positive predictive value, it has been demonstrated that the strict criteria for 
T2DM case definition may actually omit many true cases resulting in low sensitivity of 32% (Fort, 
Wilcox, and Weng 2014). To ensure proper comparison of the GPhenome model and eMERGE, both 
algorithms are applied on the held-out test set of 2,457 patients (the GPhenome model is learned on the 
training set of 9,828 patients). 
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To compare GPhenome to the eMERGE model (which outputs a cohort of patients), а probability 
threshold must be chosen. The GPhenome model assigns each patient a non-zero weight for every 
phenotype, therefore, a threshold was chosen to separate patients without T2DM from those with T2DM, 
we examined the distribution of T2DM weights visually (Figure 6.9) and chose a threshold of 0.01, 
excluding the patients at the head of the distribution.   
  
Figure 6.9 Distribution of T2DM phenotype weights.  The dotted line represents the chosen threshold of 0.01, those 
patients with a weight at or over the threshold were chosen as T2DM case patients. 
 
Additional constraints were applied to GPhenome in order to match the eMERGE algorithm’s 
removal of T1DM patients (to ensure that the T2DM cohort was not diluted by type I diabetics). The final 
selection criteria for a T2DM case patient was: 
Combined weight ≥ 0.01 for the T2DM phenotypes and  





(a) The T1DM phenotype learned around the grounded priors T1DM. 
 
(a) The additional T1DM phenotype learned by the GPhenome model. 
 
Figure 6.10 The two T1DM phenotypes used for ruling out case patients that may have T1DM instead of T2DM. 
 
The evaluation of the patient cohorts selected by the two different models included calculation of 
sensitivity, specificity, positive predictive value, and F-measure. To estimate these metrics, a clinician 
conducted chart reviews of 50 random patients selected as cases by eMERGE, 50 random patients 
selected by GPhenome, and 50 patients that neither model selected.  The clinician was given the patient 
MRN, the patient record-slice date range, and asked to answer the question: “If all you have is the 
information contained in the EHR within this date range, do you think this patient has T2DM?”  The 
MRN list was randomly shuffled and the clinician was not told which algorithm selected which patient. 
As the GPhenome model assigns a weight to each phenotype for each patient, we are able to rank 
the patients identified by the weight of their T2DM phenotype.  This ranking provides a way to list 
patients by how prevalently the T2DM diagnosis is discussed in their record in contrast to other diseases. 
We evaluated the GPhenome model ranking by using the precision at K metric, where K=50. To calculate 
the precision at K, the clinician was asked to also to do a chart review on the ranked top 50 patients 
(again, with no knowledge that these were derived from GPhenome). 
Finally, to assess the threshold of 0.01 as a phenotype weight for who a true T2DM patient is, a 
precision-recall curve was created on a subset of the 2457 test patients.  A randomly selected 10% subset 
of all test patients was labeled as having T2DM or not having T2DM with the same question as before, “If 
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all you have is the information contained in the EHR within this date range, do you think this patient has 
T2DM?”. 
6.3.3 Results of the Type II Diabetes Cohort Identification  
Study 1: Precision-Recall of the GPhenome model 
The 10% subset of test patients were ranked by their combined probabilities for the two T2DM 
phenotypes.  Using the chart review results, a precision-recall curve was created (Figure 6.11); the 
associated area under the curve was 0.87. 
 
Figure 6.11 Precision-Recall Curve for T2DM Cohort Selection.  
 
Study 2: Direct comparison of GPhenome and eMERGE 
Out of the 2457 test patients, the eMERGE algorithm identified 402 diabetic patients (16.4% of the total 
test patients).  The GPhenome model algorithm identified 497 diabetic patients (20.2%).  Overall, the 
probabilities of T2DM inferred for the test patients ranged from 1-12%.  Although there was some 
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overlap between the identified patients, almost 70% were only identified by one of the two algorithms 
(Figure 6.12).  
 
Figure 6.12 Overlap between cohorts identified by GPhenome and eMERGE cohorts. 
 
The performance measures (Table 6.1) were calculated by extrapolating from the randomly sampled 
patients evaluated by the clinician.  A bootstrap procedure was used to estimate the 95% confidence 
intervals. 




[95% CI: 0.25-0.31] 
0.953 
[95% CI: 0.91-0.99] 
0.920 
[95% CI: 0.84-0.98] 
0.433 




[95% CI: 0.22-0.27] 
0.973 
[95% CI: 0.94-1] 
0.941 
[95% CI: 0.86-1] 
0.384 
[95% CI: 0.35-0.42] 
Table 6.1 The statistical measures of performance for eMERGE and GPhenome. 
 
In addition to the measures of classification accuracy, the expert performed an evaluation of the 
GPhenome model ranking.  The clinician found that 100% of the top 50 GPhenome-identified T2DM 




The results of cohort selection by the two models suggest that cohorts selected by eMERGE rule-
based algorithms could be greatly augmented by the use of the GPhenome model. We discuss the benefits 
of using GPhenome for cohort selection below. 
The GPhenome model maintains the portability of other cohort selection tools. eMERGE 
algorithms are specifically constructed around widely-used terminologies for the purposes of portability; 
any institution can apply the eMERGE rules and gather a patient cohort.  As the GPhenome model is an 
unsupervised algorithm that learns computational disease models specifically from input data and 
publically available clinical ontologies, it can also be implemented at any institution.  
As an inherent benefit of being a probabilistic graphical model, the GPhenome model assigns a 
weight to each phenotype, for each patient.  In contrast to the eMERGE algorithms which present a binary 
result of a patient being a case or not a case, the GPhenome model has the ability to rank patients by their 
phenotype weight.  This ranking enables researchers to set thresholds based on their desired cohort size, 
sensitivity/specificity constraints, and even the presence/absence of other diseases and comorbidities as 
we demonstrated by the T1DM weight constraint.   
To examine why some patients were captured by GPhenome and not by eMERGE, we conducted 
a small and an informal chart review.  We found that in some cases, most of the diabetic evidence was in 
the clinical notes and therefore missed by the eMERGE algorithm.  In many other cases, the reason for 
exclusion was the coding of T1DM diagnosis code.  T1DM codes are often recorded by mistake for 
T2DM patients because of how similar the diagnosis code numbering is for the two diseases (250.0 vs. 
250.1); the eMERGE algorithm filters these patients out by design. The GPhenome model, however, 
weighs the T1DM diagnosis code along with other T1DM evidence and assigns each patient a probability 
of being ill with T1DM. Unfortunately, it is more difficult to assess the reason that some patients were 
included by eMERGE but excluded by GPhenome given the probabilistic nature of the model and lack of 
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explicit rule sets. However, the results of the precision-recall curve demonstrate that reducing the current 
threshold of 0.01 could yield a larger set of true T2DM patients and have higher accuracy results. 
In future work we will continue to refine the grounding, as ideally the grounding regimen would 
provide one phenotype representing the T2DM disease.  However, the current grounding mechanism 
employed in GPhenome already enables a smaller set of relevant disease models.  In the UPhenome 
model, there exist seven phenotypes that represent T2DM, three phenotypes that represent T1DM, and 
one phenotype that is a mixture of both diabetes types. In contrast, the GPhenome model only has two 
phenotypes for T2DM and two phenotypes for T1DM.    
These experiments demonstrate that a probabilistic technique and model such as the GPhenome 
model provide a promising platform for high-throughput phenotyping.  The results obtained by the 
GPhenome model are comparable to eMERGE results and carry the following additional benefits: (i) the 
unsupervised nature of the model learns directly from the data; (ii) the algorithm learns many 
computational models of disease at the same time, greatly reducing the amount of expert time needed; and 
(iii) the model enables ranking of patients by probability of having the phenotype. With further model 
refinements in areas such as data-type specific modeling, incorporation of new data, and grounding 
technique enhancements, we believe this model will provide a new platform for phenotyping across many 






Chapter 7: Conclusions and Future Work 
7.1 Conclusion 
The concluding chapter of this thesis focuses on summarizing the research presented, highlighting 
the contributions of this work, detailing the limitations of the studies described, and the offering potential 
directions for future work.   
Chapter 2 outlined the research conducted in the field of clinical summarization and identified a set 
of gaps that remain in the published literature including methods for dealing with redundancy, methods 
for mitigating the biases caused by irregular sampling, and methods for automatically determining what 
pieces of a patient record should be highlighted and what pieces should be discarded from a summary. 
The first study (Chapter 3) dealt with the question of abundant textual redundancy in clinical text: the 
chapter presented a hybrid approach to identifying redundant concepts in patient records.  
The second study (Chapter 4) focused on irregular sampling in laboratory tests:  the study 
demonstrated the importance of patterns of missingness in laboratory tests and displayed the benefit of 
including these patterns in clinical modeling. The third study (Chapter 5) focused on the question of 
saliency and featured a probabilistic graphical model created for summarizing EHR data. Finally, Chapter 
6 described two separate studies: one which explored the patterns of missingness and temporal trends of 
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laboratory tests in the context of overutilization and guideline adherence, and another which examined the 
practicality of the using the probabilistic graphical model for automated high-throughput cohort selection. 
 
7.2 Contributions 
The immense amount of EHR data collected as a byproduct of routine patient care provides a 
unique platform to perform large-scale research studies of human health. Through careful analysis of the 
variables in this vast dataset, researchers can conduct a variety of multifaceted studies such as prediction 
of future patient health state, evaluation of intervention effectiveness, computational disease modeling, 
and identification of dangerous drug-drug interactions (Prokosch and Ganslandt 2009; McCarty et al. 
2011; Xiaoyan Wang et al. 2008).  This dissertation contributes to the growing body of research on how 
to best use EHR data for a variety of tasks.  The work described here specifically investigates the 
challenges in leveraging EHR data for automated patient record summarization. The specific 
contributions of this thesis are: 
• Context-specific concept aggregation. Mapping clinical term mentions to semantic concepts in an 
ontology provides valuable abstraction from lexical variants present in text. But some concepts 
might need to be further aggregated in order to avoid problems of signal dilution. Our approach 
described in Aim I scores the similarity of two input concepts by combining complementary 
information derived from usage patterns of clinical documentation, accepted definitions, and 
position of the concepts in an ontology. Our experiments show that, given a homogeneous corpus of 
clinical notes, it is possible to determine automatically which concepts convey similar meaning in 
the context of the corpus with accuracy above that of previously proposed methods. Our work 
provides evidence to show that the similarity of clinical concepts depends on a patient’s health 
history, an insight that can help guide future semantic similarity work for the clinical domain.  Our 
method for identifying context-specific similar concept can be used as a pre-processing step in 
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many clinical NLP applications.  In addition, we contribute a novel way of combining insights from 
text written by clinicians and from ontological concept definitions and locations. 
• Demonstrating EHR biases in laboratory tests using missingness patterns. In Aim II, we show 
that surprisingly, there is often little shared information between laboratory test values and the 
laboratory test’s rate of measurement in time. Furthermore, measurement patterns are useful 
features to use in disease modeling and they can result from a combination of hospital workflow 
practices and clinical states. When the clinical and documentation biases are not in concert (as is 
often the case with laboratory tests used for multiple purposes), EHR-driven association studies 
may produce biased results. We catalogued the measurement dynamics of laboratory tests into three 
motifs, one of which has mixed patterns of measurement and is prone to biases. For the re-use of 
clinical data to facilitate novel data-driven informatics research, understanding salient features and 
correcting for EHR biases is a necessary step. We demonstrate and present a method for how to 
control for the biases by disambiguating patient health states based on laboratory measurement 
frequency, using the laboratory test lipase and acute pancreatitis as an illustrative example.  With 
this work we show that incorporating the temporality of laboratory tests, and specifically by 
capturing the phenomenon of irregular sampling and missing data, we can better understand the 
clinical state of a patient.  Laboratory tests were used to demonstrate the usefulness of missingness 
patterns, however this intuition can be applied to other clinical data as well, such as diagnosis or 
procedure codes. 
• Identifying HbA1c overutilization using temporal distribution analytics. With the growing 
interest in detecting redundant and inappropriate laboratory test utilization (Zhi et al. 2013; Bates et 
al. 1998), we apply the methodology and insight learned in Aim II to identify overutilization of 
HbA1c in a large academic medical center. The methods described in this study can easily be 
replicated to other high-volume tests. As more data-derived patterns of use are detected across labs, 
we can start to better understand key aspects of clinicians' workflow and what informatics solutions 
can be put in place to support clinicians for quality care all the while ensuring cost effectiveness. 
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• Creating a probabilistic model to learn computational representations of disease across 
heterogeneous EHR data types.   We show that latent variable models can be leveraged to handle 
some issues with EHR data. For instance, the model’s probabilistic framework enables modeling 
and reasoning over uncertain data; they can handle sparse data; they come equipped with 
mechanisms for tractable and scalable computation, and many of them are able to produce 
interpretable results.  Aim III details the creation of a new latent variable model that uses 
probabilistic graphical modeling techniques for identifying salient parts of patient records. We 
show that learning phenotypes directly from raw and heterogeneous patient records by separately 
but jointly modeling different EHR data types, is able to automatically derive coherent and useful 
computational models of disease. 
• Display a methodology for combining data from different and disparate EHR systems.  The 
methods used to create the Phenome model are capable of combining data from different EHR 
systems to create a unified patient summary.  The input patient data to the Phenome model was 
derived from two different systems used by Columbia University physicians: SCM CROWN and 
Allscripts.  This work demonstrates the potential for probabilistic graphical models to easily 
integrate and aggregate data from separate EHR systems which is an important contribution to the 
Health Information Exchange initiatives across the nation. 
• Presenting a method to enhance computational models of disease with clinical knowledge. The 
informatics community has invested a lot of effort in creating large and comprehensive ontological 
repositories of clinical knowledge.  We describe a method for automatically leveraging the 
relationships in these ontologies when phenotyping directly from EHR data. We show how 
providing informative priors derived from clinical ontologies can help guide unsupervised mixture 
models to identify more coherent and cohesive phenotypes. 
• Identifying challenges in topic model evaluation for the clinical domain. The machine learning 
community has developed some algorithms for automatic evaluation of topic models and 
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demonstrated that they correlate with human judgment of coherence. In our work, we show that this 
result may not be applicable to clinical data.  We find that clinical expert knowledge does not 
correlate with the automated measures of coherence and that healthcare process detritus that exists 
in patient records (formulaic note structure, copy and paste redundancy, etc) can create phenotypes 
that automated methods mark as highly coherent but are clinically irrelevant. 
• Designing a new method for high-throughput cohort identification from EHR data. The 
Grounded Phenome model built and discussed in this thesis can provide a new avenue for 
phenotyping from EHR data. We show that the GPhenome model can identify cohorts as well as 
well-established rule-based algorithms but with additional benefits such as limited expert 
involvement, the ability to identify many cohorts at once, and the ranking of patients by disease 




We acknowledge that there exist many limitations to the studies explored in this thesis.  The 
specific limitations are listed and described below:  
• Ontology Usage. For many studies reported in this work, we rely on ontological knowledge to 
enhance our data-driven techniques.  For the work on reducing textual redundancy, we depend on 
accurate relationships between concepts and up to date definitions for each SNOMED-CT concept.  
In the grounding of the Phenome model, we assume the links between diseases and observations 
(medications, laboratory tests, diagnosis codes), are current and comprehensive.  Errors that may 
exist in the ontologies would propagate into our methods and potentially hurt the modeling results. 
• Procedure Code Absence. The work in this thesis explores characteristics of four different EHR 
data types: clinical notes, ICD-9 codes, prescribed medications, and ordered laboratory tests. The 
thesis also presents a method for unsupervised grouping of these data.  However, it is clear that 
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many important clinical events are encoded in procedure codes, most often using the Current 
Procedural Terminology (CPT).  In our work, we did not include procedural data and this exclusion 
potentially limited our ability to learn cohesive and comprehensive phenotypes.  The addition of 
procedure codes could be especially powerful for phenotypes that have well-defined procedures 
associated with them.   
• Text Processing. The preprocessing of textual data and extraction of variables is crucial for much 
of the work in this thesis.  We used HealthTermFinder as the clinical NLP software to perform 
processing such as chunking, parsing, and named-entity recognition. As clinical text is highly 
unstructured and has varied grammar, the software is imperfect.  We recognize that the 
imperfection at the text processing phase is carried through the work and can account for errors and 
signal dilution in many of studies described.  We also made two other modeling choices that affect 
the study results: a bag-of-words assumption and removal of modifers.  We use the processed text 
in a bag-of-words fashion which does not preserve the word order and additionally, we chose not to 
capture concept modifiers that appear in the text.  These design choices give us the ability to 
represent the frequency and co-occurrence of various medical concepts, however negation and 
subtle meaning may be lost due to these simplifying assumptions. 
• Generalizability. Much of the work conducted in this thesis is carried out in a single institution. 
We applied some of our methods to another dataset (MIMIC ICU) and have presented institution-
agnostic methods and workflows. However, we recognize that while the populations we study are 
large, our findings may be limited by the data within our data warehouse.  Additionally, in the 
laboratory tests biases study, we acknowledge the limitation of using only one test to demonstrate 
the measurement gap biases. We only present the lipase and acute pancreatitis association study as 
a single proof-of-concept example to exhibit the potential importance of separating laboratory test 
values by measurement pattern. Finally, we recognize that using the Medical Entities Dictionary 
(MED) as the terminology for laboratory tests limits the generalizability of the GPhenome model.  
Known laboratory test to disease associations were easily available through the MED and although 
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there is an older version of the MED incorporated into UMLS, we recognize that using the more 
standard Logical Observation Identifiers Names and Codes (LOINC) vocabulary would increase the 
reproducibility of this work. 
• Heuristics. Within some of the work in this thesis, we chose heuristic-based thresholds.  In the 
concept aggregation research, we implemented a cutoff for note-based similarity at 75%. This 
threshold was set by looking at the curve of the similarity values and picking enough to 
demonstrate the methodology and provide the annotators with a manageable set of pairs to evaluate. 
Similarly, we chose the 3-day threshold for the laboratory test biases study by examining the 
histogram of days between consecutive measurements. Finally, in the cohort-identification study, 
the 1% threshold for choosing patients as diabetic cases was determined by inspecting the 
distribution of phenotype weights across the entire population.  In future work, finding data-driven 
ways to substantiate these different thresholds will be important. 
• Temporality.  Although we demonstrate in Chapter 4 that temporal features are very important for 
modeling EHR data, the Phenome model is currently designed to work on slices of patient records 
when the patient is at a relatively stable health status. It is possible to simulate a changing patient 
phenotype by running the Phenome model on discrete time windows within a patient record, but 
ideally, the Phenome model would be augmented to fully understand the evolution of health states 
in a patient. We fully acknowledge that developing a model, which overlooks the temporal 
component present in EHR data, is a large limitation in our work.  
 
7.4 Future Work 
The findings reported in this thesis along with the current methodological limitations point to many 
different directions for future research.  We present a set of interesting problems for future examination 
below. 
• Combining insights and methods from all three Aims.  The goal of this thesis is to create different 
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methods for dealing with quirks and pathologies of EHR data, specifically in the context of EHR 
summarization.  Combining the work from these different studies is an exciting arena for future 
research.  The concept aggregation techniques can be applied as pre-processing for the Phenome 
model.  Applying the redundancy removal technique to clinical notes and thereby reducing the 
dimensionality of the input text can help guide the Phenome model to produce more coherent and 
interpretable results.  Additionally, as we have shown, laboratory tests contain significant information 
both in their numerical value and in their sampling frequency.  Incorporating this insight in the 
Phenome model can be done in multiple ways.  We can pre-process laboratory tests to separate them 
into different sampling frequencies or identify a way to model laboratory measurement patterns along 
with laboratory test values.  The joint modeling proposal is both an interesting technical challenge that 
may reveal more latent structure and associations between measurement patterns and patient diseases. 
Finally, including other data (such as flowsheets, vital signs, demographics, procedure codes, etc.) into 
the Phenome model structure may yield different and exciting insights into disease pathologies and 
phenotype structure that exists in EHR patient populations. 
• Beyond bi-directional, pairwise similarity.  When examining the pairs of similar concepts produced 
by our method in Aim I, we noticed potential for expanding our method to higher dimensions of 
similarity and clustering concepts. The pairwise similarity often produced triangulated results, which 
suggest clustering could be carried out as an extension of the pairwise similarity methodology to 
identify groups of concepts that are semantically similar enough to be aggregated. For instance, we 
located multiple triplets (three concepts vaguely describing the same concept with each pair achieving 
high similarities) and one five-pair cluster with the five different concepts describing sputum of 
different colors (yellow, green, brown, clean, and white).  We found each of the 10 combination pairs 
scoring similar.   Extending the method to find clusters of similar concepts is exciting future work.  In 
addition, considering defining a direction of similarity as discussed by Kotlerman et al. to incorporate 
more pairs and pairs with a non-symmetric similarity (Kotlerman, Dagan, and Szpektor 2010) is an 
attractive area for further research. 
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• Increased Generalizability. Two large limitations to generalizability include (1) data-driven 
thresholding and (2) incorporation of more standard terminologies. Many of the studies described in 
this thesis relied on visual examination of different graphs to determine appropriate thresholding and 
filtering.  Applying techniques for density estimation, change-point analysis, or appropriately fitting 
mixture models would result in more generalizable methodologies that can be applied in other 
institutions.  Using more standard terminologies for data types will also result in the broader 
applicability of the work – future work will focus on mapping laboratory tests to LOINC codes instead 
of MED codes.  
• Temporality in the Phenome Model. In its current version, the Phenome model does not explicitly 
encode any temporality about given patient records. Because longitudinal records and diseases 
themselves are often not time invariant (Pivovarov et al. 2014), and progress at different time 
resolutions, it is a non-trivial task to model temporality across all diseases at once. A simple approach 
to further the Phenome model work would include experimenting with incorporating temporality by 
inferring phenotypes over time, much like the approach of dynamic topic models( Blei and Lafferty 
2006). 
• Data-type specific modeling. Each of the considered data types in the Phenome model has specific 
characteristics that can be exploited further. The EHR text, especially when learning from several 
notes for each patient, has much redundancy that can be accounted for (Cohen et al. 2014). 
Medications and diagnosis codes are hierarchical in nature, with evidence that incorporating that 
structure helps in modeling clinical information (Perotte et al. 2011). Finally, each laboratory test has 
associated values, and it is clear that different distributions of the same test can describe different 
diseases; for instance, glucose with a distribution biased towards high values would belong to a 
phenotype describing diabetes, while glucose with a distribution with mean towards low values would 
be probable in a hypoglycemia phenotype.  
• Refinement of ontological grounding.  In this thesis we show that unsupervised disease modeling can 
 
159 
be influenced to learn more coherent phenotypes by grounding with informative priors.  The question 
of how best to employ grounding for this task remains future work.  For example, it may be important 
to augment the priors differently for different data types; as there are many more words than laboratory 
tests, grounding both with the same weight may give too much weight to laboratory tests.  In addition, 
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